https://www.3ctmeeting.com/3ct-2019 daily 0.75 2018-11-07 https://www.3ctmeeting.com/3ct-2019/2019/2/7/3ct monthly 0.5 2018-11-07 https://www.3ctmeeting.com/contact daily 0.75 2025-07-22 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/742a025d-c36d-41c9-a558-d3c5832fcc1f/Overcome-logo-transparent-1.png https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753201103625-3DX56KW9F6UH80Y2MZXO/unsplash-image-Z98lwUeoiRY.jpg https://www.3ctmeeting.com/registration daily 0.75 2025-07-21 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/b20aa6bc-1519-43f0-a63f-96b84d64076f/3CT+2022+Registration.png Registration - Démarquez-vous Quel que soit le cas, la façon dont vous racontez votre histoire en ligne peut faire toute la différence. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/b20aa6bc-1519-43f0-a63f-96b84d64076f/3CT+2022+Registration.png Registration - Démarquez-vous Quel que soit le cas, la façon dont vous racontez votre histoire en ligne peut faire toute la différence. https://www.3ctmeeting.com/venue daily 0.75 2018-10-25 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1539093469029-B8I02QJ6JPDJS5G1305A/CVCT%2B-%2BJason%2BDixson%2BPhotography%2B-%2B135723%2B-%2B3594.jpg Venue https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1539093469029-B8I02QJ6JPDJS5G1305A/CVCT%2B-%2BJason%2BDixson%2BPhotography%2B-%2B135723%2B-%2B3594.jpg Venue https://www.3ctmeeting.com/how-to-get-there daily 0.75 2018-12-18 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1539093952628-5JRLG4TO0DDF5ET1FIG2/static1.squarespace.jpg How to get there https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1539093952628-5JRLG4TO0DDF5ET1FIG2/static1.squarespace.jpg How to get there https://www.3ctmeeting.com/parking daily 0.75 2018-10-18 https://www.3ctmeeting.com/committee daily 0.75 2025-12-07 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753174559492-1UBZ0H71O5LRZFXFTUKY/Michelle%252BChew%252B%252528Publication%252BInstagram%252529%252B%2525284%252529.jpg Scientific Committee - Alexandre Mebazaa https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753175169533-XUE3Z1574VKQ2DPW8FQ4/Michelle%2BChew%2B%2528Publication%2BInstagram%2529%2B%25281%2529.png Scientific Committee - Michelle Chew https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753175209803-NPE5K2R2U42YLSQNKD70/Michelle%2BChew%2B%2528Publication%2BInstagram%2529.png Scientific Committee - Sean Collins https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753175740895-7ABSWOQTLHS45G95JBG6/Michelle%2BChew%2B%2528Publication%2BInstagram%2529%2B%25281%2529.png Scientific Committee - Naoki Sato https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753175773566-AF40BK1OL3AFYWEF4GHY/Michelle%2BChew%2B%2528Publication%2BInstagram%2529%2B%25282%2529.png Scientific Committee - Michael Matthay https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753175796231-XMOWUBAEBX09WRE466BK/Michelle%2BChew%2B%2528Publication%2BInstagram%2529%2B%25283%2529.png Scientific Committee - Susanna Price https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1765126189752-7SPX223UJDD4GW65Y4OT/David.png Scientific Committee - David Morrow https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1765126189818-ZOCO7O84BBMI3YGK3AGS/Manreet.png Scientific Committee - Manreet Kanwar https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770190180927-TH51SWRGJTMXC6XTT7SP/Fran%C3%A7ois.png Scientific Committee - Bruno François CHU de Limoges, Limoges, FRA https://www.3ctmeeting.com/2023-program daily 0.75 2023-11-16 https://www.3ctmeeting.com/terms-of-use daily 0.75 2019-04-04 https://www.3ctmeeting.com/home daily 1.0 2026-02-09 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1619609160046-EESTQFLWRAG3QQ0M7XKP/Mebazaa+2.jpg Home https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1768494519931-HNC60G3HR8T5IS567Y3Z/David%2B%25281%2529.png Home - Alexandre Mebazaa Université Paris Cité Paris, FRA https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1768494228317-ZH3MCAWBL5G84KPQ5CMB/susanna+price.webp Home - Susanna Price Royal Brompton Hospital London, GBR https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1768494229730-FJGLV6JI330T11LLC9OR/Sean+Collins.webp Home - Sean Collins Vanderbilt University Medical Center Nashville, USA https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1768494230460-4RHFYCKXFCQ6LBPHL2HR/Michelle%2BChew%2B29%2B29.webp Home - Michelle Chew Linköping University Hospital Malmö, SWE https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1768494228427-GKF7W79MXW9Y1731532B/michael+matthay.webp Home - Michael Matthay University of California San Francisco, USA https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1768494227179-8051I1CZUQFBO3V0RK2V/Manreet+kanwar.webp Home - Manreet Kanwar University of Chicago Pritzker Chicago, USA https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1768494229343-I1WEDMG0142H4Z7IE6WU/Naoki+Sato.webp Home - Naoki Sato Kawaguchi Cardiovascular and Respiratory Hospital Tokyo, JPN https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1768494227233-WO0VMBKQAWLV0NSIBQKG/david+morrow.webp Home - David Morrow Brigham and Women’s Hospital Boston, USA https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770190067412-DIRTUV45MP6XAYDGXGWN/Fran%C3%A7ois.png Home - Bruno François CHU de Limoges Limoges, France https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/358c9965-4fb9-4953-9630-8c7882a752aa/FDA-Logo.png https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/776e7e5d-b624-44eb-af8a-e3ee9174b486/Design+sans+titre+%2810%29.jpg https://www.3ctmeeting.com/cookies-policy daily 0.75 2018-10-18 https://www.3ctmeeting.com/partnership daily 0.75 2025-07-22 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/f9ab72c4-5cf2-415a-bf43-e0dac640cc7a/Visuals+for+Website+3CT+%282%29.png Partnership - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/f9ab72c4-5cf2-415a-bf43-e0dac640cc7a/Visuals+for+Website+3CT+%282%29.png Partnership - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/987ea09d-74ad-456c-83b1-c7e40d5baf01/Visuals+for+Website+3CT+%281%29.png Partnership - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1748874254630-X2BS77KPA3UGB38XEUX0/Advocate%2BPartner%2B%252811%2529.jpg Partnership https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1748874289291-BU9YL4C6FJK1VQRAWMAX/Advocate%252BPartner%252B%25252812%252529.jpg Partnership https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6a5f6ddd-0de6-444d-a0dd-aa113e59b1ab/Supporter+Partner+%284%29.jpg Partnership - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1748873918005-NYS081BYY7H4U1J8NYSN/Contributor%2BPartener.jpg Partnership https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1748873946175-5GWL7N00CIOWI6TSY0IE/Contributor%252BPartener%252B%2525285%252529.jpg Partnership https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1748873905144-TQD384A2ZDRYS5J90IJ9/Contributor%2BPartener%2B%25281%2529.jpg Partnership https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1748873966012-3MIDXUKGMB9NT0TJR19B/Contributor%2BPartener%2B%25286%2529.jpg Partnership https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1748873996967-M58M25JG6SQ0J1VQPLU0/Contributor%252BPartener%252B%2525287%252529.jpg Partnership https://www.3ctmeeting.com/evaluation-21 daily 0.75 2020-03-13 https://www.3ctmeeting.com/csw-program daily 0.75 2023-11-16 https://www.3ctmeeting.com/live daily 0.75 2023-06-07 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1625653389045-J1FLJR94XJQSD6ACJKQR/overcome+111729-2-68-Edit.jpg Live - THE 3CT IS NOW LIVE. CLICK HERE TO ACCESS https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1625653389045-J1FLJR94XJQSD6ACJKQR/overcome+111729-2-68-Edit.jpg Live - THE 3CT IS NOW LIVE. CLICK HERE TO ACCESS https://www.3ctmeeting.com/evaluation-2021 daily 0.75 2021-09-07 https://www.3ctmeeting.com/reimbursement daily 0.75 2022-06-19 https://www.3ctmeeting.com/practical-information daily 0.75 2026-02-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/0247e6cd-96fd-4dca-85c5-f3ae01608c86/Guide+to+pre-record+your+presentation https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/827cc836-a55e-4566-b7cd-66268509fd88/2%5B1%5D.png https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/44a4d7f1-ca40-40de-8b04-cd163d217ef2/4%5B1%5D.png https://www.3ctmeeting.com/evaluation22 daily 0.75 2022-06-28 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1656390760371-3SGQ1KCYSL2Q44W9VYP2/unsplash-image-FlPc9_VocJ4.jpg Evaluation - How did we do? Drop below your feedback for this year’s 3CT and recommendations for next year’s edition. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1656390760371-3SGQ1KCYSL2Q44W9VYP2/unsplash-image-FlPc9_VocJ4.jpg Evaluation - How did we do? Drop below your feedback for this year’s 3CT and recommendations for next year’s edition. https://www.3ctmeeting.com/csworkshop daily 0.75 2023-03-09 https://www.3ctmeeting.com/poag daily 0.75 2023-06-07 https://www.3ctmeeting.com/csw-program-1 daily 0.75 2023-04-06 https://www.3ctmeeting.com/alexandre-mebazaa daily 0.75 2023-06-01 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c2b47897-e381-43ee-9d64-a3c1942af465/MEBAZAA+Alexandre.jpg Alexandre Mebazaa - Alexandre Mebazaa Lariboisière Hospital, University of Paris-Cité Paris, France Professor Mebazaa was appointed by the “UNIVERSITE PARIS CITE” as vice-dean of the International relations for the Health University of Paris in July 2021 and is also head of the anesthesia and critical care department of the Saint Louis-Lariboisière - Fernand Widal University Hospitals. Since January 2019, he heads the MASCOT (Cardiovascular Markers in Stressed CONdiTions - UMR-S 942) research unit, which is funded by INSERM and the University of Paris. His research interests include mechanisms of contractile impairment during acute heart failure and worldwide studies on biomarkers in acute cardiac insufficiency. He was a member or Chairman of several study steering committees such as SURVIVE, COMPOSE, TRUE-HF, FROG-ICU, Natrium, Strong-HF. He was cited as "most referenced researcher" for 2021. Since 2020 he has been the FHU PROMICE coordinator (Hospital-University Federation) and co-director for the project “Precision medicine for the comprehensive care of seriously ill patients”), the objectives of which are to show that precise phenotyping of patients associated with biophysical models and big data improve decision-making systems in the perioperative period. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c2b47897-e381-43ee-9d64-a3c1942af465/MEBAZAA+Alexandre.jpg Alexandre Mebazaa - Alexandre Mebazaa Lariboisière Hospital, University of Paris-Cité Paris, France Professor Mebazaa was appointed by the “UNIVERSITE PARIS CITE” as vice-dean of the International relations for the Health University of Paris in July 2021 and is also head of the anesthesia and critical care department of the Saint Louis-Lariboisière - Fernand Widal University Hospitals. Since January 2019, he heads the MASCOT (Cardiovascular Markers in Stressed CONdiTions - UMR-S 942) research unit, which is funded by INSERM and the University of Paris. His research interests include mechanisms of contractile impairment during acute heart failure and worldwide studies on biomarkers in acute cardiac insufficiency. He was a member or Chairman of several study steering committees such as SURVIVE, COMPOSE, TRUE-HF, FROG-ICU, Natrium, Strong-HF. He was cited as "most referenced researcher" for 2021. Since 2020 he has been the FHU PROMICE coordinator (Hospital-University Federation) and co-director for the project “Precision medicine for the comprehensive care of seriously ill patients”), the objectives of which are to show that precise phenotyping of patients associated with biophysical models and big data improve decision-making systems in the perioperative period. https://www.3ctmeeting.com/csw-comittee daily 0.75 2023-05-30 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/cb24b809-bc7c-4375-b2fb-5a6361302b75/Mebazaa%2B2.jpg CSW committee - Alexandre Mebazaa https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e3d02f12-690e-4ddd-81d9-357d7944fa17/22c05dde47d74f25bdddd51c1d290746.jpg CSW committee - Susanna Price https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/10863904-2b72-44e6-9a6a-db9e11cf0f1f/csm_Kardiologie_Holger_Thiele_d7336c4d42.jpg CSW committee - Holger Thiele https://www.3ctmeeting.com/sean-collins daily 0.75 2025-07-24 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/ee1543ae-15ab-48af-bdcc-5d470ca71c20/COLLINS+Sean.png Sean Collins - Sean Collins Vanderbilt University Medical Center Brentwood, USA Dr. Collins is Professor of Emergency Medicine and co-director of the Vanderbilt Coordinating Center, Associate Director of Clinical Trials in the Institute for Medicine and Public Health, and Director of the Center for Emergency Care Research and Innovation at Vanderbilt University Medical Center. His current research interests are in cardiovascular and acute care clinical trials. He has directed and served on several steering committees for international cardiovascular trials and has published over 200 peer-reviewed manuscripts often as first or senior author. He is currently PI of several federally funded cardiovascular and acute care clinical trials including 3 from NHLBI and 1 from PCORI. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/ee1543ae-15ab-48af-bdcc-5d470ca71c20/COLLINS+Sean.png Sean Collins - Sean Collins Vanderbilt University Medical Center Brentwood, USA Dr. Collins is Professor of Emergency Medicine and co-director of the Vanderbilt Coordinating Center, Associate Director of Clinical Trials in the Institute for Medicine and Public Health, and Director of the Center for Emergency Care Research and Innovation at Vanderbilt University Medical Center. His current research interests are in cardiovascular and acute care clinical trials. He has directed and served on several steering committees for international cardiovascular trials and has published over 200 peer-reviewed manuscripts often as first or senior author. He is currently PI of several federally funded cardiovascular and acute care clinical trials including 3 from NHLBI and 1 from PCORI. https://www.3ctmeeting.com/new-page-2 daily 0.75 2023-06-01 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1545145304653-EIO85I1S3JTMKZ6KFC8R/Laterre.jpg Pierre-François Laterre - Pierre-François Laterre Saint Luc University Hospital, UCL Brussels, Belgium Pierre-François Laterre is Chief of the Intensive Care Service at Saint-Luc University Hospital, Brussels, Belgium. His research interests centre on the management of severe sepsis and septic shock, ARDS but also severe pancreatitis and liver failure. He is a member of many national and international societies including the Belgian Intensive Care Society, the European Intensive Care Society, the Belgian Society of Infectology, the Society of Critical Care Medicine and the Belgian Society of Clinical Nutrition. He is a member of the scientific commission of the French Society of CCM. Dr Laterre is the author of over 180 papers. He is reviewer in Critical Care medicine, Intensive Care Medicine, Critical Care, European Respiratory Journal, Shock, Clinical Infectious Diseases, Arteriosclerosis, Thrombosis and Vascular Biology, American Journal of Respiratory and Critical Care medicine, American Journal of Infectious Diseases, European J. Internal Medicine, Cytokines. He is a member of BMC Infectious Diseases editorial board. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1545145304653-EIO85I1S3JTMKZ6KFC8R/Laterre.jpg Pierre-François Laterre - Pierre-François Laterre Saint Luc University Hospital, UCL Brussels, Belgium Pierre-François Laterre is Chief of the Intensive Care Service at Saint-Luc University Hospital, Brussels, Belgium. His research interests centre on the management of severe sepsis and septic shock, ARDS but also severe pancreatitis and liver failure. He is a member of many national and international societies including the Belgian Intensive Care Society, the European Intensive Care Society, the Belgian Society of Infectology, the Society of Critical Care Medicine and the Belgian Society of Clinical Nutrition. He is a member of the scientific commission of the French Society of CCM. Dr Laterre is the author of over 180 papers. He is reviewer in Critical Care medicine, Intensive Care Medicine, Critical Care, European Respiratory Journal, Shock, Clinical Infectious Diseases, Arteriosclerosis, Thrombosis and Vascular Biology, American Journal of Respiratory and Critical Care medicine, American Journal of Infectious Diseases, European J. Internal Medicine, Cytokines. He is a member of BMC Infectious Diseases editorial board. https://www.3ctmeeting.com/michael-matthay daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/f2361239-1bf2-436e-a367-03538c09989a/Matthay+Michael.jpg Michael Matthay - Michael Matthay University of California San Francisco San Francisco, United States Michael A. Matthay, MD is Professor of Medicine and Anesthesia at the University of California at San Fransisoc, Senior Associate at the Cardiovascular Research Institute and Associate Director of Critical Care Medicine. He received his AB from Harvard University and his MD from the University of Pennsylvania School of Medicine. He received an ATS award for Scientific Achievement in 2002, the UCSF Award for Outstanding Clinical Research in 2006, Honora Causa from the University of Paris (2011), Lifetime Achievement award for Mentoring at UCSF (2013), the Trudeau Medal for research, teaching and clinical contributions from the American Thoracic Society (2014). He is a member of the American Association of Physicians (2001). He also received the UCSF Molecular Medicine Mentor of the Year (2016), the SMART award for Innovative Research Contributions (Milan, Italy) (2019) and the UCSF School of Medicine Inquiry Award for Long Term Mentoring (2021). Research interests include basic and clinical studies of sepsis and ARDS, and leading NIH funded clinical trials. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/f2361239-1bf2-436e-a367-03538c09989a/Matthay+Michael.jpg Michael Matthay - Michael Matthay University of California San Francisco San Francisco, United States Michael A. Matthay, MD is Professor of Medicine and Anesthesia at the University of California at San Fransisoc, Senior Associate at the Cardiovascular Research Institute and Associate Director of Critical Care Medicine. He received his AB from Harvard University and his MD from the University of Pennsylvania School of Medicine. He received an ATS award for Scientific Achievement in 2002, the UCSF Award for Outstanding Clinical Research in 2006, Honora Causa from the University of Paris (2011), Lifetime Achievement award for Mentoring at UCSF (2013), the Trudeau Medal for research, teaching and clinical contributions from the American Thoracic Society (2014). He is a member of the American Association of Physicians (2001). He also received the UCSF Molecular Medicine Mentor of the Year (2016), the SMART award for Innovative Research Contributions (Milan, Italy) (2019) and the UCSF School of Medicine Inquiry Award for Long Term Mentoring (2021). Research interests include basic and clinical studies of sepsis and ARDS, and leading NIH funded clinical trials. https://www.3ctmeeting.com/new-page daily 0.75 2023-06-01 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c6d74c0e-06f9-4e1b-8040-47882903c0de/PRICE+Susanna.jpg Susanna Price - Susanna Price Royal Brompton & Harefield Hosptials, NHS London, UK Professor Susanna Price is a consultant Cardiologist and Intensivist at the Royal Brompton Hospital where she is lead for the Combined Guy’s & St Thomas’, Royal Brompton & Harefield Cardiogenic Shock Programme. She is Professoressor of cardiology and intensive care, National Heart & Lung Institute, Imperial College London. Susanna is a Board Member, Councillor and Chair of the ESC Education Committee, previous President of the ESC ACVC, and sits on numerous ESC Committees and the ALS subcommittee of RCUK. She has been awarded Honorary Membership of the ESICM in recognition of her contribution to the specialty of critical care. She is a Deputy Editor of the European Heart Journal & has been a member of numerous Task Forces relating to international guidelines & position papers including heart failure, valvular disease, endocarditis, non-cardiac surgery, pulmonary hypertension, pericardial disease, cardiovascular disease in pregnancy and ACHD, ECMO, and echocardiography in critical care. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c6d74c0e-06f9-4e1b-8040-47882903c0de/PRICE+Susanna.jpg Susanna Price - Susanna Price Royal Brompton & Harefield Hosptials, NHS London, UK Professor Susanna Price is a consultant Cardiologist and Intensivist at the Royal Brompton Hospital where she is lead for the Combined Guy’s & St Thomas’, Royal Brompton & Harefield Cardiogenic Shock Programme. She is Professoressor of cardiology and intensive care, National Heart & Lung Institute, Imperial College London. Susanna is a Board Member, Councillor and Chair of the ESC Education Committee, previous President of the ESC ACVC, and sits on numerous ESC Committees and the ALS subcommittee of RCUK. She has been awarded Honorary Membership of the ESICM in recognition of her contribution to the specialty of critical care. She is a Deputy Editor of the European Heart Journal & has been a member of numerous Task Forces relating to international guidelines & position papers including heart failure, valvular disease, endocarditis, non-cardiac surgery, pulmonary hypertension, pericardial disease, cardiovascular disease in pregnancy and ACHD, ECMO, and echocardiography in critical care. https://www.3ctmeeting.com/new-page-4 daily 0.75 2023-06-02 https://www.3ctmeeting.com/evaluation-23 daily 0.75 2025-07-07 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/d43c8cdb-13c7-4054-8335-72aeeb215bce/Thank+you%21+%285%29.gif Evaluation - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/d43c8cdb-13c7-4054-8335-72aeeb215bce/Thank+you%21+%285%29.gif Evaluation - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.3ctmeeting.com/scientific-program-copy daily 0.75 2024-01-29 https://www.3ctmeeting.com/scientific-program-copy-1 daily 0.75 2024-01-29 https://www.3ctmeeting.com/alexandre-mebazaa-copy daily 0.75 2025-05-28 https://www.3ctmeeting.com/sean-collins-copy daily 0.75 2025-04-17 https://www.3ctmeeting.com/pierrefranois-laterre-copy daily 0.75 2025-04-17 https://www.3ctmeeting.com/michael-matthay-copy daily 0.75 2024-04-11 https://www.3ctmeeting.com/david-baran daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2ac308d7-81a8-4545-8106-17ce2f61712c/thumbnail_Baran_David_MD_CCF_5x7.jpg David Baran - David Baran Fort Lauderdale, United States David Baran, MD, FACC, FSCAI, FHFSA, Section Head of Advanced Heart Failure, Transplant and Mechanical Circulatory Support, Cleveland Clinic Weston Hospital. David A. Baran, MD, serves as Section Head of Advanced Heart Failure, Transplant and Mechanical Circulatory Support (MCS) at Cleveland Clinic Weston Hospital. Prior to joining Cleveland Clinic, Dr. Baran was System Director for Advanced Heart Failure, Transplant, and Mechanical Circulatory Support at Sentara Heart Hospital in Norfolk, Virginia. He also served for 14 years as Director of Heart Failure and Transplant Research at Newark Beth Israel Medical Center. Dr. Baran earned his undergraduate degree at Florida Atlantic University in Boca Raton and his medical degree at the University of South Florida Morsani College of Medicine in Tampa. He completed an internal medicine residency at Columbia Presbyterian Medical Center in New York City. His advanced training includes a clinical cardiology fellowship at New York’s Mount Sinai Medical Center and two fellowships at Columbia-Presbyterian Medical Center, one in congestive heart failure and another in transplant cardiology and mechanical assist device. As a clinical researcher, Dr. Baran is largely focused on transplant immunosuppression and the management of cardiogenic shock including device therapies. He led the team that created the SCAI Shock classification system, which is used worldwide to describe the severity of cardiogenic shock. His research consists of co-authoring more than 120 peer-reviewed articles, publishing 150 abstracts, and conducting more than 125 lectures/presentations. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2ac308d7-81a8-4545-8106-17ce2f61712c/thumbnail_Baran_David_MD_CCF_5x7.jpg David Baran - David Baran Fort Lauderdale, United States David Baran, MD, FACC, FSCAI, FHFSA, Section Head of Advanced Heart Failure, Transplant and Mechanical Circulatory Support, Cleveland Clinic Weston Hospital. David A. Baran, MD, serves as Section Head of Advanced Heart Failure, Transplant and Mechanical Circulatory Support (MCS) at Cleveland Clinic Weston Hospital. Prior to joining Cleveland Clinic, Dr. Baran was System Director for Advanced Heart Failure, Transplant, and Mechanical Circulatory Support at Sentara Heart Hospital in Norfolk, Virginia. He also served for 14 years as Director of Heart Failure and Transplant Research at Newark Beth Israel Medical Center. Dr. Baran earned his undergraduate degree at Florida Atlantic University in Boca Raton and his medical degree at the University of South Florida Morsani College of Medicine in Tampa. He completed an internal medicine residency at Columbia Presbyterian Medical Center in New York City. His advanced training includes a clinical cardiology fellowship at New York’s Mount Sinai Medical Center and two fellowships at Columbia-Presbyterian Medical Center, one in congestive heart failure and another in transplant cardiology and mechanical assist device. As a clinical researcher, Dr. Baran is largely focused on transplant immunosuppression and the management of cardiogenic shock including device therapies. He led the team that created the SCAI Shock classification system, which is used worldwide to describe the severity of cardiogenic shock. His research consists of co-authoring more than 120 peer-reviewed articles, publishing 150 abstracts, and conducting more than 125 lectures/presentations. https://www.3ctmeeting.com/mir-babar-basir daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/09ac3a74-d330-482d-99ea-3281da315d58/Basir+Babar.jpg Mir Babar Basir - Mir Babar Basir Detroit, USA Dr. Babar Basir, DO, FACC, FSCAI is an interventional cardiologist at Henry Ford Health. He serves as the Director of the STEMI Program and the Director of the Acute Mechanical Circulatory Support Program at Henry Ford Hospital. His specializes in the treatment of complex coronary interventions, including chronic total occlusion interventions and the use of mechanical circulatory support devices. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/09ac3a74-d330-482d-99ea-3281da315d58/Basir+Babar.jpg Mir Babar Basir - Mir Babar Basir Detroit, USA Dr. Babar Basir, DO, FACC, FSCAI is an interventional cardiologist at Henry Ford Health. He serves as the Director of the STEMI Program and the Director of the Acute Mechanical Circulatory Support Program at Henry Ford Hospital. His specializes in the treatment of complex coronary interventions, including chronic total occlusion interventions and the use of mechanical circulatory support devices. https://www.3ctmeeting.com/mona-fiuzat daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3264d522-45d7-40fc-81b8-29dfcfc9ad84/Dr_Fiuzat_IMG_9886.jpg Mona Fiuzat - Mona Fiuzat Arlington, United States Mona Fiuzat, PharmD, FACC, FHFA, FHFSA is an Associate Professor of Medicine at Duke University, Senior Scientific Advisor for FDA, Division of Cardiology and Nephrology (CDER, DCN), former Executive Editor and current editorial consultant for JACC: Heart Failure, and former Senior Scientific Advisor to the FDA Commissioner. Her clinical research experience has been in clinical trials with a focus on pharmacogenetics in heart failure, and she helped file an NDA for the first proposed pharmacogenetically targeted heart failure drug. She worked in the Heart Failure research program at Duke on a number of key clinical trials as an investigator and steering committee member, and has authored or co-authored over 100 papers in the field of heart failure. Most recently, she helped develop and facilitate the “Heart Failure Collaboratory”, an effort of government agencies, academicians, patients, societies and payers to improve heart failure research and therapeutic development. She is a former Program Chair for the Heart Failure Society of America’s (HFSA) Scientific Sessions, former Membership Co-Chair, Research Network Taskforce, and served on the HFSA Board of Directors including officer roles as HFSA Secretary and Treasurer. She has also served on the ACC Education and Outcomes Committee, and AHA Nominations Committee. She was the recipient of the 2019 ACC Distinguished Associate Award. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3264d522-45d7-40fc-81b8-29dfcfc9ad84/Dr_Fiuzat_IMG_9886.jpg Mona Fiuzat - Mona Fiuzat Arlington, United States Mona Fiuzat, PharmD, FACC, FHFA, FHFSA is an Associate Professor of Medicine at Duke University, Senior Scientific Advisor for FDA, Division of Cardiology and Nephrology (CDER, DCN), former Executive Editor and current editorial consultant for JACC: Heart Failure, and former Senior Scientific Advisor to the FDA Commissioner. Her clinical research experience has been in clinical trials with a focus on pharmacogenetics in heart failure, and she helped file an NDA for the first proposed pharmacogenetically targeted heart failure drug. She worked in the Heart Failure research program at Duke on a number of key clinical trials as an investigator and steering committee member, and has authored or co-authored over 100 papers in the field of heart failure. Most recently, she helped develop and facilitate the “Heart Failure Collaboratory”, an effort of government agencies, academicians, patients, societies and payers to improve heart failure research and therapeutic development. She is a former Program Chair for the Heart Failure Society of America’s (HFSA) Scientific Sessions, former Membership Co-Chair, Research Network Taskforce, and served on the HFSA Board of Directors including officer roles as HFSA Secretary and Treasurer. She has also served on the ACC Education and Outcomes Committee, and AHA Nominations Committee. She was the recipient of the 2019 ACC Distinguished Associate Award. https://www.3ctmeeting.com/michelle-chew daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/d4410c0f-daa5-4897-bd6e-239c5ff90f4a/MichelleChewLiU3smalll.png Michelle Chew - Michelle Chew Malmö, Sweden Michelle Chew is Academic Chair and Professor in Anaesthesiology, Intensive Care and Acute Care at Linköping University Hospital, Sweden. Professor Chew’s research interests revolve around the heart in the high-risk patient, perioperatively and during critical illness. Additional research focuses on perioperative outcomes and echocardiography in the critically ill. She is an executive member of the Swedish Perioperative Registry, the Scandinavian Clinical Practice Guidelines Committee, faculty member for the European Diploma of Advanced Echocardiography and the European Society of Anaesthesiology and Intensive Care where she chairs the Cardiodynamics section. Disclosures (last five years): Travel reimbursements and advisory and speaker’s fees for Edwards LifeSciences and AOP Health. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/d4410c0f-daa5-4897-bd6e-239c5ff90f4a/MichelleChewLiU3smalll.png Michelle Chew - Michelle Chew Malmö, Sweden Michelle Chew is Academic Chair and Professor in Anaesthesiology, Intensive Care and Acute Care at Linköping University Hospital, Sweden. Professor Chew’s research interests revolve around the heart in the high-risk patient, perioperatively and during critical illness. Additional research focuses on perioperative outcomes and echocardiography in the critically ill. She is an executive member of the Swedish Perioperative Registry, the Scandinavian Clinical Practice Guidelines Committee, faculty member for the European Diploma of Advanced Echocardiography and the European Society of Anaesthesiology and Intensive Care where she chairs the Cardiodynamics section. Disclosures (last five years): Travel reimbursements and advisory and speaker’s fees for Edwards LifeSciences and AOP Health. https://www.3ctmeeting.com/alice-sacco daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2b85d037-86a5-45a5-8eb1-81bbe74e384a/PHOTO-2021-12-07-15-59-27+copia.jpg Alice Sacco - Alice Sacco Milan, Italy Dr. Alice Sacco, an intensivist cardiologist, has been working at the CICU of "De Gasperis" Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, since 2008. She obtained the "Lifelong II level Certification in Acute Cardiac Care" from the European Society of Cardiology in 2016. Her expertise lies in the management of acute coronary syndromes, myocarditis, pulmonary embolism and cardiogenic shock. Her research focuses on cardiogenic shock and pulmonary embolism, with a strong interest in end-of-life management and bioethics. She loves classical music and the mountains. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2b85d037-86a5-45a5-8eb1-81bbe74e384a/PHOTO-2021-12-07-15-59-27+copia.jpg Alice Sacco - Alice Sacco Milan, Italy Dr. Alice Sacco, an intensivist cardiologist, has been working at the CICU of "De Gasperis" Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, since 2008. She obtained the "Lifelong II level Certification in Acute Cardiac Care" from the European Society of Cardiology in 2016. Her expertise lies in the management of acute coronary syndromes, myocarditis, pulmonary embolism and cardiogenic shock. Her research focuses on cardiogenic shock and pulmonary embolism, with a strong interest in end-of-life management and bioethics. She loves classical music and the mountains. https://www.3ctmeeting.com/carolyn-rosner daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/41cb91f8-acdd-4c63-b4c3-3f531e942c85/Rosner+Carolyn.jpg Carolyn Rosner - Carolyn Rosner Inova, United States Carolyn Rosner, MSN, NP-C, MBA is the Director of Innovative Programs at Inova Heart and Vascular Institute, overseeing the strategy and operations of several cardiovascular programs, including ECMO, cardiogenic shock, complex coronary therapeutics and interventional heart failure. Clinical and research expertise encompasses the management of cardiogenic shock, complex coronary artery disease, as well as decompensated heart failure and adult congenital heart disease. She completed all of her nursing education at Marymount University, including an MSN with a concentration as a Family Nurse Practitioner in 2011, and completed an MBA in Health Care Management from the Johns Hopkins University’s Carey Business School. She is passionate about improving access, quality and value in cardiovascular care and improving the utilization of advanced practice providers in the health care system. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/41cb91f8-acdd-4c63-b4c3-3f531e942c85/Rosner+Carolyn.jpg Carolyn Rosner - Carolyn Rosner Inova, United States Carolyn Rosner, MSN, NP-C, MBA is the Director of Innovative Programs at Inova Heart and Vascular Institute, overseeing the strategy and operations of several cardiovascular programs, including ECMO, cardiogenic shock, complex coronary therapeutics and interventional heart failure. Clinical and research expertise encompasses the management of cardiogenic shock, complex coronary artery disease, as well as decompensated heart failure and adult congenital heart disease. She completed all of her nursing education at Marymount University, including an MSN with a concentration as a Family Nurse Practitioner in 2011, and completed an MBA in Health Care Management from the Johns Hopkins University’s Carey Business School. She is passionate about improving access, quality and value in cardiovascular care and improving the utilization of advanced practice providers in the health care system. https://www.3ctmeeting.com/christopher-oconnor daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/de79efdb-48d9-4968-822d-11b90ef60d6c/CMO+headshot.jpg Christopher O'Connor - Christopher O'Connor Falls Church, United States Dr. Christopher O’Connor is the President of the Inova Schar Heart and Vascular, a 5-hospital system that serves over 2 million people in the Northern Virginia / Washington, DC area. He is a Professor of Medicine in Cardiology at Duke University, and was previously the chief of the Division of Cardiology and director of the Duke Heart Center. Under his leadership, Duke Heart Center was ranked the #4 Heart Center in the country by U.S. News and World Report. Dr. O’Connor, who first joined the Duke faculty in 1989, is an internationally recognized cardiologist and authority on heart failure. His clinical investigations have dramatically expanded the understanding of numerous aspects of cardiac function and dysfunction, including the influence of depression and stress on heart failure patients. His research has led to profound insights into both pharmacologic and non-pharmacologic therapies to treat heart failure and has had a direct impact on the lives of thousands of patients. Dr. O’Connor was one of the first investigators to lead initiatives to study therapies in acute decompensated heart failure, which has led to a number of novel therapeutic interventions. He was the Principal Investigator of the landmark HF-ACTION clinical trial, which studied exercise training in more than 2,000 heart failure patients, and eventually led to a change in the international guidelines, change in the national reimbursement of cardiac rehabilitation for heart failure patients by CMS, and validation of two novel biomarkers that were later approved by the FDA. Dr. O’Connor was an editor of the textbook, Managing Acute Decompensated Heart Failure, the first one published on the topic. Founding editor-in-chief of the Journal of the American College of Cardiology: Heart Failure. Dr. O’Connor was elected as Master of the https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/de79efdb-48d9-4968-822d-11b90ef60d6c/CMO+headshot.jpg Christopher O'Connor - Christopher O'Connor Falls Church, United States Dr. Christopher O’Connor is the President of the Inova Schar Heart and Vascular, a 5-hospital system that serves over 2 million people in the Northern Virginia / Washington, DC area. He is a Professor of Medicine in Cardiology at Duke University, and was previously the chief of the Division of Cardiology and director of the Duke Heart Center. Under his leadership, Duke Heart Center was ranked the #4 Heart Center in the country by U.S. News and World Report. Dr. O’Connor, who first joined the Duke faculty in 1989, is an internationally recognized cardiologist and authority on heart failure. His clinical investigations have dramatically expanded the understanding of numerous aspects of cardiac function and dysfunction, including the influence of depression and stress on heart failure patients. His research has led to profound insights into both pharmacologic and non-pharmacologic therapies to treat heart failure and has had a direct impact on the lives of thousands of patients. Dr. O’Connor was one of the first investigators to lead initiatives to study therapies in acute decompensated heart failure, which has led to a number of novel therapeutic interventions. He was the Principal Investigator of the landmark HF-ACTION clinical trial, which studied exercise training in more than 2,000 heart failure patients, and eventually led to a change in the international guidelines, change in the national reimbursement of cardiac rehabilitation for heart failure patients by CMS, and validation of two novel biomarkers that were later approved by the FDA. Dr. O’Connor was an editor of the textbook, Managing Acute Decompensated Heart Failure, the first one published on the topic. Founding editor-in-chief of the Journal of the American College of Cardiology: Heart Failure. Dr. O’Connor was elected as Master of the https://www.3ctmeeting.com/nathan-nielsen daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/a611e791-1140-4780-9c0d-91305db62c6c/NIELSEN+Nathan.jpg Nathan Nielsen - Nathan Nielsen Albuquerque, United States Nathan D. Nielsen, M.D., M.Sc., FCCM, is an Intensivist and Transfusion Medicine specialist presently based in Albuquerque, New Mexico in the United States. He is the International Representative for North America on the Council of the European Society of Intensive Care Medicine (ESICM), the Executive Editor of the ESICM Academy and Co-Chair of the Disseminated Intravascular Coagulation (DIC) Scientific and Standardization Committee of the International Society of Thrombosis and Hemostasis. He has been the Scientific Content Editor of the Global Sepsis Alliance since 2018, and has lectured on sepsis, blood transfusion, DIC, and other critical care topics on five continents. Dr. Nielsen has been a major contributor to several innovative global intensive care training initiatives and an active participant in several multinational sepsis therapeutic trials. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/a611e791-1140-4780-9c0d-91305db62c6c/NIELSEN+Nathan.jpg Nathan Nielsen - Nathan Nielsen Albuquerque, United States Nathan D. Nielsen, M.D., M.Sc., FCCM, is an Intensivist and Transfusion Medicine specialist presently based in Albuquerque, New Mexico in the United States. He is the International Representative for North America on the Council of the European Society of Intensive Care Medicine (ESICM), the Executive Editor of the ESICM Academy and Co-Chair of the Disseminated Intravascular Coagulation (DIC) Scientific and Standardization Committee of the International Society of Thrombosis and Hemostasis. He has been the Scientific Content Editor of the Global Sepsis Alliance since 2018, and has lectured on sepsis, blood transfusion, DIC, and other critical care topics on five continents. Dr. Nielsen has been a major contributor to several innovative global intensive care training initiatives and an active participant in several multinational sepsis therapeutic trials. https://www.3ctmeeting.com/antoine-kimmoun daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/718e45fe-976d-4b1c-8b8a-afe0188bd76e/Capture+d%27%C3%A9cran+2024-03-20+%C3%A0+19.06.30.jpg Antoine Kimmoun - Antoine Kimmoun Nancy, France Professor of intensive medicine and critical care since 2020, I work in a critical care unit specializing in the management of cardiogenic shock and cardiac assistance. My research themes are translational, ranging from acute heart failure to cardiogenic shock, with a particular focus on methodological issues https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/718e45fe-976d-4b1c-8b8a-afe0188bd76e/Capture+d%27%C3%A9cran+2024-03-20+%C3%A0+19.06.30.jpg Antoine Kimmoun - Antoine Kimmoun Nancy, France Professor of intensive medicine and critical care since 2020, I work in a critical care unit specializing in the management of cardiogenic shock and cardiac assistance. My research themes are translational, ranging from acute heart failure to cardiogenic shock, with a particular focus on methodological issues https://www.3ctmeeting.com/jason-katz daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/31b59d8e-b689-481d-9c81-cd60fc3dffb4/Image.jpeg Jason Katz - Jason Katz New York, USA Jason N. Katz MD, MHS, FACC, FAHA is a Professor of Medicine in the NYU Grossman School of Medicine. He is Associate Chief of Cardiology and Director of Inpatient Cardiology at Bellevue Hospital. In addition, he serves as Associate Director of the NYU LVAD Program and as Program Director for the NYU Advanced Heart Failure & Transplant Cardiology Fellowship. His research interests focus on optimizing the care of patients with cardiogenic shock, examining best practices for the use of temporary and durable mechanical circulatory support devices, and enhancing the delivery and quality of care within the contemporary cardiovascular ICU. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/31b59d8e-b689-481d-9c81-cd60fc3dffb4/Image.jpeg Jason Katz - Jason Katz New York, USA Jason N. Katz MD, MHS, FACC, FAHA is a Professor of Medicine in the NYU Grossman School of Medicine. He is Associate Chief of Cardiology and Director of Inpatient Cardiology at Bellevue Hospital. In addition, he serves as Associate Director of the NYU LVAD Program and as Program Director for the NYU Advanced Heart Failure & Transplant Cardiology Fellowship. His research interests focus on optimizing the care of patients with cardiogenic shock, examining best practices for the use of temporary and durable mechanical circulatory support devices, and enhancing the delivery and quality of care within the contemporary cardiovascular ICU. https://www.3ctmeeting.com/mahir-karakas daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/4070c985-d1f5-4e44-b10f-98ac4ce937f3/Karakas+Mahir.jpg Mahir Karakas - Mahir Karakas Hamburg, Germany Dr. Mahir Karakas is a 41-year-old specialist for cardiology, intensive care medicine, emergency medicine and genetic counseling at the University Medical Center Hamburg-Eppendorf in Germany. He is the designated “W3-Professoressor for translational research and innovative clinical trials” at the Hamburg University (Else Kroener-Fresenius-Foundation). His research ranges from issues related to the prevention of cardiovascular disease, biomarkers of cardiometabolic diseases to clinical pharmacology of cardiovascular compounds, and animal models of myocardial infarction. Furthermore, he is involved in multiple randomized multi-centre clinical trials evaluating the effects of new pharmacologic compounds in cardiometabolic diseases, infectious diseases and sepsis, and is the head of the steering committee of various multi-centre, randomized, double-blinded investigator-initiated trials in the field of acute coronary syndrome, atrial fibrillation, heart failure, cardiogenic shock, COVID-19, ARDS, and sepsis. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/4070c985-d1f5-4e44-b10f-98ac4ce937f3/Karakas+Mahir.jpg Mahir Karakas - Mahir Karakas Hamburg, Germany Dr. Mahir Karakas is a 41-year-old specialist for cardiology, intensive care medicine, emergency medicine and genetic counseling at the University Medical Center Hamburg-Eppendorf in Germany. He is the designated “W3-Professoressor for translational research and innovative clinical trials” at the Hamburg University (Else Kroener-Fresenius-Foundation). His research ranges from issues related to the prevention of cardiovascular disease, biomarkers of cardiometabolic diseases to clinical pharmacology of cardiovascular compounds, and animal models of myocardial infarction. Furthermore, he is involved in multiple randomized multi-centre clinical trials evaluating the effects of new pharmacologic compounds in cardiometabolic diseases, infectious diseases and sepsis, and is the head of the steering committee of various multi-centre, randomized, double-blinded investigator-initiated trials in the field of acute coronary syndrome, atrial fibrillation, heart failure, cardiogenic shock, COVID-19, ARDS, and sepsis. https://www.3ctmeeting.com/sarah-gorgis daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/10f7c1c0-676e-4ed4-8713-ba1d0999cc1f/Gorgis+Sarah.jpg Sarah Gorgis - Sarah Gorgis Cleveland, United States Sarah Gorgis MD is a Cardiac Intensivist at Henry Ford Hospital in Detroit, Michigan. She served as Chief Medical Resident and Chief Cardiology Fellow at Henry Ford Hospital and went on to do Critical Care Medicine training at the Cleveland Clinic. She was an investigator with the National Cardiogenic Shock Initiative and has participated in many prospective trials involving acute myocardial infarction and cardiogenic shock. Her clinical interests are in managing complex mixed shock, optimizing ventilator settings in cardiogenic shock, mechanical support devices, RV dysfunction, antiplatelet therapy in AMICS, and cardiopulmonary exercise testing. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/10f7c1c0-676e-4ed4-8713-ba1d0999cc1f/Gorgis+Sarah.jpg Sarah Gorgis - Sarah Gorgis Cleveland, United States Sarah Gorgis MD is a Cardiac Intensivist at Henry Ford Hospital in Detroit, Michigan. She served as Chief Medical Resident and Chief Cardiology Fellow at Henry Ford Hospital and went on to do Critical Care Medicine training at the Cleveland Clinic. She was an investigator with the National Cardiogenic Shock Initiative and has participated in many prospective trials involving acute myocardial infarction and cardiogenic shock. Her clinical interests are in managing complex mixed shock, optimizing ventilator settings in cardiogenic shock, mechanical support devices, RV dysfunction, antiplatelet therapy in AMICS, and cardiopulmonary exercise testing. https://www.3ctmeeting.com/bruno-franois daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/dd9398b3-bea6-447e-80c3-3633a45d8044/FRANCOIS+Bruno.jpg Bruno François - Bruno François Limoges, France Dr. François is a critical care physician at the University Hospital of Limoges, France. He works in a 22 bed medical/surgical ICU and is the head of the Limoges Clinical Investigation Center of which main expertise is Infectious Diseases in critically ill patients. He has been national coordinator for numerous emergency trials especially in Sepsis and VAP, and has participated in several advisory boards for multinational trials, Clinical Evaluation Committees and Adjudication Committees. He is more specifically interested in new drugs and innovative strategies in critically ill patients. He is author of many publications in the ICU field especially about Sepsis and VAP and is also reviewer for several medical journals. He has an expertise in the bedside organization of clinical research in the ICU. He created the CRICS network and has lead the CRICS-TRIGGERSEP network which integrate all research activities in Sepsis from basic science to clinical trials. Since 2012, he is co-coordinating the COMBACTE-Net consortium. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/dd9398b3-bea6-447e-80c3-3633a45d8044/FRANCOIS+Bruno.jpg Bruno François - Bruno François Limoges, France Dr. François is a critical care physician at the University Hospital of Limoges, France. He works in a 22 bed medical/surgical ICU and is the head of the Limoges Clinical Investigation Center of which main expertise is Infectious Diseases in critically ill patients. He has been national coordinator for numerous emergency trials especially in Sepsis and VAP, and has participated in several advisory boards for multinational trials, Clinical Evaluation Committees and Adjudication Committees. He is more specifically interested in new drugs and innovative strategies in critically ill patients. He is author of many publications in the ICU field especially about Sepsis and VAP and is also reviewer for several medical journals. He has an expertise in the bedside organization of clinical research in the ICU. He created the CRICS network and has lead the CRICS-TRIGGERSEP network which integrate all research activities in Sepsis from basic science to clinical trials. Since 2012, he is co-coordinating the COMBACTE-Net consortium. https://www.3ctmeeting.com/debra-foster daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/890d2ea5-31c5-47de-867a-3e91ffdcb0fc/sepsis+heroes+2014+%282%29.jpg Debra Foster - Debra Foster Toronto, Canada Debra M. Foster, BSc spent 11 years as an RN in the adult critical care area. Thereafter Debra joined the critical care clinical research team at Toronto General Hospital. She was project lead for a multi-national, multi-center clinical trial, the MEDIC study. The data was used for a successful 510(k) de novo submission to the FDA for the Endotoxin Activity Assay (EAA). It was the first IVD for sepsis. Debra went on to follow the device to its commercial partner, Spectral Medical, Inc. She became VP of Clinical Development in 2011. Debra led many clinical research projects, including the MEDIC, EUPHRATES and TIGRIS clinical trials, aimed at endotoxin in critical illness. Currently, Debra is a clinical consultant for Spectral Medical. Debra has lectured to medical professionals on the topics of sepsis, endotoxin and clinical trials for sepsis and has been a co-author of more than 50 articles in peer-reviewed journals. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/890d2ea5-31c5-47de-867a-3e91ffdcb0fc/sepsis+heroes+2014+%282%29.jpg Debra Foster - Debra Foster Toronto, Canada Debra M. Foster, BSc spent 11 years as an RN in the adult critical care area. Thereafter Debra joined the critical care clinical research team at Toronto General Hospital. She was project lead for a multi-national, multi-center clinical trial, the MEDIC study. The data was used for a successful 510(k) de novo submission to the FDA for the Endotoxin Activity Assay (EAA). It was the first IVD for sepsis. Debra went on to follow the device to its commercial partner, Spectral Medical, Inc. She became VP of Clinical Development in 2011. Debra led many clinical research projects, including the MEDIC, EUPHRATES and TIGRIS clinical trials, aimed at endotoxin in critical illness. Currently, Debra is a clinical consultant for Spectral Medical. Debra has lectured to medical professionals on the topics of sepsis, endotoxin and clinical trials for sepsis and has been a co-author of more than 50 articles in peer-reviewed journals. https://www.3ctmeeting.com/allen-waziri daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/8507d042-e763-4041-ba9c-e0f3ffeb775a/Waziri+head+shot.jpg Allen Waziri - Allen Waziri iCE Neurosystems, USA Dr. Waziri is a neurosurgeon and translational neuroscientist. He is currently Co-Founder and CEO of iCE Neurosystems, a commercial-stage neurotech startup that provides a comprehensive device/software/data platform to revolutionize brain care in critically ill patients. He serves as Board Member, Scientific Advisor and consultant to a range of medtech and biotech companies in the neuro space. Dr. Waziri completed his clinical and research training at Columbia University and the National Institutes of Health. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/8507d042-e763-4041-ba9c-e0f3ffeb775a/Waziri+head+shot.jpg Allen Waziri - Allen Waziri iCE Neurosystems, USA Dr. Waziri is a neurosurgeon and translational neuroscientist. He is currently Co-Founder and CEO of iCE Neurosystems, a commercial-stage neurotech startup that provides a comprehensive device/software/data platform to revolutionize brain care in critically ill patients. He serves as Board Member, Scientific Advisor and consultant to a range of medtech and biotech companies in the neuro space. Dr. Waziri completed his clinical and research training at Columbia University and the National Institutes of Health. https://www.3ctmeeting.com/mireia-padilla-lopez daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3c90323f-44c9-4a8a-96b0-62dc3157da5f/FC3EBD9B-0FB6-40E5-83C6-EB3182D7B539_1_105_c.jpeg Mireia Padilla Lopez - Mireia Padilla Lopez Barcelona, Spain Dr. Padilla López is a Junior Consultant in the Cardiac Intensive Care Unit at Hospital de la Santa Creu i Sant Pau in Barcelona. She completed her cardiology specialty training at Hospital de la Santa Creu i Sant Pau, and in the last year, she conducted a research fellowship in Acute Cardiovascular Care at NYU Langone Health in New York. She is a member of the Young Association for Acute Cardiovascular Care of the European Society of Cardiology. Her research interests have focused on acute and critical care cardiology. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3c90323f-44c9-4a8a-96b0-62dc3157da5f/FC3EBD9B-0FB6-40E5-83C6-EB3182D7B539_1_105_c.jpeg Mireia Padilla Lopez - Mireia Padilla Lopez Barcelona, Spain Dr. Padilla López is a Junior Consultant in the Cardiac Intensive Care Unit at Hospital de la Santa Creu i Sant Pau in Barcelona. She completed her cardiology specialty training at Hospital de la Santa Creu i Sant Pau, and in the last year, she conducted a research fellowship in Acute Cardiovascular Care at NYU Langone Health in New York. She is a member of the Young Association for Acute Cardiovascular Care of the European Society of Cardiology. Her research interests have focused on acute and critical care cardiology. https://www.3ctmeeting.com/maciej-kostrubiec daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/b1d1902e-59c6-46fa-994f-50434f885ebf/KOSTRUBIEC+Maciej.jpg Maciej Kostrubiec - Maciej Kostrubiec EMA, Poland Prof. Maciej Kostrubiec, MD, PhD has been a cardiologist consultant at Mid and South Essex Hospital NHS Trust in the United Kingdom since 2019 and he is a lecturer at The Medical University of Warsaw, Fellow of the European Cardiac Society (FESC), and Fellow of European Association of Cardiovascular Imaging (FEACVI). Since 2012, he has been a subject matter expert at The Office for Registration of Medicinal Products in Poland and The European Medicines Agency (EMA). Also, a member of the EMA Cardiovascular Working Party of CHMP. Prof. Kostrubiec is an expert in the fields of right heart failure, especially secondary to venous thromboembolic disease and imaging cardiology including invasive investigations (RHC/LHC). Currently, in the UK he is primarily involved in specialist service for patients with heart failure with a special interest in HFpHF and cardiac imaging (echo and cardiac CT). https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/b1d1902e-59c6-46fa-994f-50434f885ebf/KOSTRUBIEC+Maciej.jpg Maciej Kostrubiec - Maciej Kostrubiec EMA, Poland Prof. Maciej Kostrubiec, MD, PhD has been a cardiologist consultant at Mid and South Essex Hospital NHS Trust in the United Kingdom since 2019 and he is a lecturer at The Medical University of Warsaw, Fellow of the European Cardiac Society (FESC), and Fellow of European Association of Cardiovascular Imaging (FEACVI). Since 2012, he has been a subject matter expert at The Office for Registration of Medicinal Products in Poland and The European Medicines Agency (EMA). Also, a member of the EMA Cardiovascular Working Party of CHMP. Prof. Kostrubiec is an expert in the fields of right heart failure, especially secondary to venous thromboembolic disease and imaging cardiology including invasive investigations (RHC/LHC). Currently, in the UK he is primarily involved in specialist service for patients with heart failure with a special interest in HFpHF and cardiac imaging (echo and cardiac CT). https://www.3ctmeeting.com/diana-stanley daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/aa5f1daa-e7d0-44fe-9655-c0d49111aefc/Stanley+Diana.jpg Diana Stanley - Diana Stanley New York, USA Dr Diana Stanley trained as a physician in the UK and worked in general practice before beginning her career in publishing at the BMJ Evidence Centre in 2011. She joined the inaugural team of The Lancet Respiratory Medicine in 2012 where she is now Deputy Editor for the journal, based in the New York office. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/aa5f1daa-e7d0-44fe-9655-c0d49111aefc/Stanley+Diana.jpg Diana Stanley - Diana Stanley New York, USA Dr Diana Stanley trained as a physician in the UK and worked in general practice before beginning her career in publishing at the BMJ Evidence Centre in 2011. She joined the inaugural team of The Lancet Respiratory Medicine in 2012 where she is now Deputy Editor for the journal, based in the New York office. https://www.3ctmeeting.com/emma-grainger daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e9279912-8ab9-4da1-b469-459ddc6665be/050215_57.jpg Emma Grainger - Emma Grainger The Lancet, United Kingdom Dr Emma Grainger has been an editor at The Lancet Oncology since 2005, starting as a Senior Editor and then as Deputy Editor from 2008, and is founding Editor-in-Chief of The Lancet Respiratory Medicine. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e9279912-8ab9-4da1-b469-459ddc6665be/050215_57.jpg Emma Grainger - Emma Grainger The Lancet, United Kingdom Dr Emma Grainger has been an editor at The Lancet Oncology since 2005, starting as a Senior Editor and then as Deputy Editor from 2008, and is founding Editor-in-Chief of The Lancet Respiratory Medicine. https://www.3ctmeeting.com/rhonda-monroe daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/604a2ff4-e9cf-4299-9745-2a9337302bd9/MONROE+Rhonda.jpeg Rhonda Monroe - Rhonda Monroe Charlotte, USA Rhonda E. Monroe has overcome five coronary artery dissections, three heart attacks, two strokes, congestive heart failure, 3 defibrillator implants, a hematoma evacuation, a failed quadruple bypass surgery, failed stents, repeat bypass surgery, a pericardial window, and much more. She now advocates for others. Rhonda recently launched BOOST – Better Outcomes Optimal Scientific Therapies™ to shift the culture of care and promote evidence-based therapies to improve patient outcomes. Rhonda’s work has garnered media attention including US News & World Report, WebMD, and CNNHealth.com. She appeared on the Today Show and has been featured in TIME magazine for her innovative community education program, Look Good, Feel Good: A Heart and Hair Affair which addresses disparities in healthcare. Rhonda also starred in a national Bayer aspirin commercial and was the recipient of the West Virginia Governor’s Volunteer Service Award. Rhonda is a native of Washington, D.C. currently residing in Charlotte, NC https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/604a2ff4-e9cf-4299-9745-2a9337302bd9/MONROE+Rhonda.jpeg Rhonda Monroe - Rhonda Monroe Charlotte, USA Rhonda E. Monroe has overcome five coronary artery dissections, three heart attacks, two strokes, congestive heart failure, 3 defibrillator implants, a hematoma evacuation, a failed quadruple bypass surgery, failed stents, repeat bypass surgery, a pericardial window, and much more. She now advocates for others. Rhonda recently launched BOOST – Better Outcomes Optimal Scientific Therapies™ to shift the culture of care and promote evidence-based therapies to improve patient outcomes. Rhonda’s work has garnered media attention including US News & World Report, WebMD, and CNNHealth.com. She appeared on the Today Show and has been featured in TIME magazine for her innovative community education program, Look Good, Feel Good: A Heart and Hair Affair which addresses disparities in healthcare. Rhonda also starred in a national Bayer aspirin commercial and was the recipient of the West Virginia Governor’s Volunteer Service Award. Rhonda is a native of Washington, D.C. currently residing in Charlotte, NC https://www.3ctmeeting.com/uwe-zeymer daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/8e46c5c6-3c66-4e5a-9cf4-b96c75541907/Zeymer+Uwe.JPG Uwe Zeymer - Uwe Zeymer Ludwigshafen, Germany Doctor Uwe Zeymer is Head of Interventional Cardiology at the Heart Center Ludwigshafen, Department of Cardiology, Germany. He is Vice-Director of the Institut für Herzinfarktforschung Ludwigshafen. He has been board certified in internal medicine, cardiology, interventional cardiology and intensive care medicine. After his graduation from Medical School at the Universities of Munich and Marburg in 1985, Dr Zeymer gained experience as a resident, fellow and attendee in the Department of Cardiology, Municipal Hospital, Kassel, and as a clinical research fellow in the Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, USA. He is full Professoressor of Medicine at the University of Göttingen. Dr. Zeymer is or has chaired or been a member of the Steering Committee numerous trials in patients with acute coronary syndromes, antithrombotic therapies and anticoagulants. In addition he has been chair or member of the Steering committee of several international registries in interventional cardiology, treatment of hypertension, anticoagulation for atrial fibrillation and acute coronary syndromes. Dr. Zeymer has authored and co-authored over 450 scientific papers on cardiovascular disease in journals such as the New England Journal of Medicine, Lancet, JAMA, European Heart Journal, Circulation and Journal of the American College of Cardiology. Dr. Zeymer has been the Chair of the Scientific Committee of the Acute Cardiovascular Care Association of the ESC, the Chair of the Workung Group of Thrombosis of the German Cardiac Society and the Chair of the Working for Quality Insurance and Registries of the German Cardiac Society. He was President of the annual Autumn Meeting of the German Cardiac Society 2013. He is currently chairing the ongoing STEMI-Registry of the EORP of the ESC. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/8e46c5c6-3c66-4e5a-9cf4-b96c75541907/Zeymer+Uwe.JPG Uwe Zeymer - Uwe Zeymer Ludwigshafen, Germany Doctor Uwe Zeymer is Head of Interventional Cardiology at the Heart Center Ludwigshafen, Department of Cardiology, Germany. He is Vice-Director of the Institut für Herzinfarktforschung Ludwigshafen. He has been board certified in internal medicine, cardiology, interventional cardiology and intensive care medicine. After his graduation from Medical School at the Universities of Munich and Marburg in 1985, Dr Zeymer gained experience as a resident, fellow and attendee in the Department of Cardiology, Municipal Hospital, Kassel, and as a clinical research fellow in the Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, USA. He is full Professoressor of Medicine at the University of Göttingen. Dr. Zeymer is or has chaired or been a member of the Steering Committee numerous trials in patients with acute coronary syndromes, antithrombotic therapies and anticoagulants. In addition he has been chair or member of the Steering committee of several international registries in interventional cardiology, treatment of hypertension, anticoagulation for atrial fibrillation and acute coronary syndromes. Dr. Zeymer has authored and co-authored over 450 scientific papers on cardiovascular disease in journals such as the New England Journal of Medicine, Lancet, JAMA, European Heart Journal, Circulation and Journal of the American College of Cardiology. Dr. Zeymer has been the Chair of the Scientific Committee of the Acute Cardiovascular Care Association of the ESC, the Chair of the Workung Group of Thrombosis of the German Cardiac Society and the Chair of the Working for Quality Insurance and Registries of the German Cardiac Society. He was President of the annual Autumn Meeting of the German Cardiac Society 2013. He is currently chairing the ongoing STEMI-Registry of the EORP of the ESC. https://www.3ctmeeting.com/hariette-van-spall daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/90c5b056-08e6-4b14-b9c1-a9ec4ff3312d/Harriette+Van+Spall+Blue+2.jpg Hariette Van Spall - Hariette Van Spall Hamilton, Canada Dr. Van Spall is a cardiologist, clinical trialist, and implementation scientist funded by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada. She leads both investigator-initiated and industry-sponsored Phase III clinical trials in heart failure. In addition to industry funding, she has garnered more than $6.2 million in peer-reviewed research funding and has won several research awards, including the prestigious Canadian Institutes of Health Research Mid-Career Lectureship Award in Cardiovascular Sciences and the American Heart Association Nanette Wenger Research Award. Her work is published in high-impact medical journals and cited in international guidelines and by regulatory and federal funding agencies. She is a member of international guideline committees and clinical trial steering committees. She is an invited speaker, media correspondent, and an editorial board member at several leading CV journals including those in the EHJ, Circulation, and JACC family. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/90c5b056-08e6-4b14-b9c1-a9ec4ff3312d/Harriette+Van+Spall+Blue+2.jpg Hariette Van Spall - Hariette Van Spall Hamilton, Canada Dr. Van Spall is a cardiologist, clinical trialist, and implementation scientist funded by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada. She leads both investigator-initiated and industry-sponsored Phase III clinical trials in heart failure. In addition to industry funding, she has garnered more than $6.2 million in peer-reviewed research funding and has won several research awards, including the prestigious Canadian Institutes of Health Research Mid-Career Lectureship Award in Cardiovascular Sciences and the American Heart Association Nanette Wenger Research Award. Her work is published in high-impact medical journals and cited in international guidelines and by regulatory and federal funding agencies. She is a member of international guideline committees and clinical trial steering committees. She is an invited speaker, media correspondent, and an editorial board member at several leading CV journals including those in the EHJ, Circulation, and JACC family. https://www.3ctmeeting.com/holger-thiele daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c35c3d37-861b-442e-bdac-e683237f2412/Thiele+Holger.jpg Holger Thiele - Holger Thiele Leipzig, Germany Holger Thiele is the Medical Director of the Department of Internal Medicine/Cardiology at the Heart Center Leipzig at University of Leipzig which is one of the largest heart centers in Europe. He is full professor of cardiology at the University of Leipzig and he is also the president elect of the German Cardiac Society (term 2023-2025). His main research interests are acute myocardial infarction, acute heart failure, cardiogenic shock, mechanical circulatory support, acute cardiovascular care, interventional cardiology and structural heart disease. He has been the guideline chair of the ESC NSTE-ACS guidelines 2020. Professor Thiele has published over 780 articles in international scientific journals such as the New England Journal of Medicine, The Lancet, JAMA, Circulation, JACC, and the European Heart Journal with a cumulative impact factor of >8900, h-index 121. He has received multiple awards from the German Society of Cardiology and other organisations. Furthermore, he has been awarded as most cited researcher in 2020, 2021 and also once again in 2022. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c35c3d37-861b-442e-bdac-e683237f2412/Thiele+Holger.jpg Holger Thiele - Holger Thiele Leipzig, Germany Holger Thiele is the Medical Director of the Department of Internal Medicine/Cardiology at the Heart Center Leipzig at University of Leipzig which is one of the largest heart centers in Europe. He is full professor of cardiology at the University of Leipzig and he is also the president elect of the German Cardiac Society (term 2023-2025). His main research interests are acute myocardial infarction, acute heart failure, cardiogenic shock, mechanical circulatory support, acute cardiovascular care, interventional cardiology and structural heart disease. He has been the guideline chair of the ESC NSTE-ACS guidelines 2020. Professor Thiele has published over 780 articles in international scientific journals such as the New England Journal of Medicine, The Lancet, JAMA, Circulation, JACC, and the European Heart Journal with a cumulative impact factor of >8900, h-index 121. He has received multiple awards from the German Society of Cardiology and other organisations. Furthermore, he has been awarded as most cited researcher in 2020, 2021 and also once again in 2022. https://www.3ctmeeting.com/helle-sholm daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c39ccda3-82a8-4838-8a7f-ad3e34bf5df8/EuroPCR_portr%C3%A6t_2022.png Helle Søholm - Helle Søholm Copenhagen, Denmark Mrs. Helle Soeholm graduated from Copenhagen University Medical School in 2010 and gained her PhD in 2015 in acute cardiac care with focus on cardiac arrest. In 2021 she finished her specialist training in cardiology, and she is now working as an interventional cardiologist primarily with percutaneous coronary interventions at Copenhagen University Hospital, Rigshospitalet. Her research focus is acute cardiac care with a special focus on cardiogenic shock, cardiac arrest and acute coronary syndrome. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c39ccda3-82a8-4838-8a7f-ad3e34bf5df8/EuroPCR_portr%C3%A6t_2022.png Helle Søholm - Helle Søholm Copenhagen, Denmark Mrs. Helle Soeholm graduated from Copenhagen University Medical School in 2010 and gained her PhD in 2015 in acute cardiac care with focus on cardiac arrest. In 2021 she finished her specialist training in cardiology, and she is now working as an interventional cardiologist primarily with percutaneous coronary interventions at Copenhagen University Hospital, Rigshospitalet. Her research focus is acute cardiac care with a special focus on cardiogenic shock, cardiac arrest and acute coronary syndrome. https://www.3ctmeeting.com/alessandro-sionis daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c767778f-e23c-44a5-a3ac-3b63669d1b04/Sionis+Alessandro.jpg Alessandro Sionis - Alessandro Sionis Barcelona, Spain Dr. Sionis is the Director of the Acute Cardiac Unit at Hospital de la Santa Creu i Sant Pau in Barcelona and Professor of Cardiology at the Universitat Autònoma de Barcelona. He is the past-President of the Acute Cardiovascular Care Chapter of the Spanish Society of Cardiology. He is the current Secretary and member of the executive Board of the Association for Acute Cardiovascular Care of the European Society of Cardiology (ESC), member of the Education Committee of ESC, Chair of the Council for Accreditation and Certification of the ESC and Vice-president for UEMS (European Union of Medical Specialists) Cardiology. He has published over 300 scientific articles in peer-reviewed medical journals mainly in the fields of cardiology, emergency medicine and critical care. His research interests have largely focused on acute and critical care cardiology. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c767778f-e23c-44a5-a3ac-3b63669d1b04/Sionis+Alessandro.jpg Alessandro Sionis - Alessandro Sionis Barcelona, Spain Dr. Sionis is the Director of the Acute Cardiac Unit at Hospital de la Santa Creu i Sant Pau in Barcelona and Professor of Cardiology at the Universitat Autònoma de Barcelona. He is the past-President of the Acute Cardiovascular Care Chapter of the Spanish Society of Cardiology. He is the current Secretary and member of the executive Board of the Association for Acute Cardiovascular Care of the European Society of Cardiology (ESC), member of the Education Committee of ESC, Chair of the Council for Accreditation and Certification of the ESC and Vice-president for UEMS (European Union of Medical Specialists) Cardiology. He has published over 300 scientific articles in peer-reviewed medical journals mainly in the fields of cardiology, emergency medicine and critical care. His research interests have largely focused on acute and critical care cardiology. https://www.3ctmeeting.com/hannah-schaubroeck daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/aba015c0-a611-4418-ae0c-a4be1f4a8624/Schaubroeck+Hannah.jpg Hannah Schaubroeck - Hannah Schaubroeck Ghent, Belguim Hannah Schaubroeck is staff member at the intensive care unit (ICU) of Ghent University Hospital, Belgium, since 2017. She takes care of patients post cardiac surgery and patients with advanced heart failure and cardiogenic shock. She was trained as a cardiologist and intensive care specialist at Ghent University Hospital. Additionally she worked as clinical fellow at the cardiothoracic ICU of Harefield and Royal Brompton Hospital in London to get more expertise in advanced heart failure management, especially the use of mechanical circulatory support. She is fully certified by ACVC. She was president of the Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC) from 2020 till 2022. Since 2022 she is the chair of the young ESC-ACVC community. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/aba015c0-a611-4418-ae0c-a4be1f4a8624/Schaubroeck+Hannah.jpg Hannah Schaubroeck - Hannah Schaubroeck Ghent, Belguim Hannah Schaubroeck is staff member at the intensive care unit (ICU) of Ghent University Hospital, Belgium, since 2017. She takes care of patients post cardiac surgery and patients with advanced heart failure and cardiogenic shock. She was trained as a cardiologist and intensive care specialist at Ghent University Hospital. Additionally she worked as clinical fellow at the cardiothoracic ICU of Harefield and Royal Brompton Hospital in London to get more expertise in advanced heart failure management, especially the use of mechanical circulatory support. She is fully certified by ACVC. She was president of the Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC) from 2020 till 2022. Since 2022 she is the chair of the young ESC-ACVC community. https://www.3ctmeeting.com/naoki-sato daily 0.75 2024-04-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c5ec1bf9-a70a-41b1-9e5b-e26cc48fb60f/sato+photo2019+2.png Naoki Sato - Naoki Sato Tokyo, Japan After completing medical school from Nippon Medical School (NMS) in Tokyo, Japan, Dr.Sato did his residency for two years at NMS and had trained cardiac catheterization and intervention for another three years. He had done basic research regarding heart failure under the direction of Prof. Stephen F. Vatner at Harvard Medical School for 4 years. He had several awards, e.g., AHA Melvin L. Marcus Young Investigator Award in Cardiovascular Integrated Physiology, the Samuel A. Levine award from AHA, Massachusetts affiliate, etc. He was professor of department of cardiovascular medicine and director of intensive care unit in NMS. He conducted many trials and registries, such as the largest acute heart failure registry (ATTEND) in Japan and works as a PI for many HF trials including global trials. His speciality is heart failure. He works as executive director of the Japanese Heart Failure Society and Japanese Society of Intensive Care Medicine. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c5ec1bf9-a70a-41b1-9e5b-e26cc48fb60f/sato+photo2019+2.png Naoki Sato - Naoki Sato Tokyo, Japan After completing medical school from Nippon Medical School (NMS) in Tokyo, Japan, Dr.Sato did his residency for two years at NMS and had trained cardiac catheterization and intervention for another three years. He had done basic research regarding heart failure under the direction of Prof. Stephen F. Vatner at Harvard Medical School for 4 years. He had several awards, e.g., AHA Melvin L. Marcus Young Investigator Award in Cardiovascular Integrated Physiology, the Samuel A. Levine award from AHA, Massachusetts affiliate, etc. He was professor of department of cardiovascular medicine and director of intensive care unit in NMS. He conducted many trials and registries, such as the largest acute heart failure registry (ATTEND) in Japan and works as a PI for many HF trials including global trials. His speciality is heart failure. He works as executive director of the Japanese Heart Failure Society and Japanese Society of Intensive Care Medicine. https://www.3ctmeeting.com/sarina-saheyta daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/42a63ba0-2286-4a51-9fb8-64fd2a07a0e7/SAHETYA+sarina+1.jpg Sarina Saheyta - Sarina Saheyta Baltimore, United States Dr. Sarina Sahetya is an Assistant Professor and the Director of Quality and Safety for the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University. Dr. Sahetya received her undergraduate degree from Vanderbilt University and her medical degree from the University of Louisville School of Medicine. She completed her Internal Medicine residency and Pulmonary and Critical Care training at Johns Hopkins Hospital prior to joining as faculty. She also earned a Masters of Health Sciences in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Sahetya’s research focuses on utilizing respiratory physiology to optimize mechanical ventilation for patients with acute respiratory failure. Currently, she has funding from the NIH and DoD to investigate the use of a driving pressure-targeted mechanical ventilation strategy for patients with ARDS. She has contributed to international consensus recommendations on lung and diaphragm protective mechanical ventilation and was a co-chair for the recent American Thoracic Society Clinical Practice Guideline for the Management of Patients with Acute Respiratory Distress Syndrome. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/42a63ba0-2286-4a51-9fb8-64fd2a07a0e7/SAHETYA+sarina+1.jpg Sarina Saheyta - Sarina Saheyta Baltimore, United States Dr. Sarina Sahetya is an Assistant Professor and the Director of Quality and Safety for the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University. Dr. Sahetya received her undergraduate degree from Vanderbilt University and her medical degree from the University of Louisville School of Medicine. She completed her Internal Medicine residency and Pulmonary and Critical Care training at Johns Hopkins Hospital prior to joining as faculty. She also earned a Masters of Health Sciences in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Sahetya’s research focuses on utilizing respiratory physiology to optimize mechanical ventilation for patients with acute respiratory failure. Currently, she has funding from the NIH and DoD to investigate the use of a driving pressure-targeted mechanical ventilation strategy for patients with ARDS. She has contributed to international consensus recommendations on lung and diaphragm protective mechanical ventilation and was a co-chair for the recent American Thoracic Society Clinical Practice Guideline for the Management of Patients with Acute Respiratory Distress Syndrome. https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy daily 0.75 2024-05-30 https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy daily 0.75 2024-05-30 https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy daily 0.75 2024-05-30 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/49928806-770c-425d-8626-ce05df60d5d0/Brian+Cuthbertson+photo+2017+%281%29.JPG Brian Cuthbertson - Brian Cuthbertson Toronto, Canada Brian Cuthbertson is an Attending Physician and former Chief of the Department of Critical Care Medicine at Sunnybrook Health Sciences Centre. He is a Professor in the University Department of Anaesthesiology and Pain Medicine as well as the Interdepartmental Division of Critical Care Medicine at the University of Toronto. He is the Vice Chair (Research) in the University Department of Anaesthesiology and Pain Medicine. He is also an Honorary Professor of Critical Care Medicine at the University of Aberdeen. His research interests include improving outcomes from critical illness and major surgery and he has led a large number of multicentre trials in these areas. He has over 200 peer-reviewed publications, $40million of research grants and an H index of 52. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/49928806-770c-425d-8626-ce05df60d5d0/Brian+Cuthbertson+photo+2017+%281%29.JPG Brian Cuthbertson - Brian Cuthbertson Toronto, Canada Brian Cuthbertson is an Attending Physician and former Chief of the Department of Critical Care Medicine at Sunnybrook Health Sciences Centre. He is a Professor in the University Department of Anaesthesiology and Pain Medicine as well as the Interdepartmental Division of Critical Care Medicine at the University of Toronto. He is the Vice Chair (Research) in the University Department of Anaesthesiology and Pain Medicine. He is also an Honorary Professor of Critical Care Medicine at the University of Aberdeen. His research interests include improving outcomes from critical illness and major surgery and he has led a large number of multicentre trials in these areas. He has over 200 peer-reviewed publications, $40million of research grants and an H index of 52. https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy-copy daily 0.75 2024-05-30 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2c71b074-4138-4637-80a9-2311ab437b63/ALAIN+COMBES+REAPITIESALPETRIERE001.jpg Alain Combes - Alain Combes Paris, France Professor Alain Combes, MD, PhD is Professor of Intensive Care Medicine at Sorbonne Université, Paris, and head of the ICU department at La Pitié-Salpêtrière Hospital, Assistance Publique Hopitaux de Paris, France. Main research interests: -Care of the critically ill cardiac patient (cardiogenic shock, acute myocardial infarction, cardiac arrest, complicated heart surgery and heart transplantation) -Mechanical circulatory assistance and extracorporeal membrane oxygenation - Rescue therapies for severe respiratory failure, including ECMO and ECCO2R -Infections in critically patients, such as pulmonary infections in mechanically ventilated ICU patients and endocarditis. Professor Combes is Member of -The Société de Réanimation de Langue Française (SRLF) -The European Society of Intensive Care Medicine (ESICM) -Editor of Intensive Care Medicine -The American Thoracic Society (ATS) -The European Society of Cardiology (ESC) -The Association for Acute CardioVascular Care, ESC-ACVC oBoard member of the ESC-ACVC -The Extra Corporeal Life Support Organization (ELSO), oPast President of the EURO-ELSO -The International ECMO network (ECMONet) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2c71b074-4138-4637-80a9-2311ab437b63/ALAIN+COMBES+REAPITIESALPETRIERE001.jpg Alain Combes - Alain Combes Paris, France Professor Alain Combes, MD, PhD is Professor of Intensive Care Medicine at Sorbonne Université, Paris, and head of the ICU department at La Pitié-Salpêtrière Hospital, Assistance Publique Hopitaux de Paris, France. Main research interests: -Care of the critically ill cardiac patient (cardiogenic shock, acute myocardial infarction, cardiac arrest, complicated heart surgery and heart transplantation) -Mechanical circulatory assistance and extracorporeal membrane oxygenation - Rescue therapies for severe respiratory failure, including ECMO and ECCO2R -Infections in critically patients, such as pulmonary infections in mechanically ventilated ICU patients and endocarditis. Professor Combes is Member of -The Société de Réanimation de Langue Française (SRLF) -The European Society of Intensive Care Medicine (ESICM) -Editor of Intensive Care Medicine -The American Thoracic Society (ATS) -The European Society of Cardiology (ESC) -The Association for Acute CardioVascular Care, ESC-ACVC oBoard member of the ESC-ACVC -The Extra Corporeal Life Support Organization (ELSO), oPast President of the EURO-ELSO -The International ECMO network (ECMONet) https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy-copy-copy daily 0.75 2024-05-30 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/49167ffd-10dc-41d6-8759-ce37b7d63220/Barkauskas+Christina.jpg Christina Barkauskas - Christina Barkauskas Durham NC, United States Christina Barkauskas is a pulmonologist, intensivist, and stem cell biologist (Assistant Professoressor of Medicine - Pulmonary, Allergy, and Critical Care Medicine at Duke University). She has extensive experience with multi-site COVID therapeutic trials, and has extensive basic science background with expertise in understanding the fundamental mechanisms involved in lung injury and repair and in exploring novel treatments for acute respiratory distress syndrome (ARDS). As a practicing pulmonary and critical care physician, she is an expert in management of patients with lung disorders, critical illness, and the sequelae thereof. She is currently the co-chair of ACTIV3b/TESICO: Therapeutics for Severely Ill Inpatients with COVID-19, a multi-site international platform study evaluating the safety and efficacy of aviptadil vs. placebo in patients with ARDS. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/49167ffd-10dc-41d6-8759-ce37b7d63220/Barkauskas+Christina.jpg Christina Barkauskas - Christina Barkauskas Durham NC, United States Christina Barkauskas is a pulmonologist, intensivist, and stem cell biologist (Assistant Professoressor of Medicine - Pulmonary, Allergy, and Critical Care Medicine at Duke University). She has extensive experience with multi-site COVID therapeutic trials, and has extensive basic science background with expertise in understanding the fundamental mechanisms involved in lung injury and repair and in exploring novel treatments for acute respiratory distress syndrome (ARDS). As a practicing pulmonary and critical care physician, she is an expert in management of patients with lung disorders, critical illness, and the sequelae thereof. She is currently the co-chair of ACTIV3b/TESICO: Therapeutics for Severely Ill Inpatients with COVID-19, a multi-site international platform study evaluating the safety and efficacy of aviptadil vs. placebo in patients with ARDS. https://www.3ctmeeting.com/2026-preliminary-program daily 0.75 2026-03-02 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441752224-B38ONBNP788WME0DZFCV/1.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441750242-1UBP0K63I0LPMEMZSPYQ/5.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441751800-VPVTBACZHS7JAXESE3VJ/6.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441752927-N3WX7689APIE0QLXVLRR/8.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441753561-53LBZWE56XH40UEY0E2A/9.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441754162-68U2WUAXWMWVBCY2NRSR/10.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441754882-AQ5I78HT8KS36G6XY781/11.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441755346-LGSMK2Q6D20QCRFYGYSG/12.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441756072-FEISSWL9FCYEOHO3GTNE/13.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441756598-YC3OILAV1LQOYB134K8P/14.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441757355-K9WVCBX7M7W7S9SMJJNT/15.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441757685-2EAFRHALZNR4HHMG8QLM/18.png 2026 Preliminary Program https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1772441758442-6PIMJ7HQK5JQ6ZET3FNR/19.png 2026 Preliminary Program https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-1 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e514b9a7-6487-4101-802a-db3a01b7a3ce/fin+3+%281%29.jpg Florian Wenzl - Florian Wenzl Zürich, Switzerland Florian Wenzl, MD FESC completed his postgraduate training at the University of Pennsylvania and continued his cardiology fellowship at the German Heart Centre Munich before joining the University of Zurich in 2021. Florian and his team are based in Zurich and focus on risk prediction and biomarker research to refine personalised treatment approaches. He received numerous prizes and awards for his engagement in research and teaching including the Ars Docendi National Prize awarded by the Austrian Minister of Education, the ESC Young Investigator Award, and the FAN Award for Medicine and Natural Sciences awarded by the University of Zurich. Florian is Honorary Fellow of the University of Leicester, fellow of the SPUM-ACS and MINAP cohorts, and serves in the steering committee of the Swiss National Registry of Myocardial Infarction (AMIS Plus). https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e514b9a7-6487-4101-802a-db3a01b7a3ce/fin+3+%281%29.jpg Florian Wenzl - Florian Wenzl Zürich, Switzerland Florian Wenzl, MD FESC completed his postgraduate training at the University of Pennsylvania and continued his cardiology fellowship at the German Heart Centre Munich before joining the University of Zurich in 2021. Florian and his team are based in Zurich and focus on risk prediction and biomarker research to refine personalised treatment approaches. He received numerous prizes and awards for his engagement in research and teaching including the Ars Docendi National Prize awarded by the Austrian Minister of Education, the ESC Young Investigator Award, and the FAN Award for Medicine and Natural Sciences awarded by the University of Zurich. Florian is Honorary Fellow of the University of Leicester, fellow of the SPUM-ACS and MINAP cohorts, and serves in the steering committee of the Swiss National Registry of Myocardial Infarction (AMIS Plus). https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-1 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6df9ed65-1354-49dd-be3c-23a32851c4bc/Pickkers+Peter+%281%29.jpg Peter Pickkers - Peter Pickkers Nijmegen, Netherlands Peter Pickkers is Professoressor of Intensive Care Medicine at the Radboud University Medical Center Nijmegen, the Netherlands. He qualified as MD (1991) and completed his residency in Internal and Intensive Care Medicine at the Radboud University Nijmegen. In 2000 he received his doctorate, titled ‘Vascular effects of diuretics’, cum laude. His research focuses on pharmacological modulation of the innate immune response in translational models and patients, and the consequences for organ function, with a focus on the kidney and brain. Up to now, 28 PhD’s were completed under his supervision. With over 2000 endotoxemia experiments performed, he leads the most active group using this human in vivo model of inflammation worldwide. He has given invited lectures on all major meetings in the field of intensive care medicine and nephrology. He cooperates with various international experts in the field of sepsis and nephrology and has participated in several guideline and steering committees. He is in the editorial board of Intensive Care Medicine, Intensive Care Medicine Experimental and Shock. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6df9ed65-1354-49dd-be3c-23a32851c4bc/Pickkers+Peter+%281%29.jpg Peter Pickkers - Peter Pickkers Nijmegen, Netherlands Peter Pickkers is Professoressor of Intensive Care Medicine at the Radboud University Medical Center Nijmegen, the Netherlands. He qualified as MD (1991) and completed his residency in Internal and Intensive Care Medicine at the Radboud University Nijmegen. In 2000 he received his doctorate, titled ‘Vascular effects of diuretics’, cum laude. His research focuses on pharmacological modulation of the innate immune response in translational models and patients, and the consequences for organ function, with a focus on the kidney and brain. Up to now, 28 PhD’s were completed under his supervision. With over 2000 endotoxemia experiments performed, he leads the most active group using this human in vivo model of inflammation worldwide. He has given invited lectures on all major meetings in the field of intensive care medicine and nephrology. He cooperates with various international experts in the field of sepsis and nephrology and has participated in several guideline and steering committees. He is in the editorial board of Intensive Care Medicine, Intensive Care Medicine Experimental and Shock. https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy-1 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6058477e-7f04-4697-9d97-6e25a26c46e7/SOUSSI+Sabri+%281%29.jpg Sabri Soussi - Sabri Soussi Toronto, Canada Dr Sabri Soussi completed his specialty training in Anesthesia and Critical Care in 2010 in France and had as of 2011 a clinical associate and then attending physician positions in the Medical Surgical and Cardiovascular ICUs of La Pitié-Salpétrière and Lariboisière-St Louis University Hospitals (Paris, France). vIn 2022, he obtained a PhD in “Genes, Omics, Bioinformatics and Systems biology” from the University of Paris. vDr SOUSSI published 34 peer reviewed articles in the last 5 years mainly in the field of shock states monitoring, management and novel biomarkers assessment (e.g., septic, cardiogenic, related to burn injury), in specialty-leading and high-impact medical journals (e.g., Anesthesiology Intensive Care Medicine). He set up a research collaborative network between his inner research group in Saint Louis and Lariboisière Hospitals, Paris, France and the academic group at St Michael’s Hospital, University of Toronto (Dr Claudia DOS SANTOS, Dr Laurent BROCHARD and Dr John MARSHALL). https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6058477e-7f04-4697-9d97-6e25a26c46e7/SOUSSI+Sabri+%281%29.jpg Sabri Soussi - Sabri Soussi Toronto, Canada Dr Sabri Soussi completed his specialty training in Anesthesia and Critical Care in 2010 in France and had as of 2011 a clinical associate and then attending physician positions in the Medical Surgical and Cardiovascular ICUs of La Pitié-Salpétrière and Lariboisière-St Louis University Hospitals (Paris, France). vIn 2022, he obtained a PhD in “Genes, Omics, Bioinformatics and Systems biology” from the University of Paris. vDr SOUSSI published 34 peer reviewed articles in the last 5 years mainly in the field of shock states monitoring, management and novel biomarkers assessment (e.g., septic, cardiogenic, related to burn injury), in specialty-leading and high-impact medical journals (e.g., Anesthesiology Intensive Care Medicine). He set up a research collaborative network between his inner research group in Saint Louis and Lariboisière Hospitals, Paris, France and the academic group at St Michael’s Hospital, University of Toronto (Dr Claudia DOS SANTOS, Dr Laurent BROCHARD and Dr John MARSHALL). https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy-copy-1 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/58ddcbac-76e0-4bf3-a89f-a8d69593855d/Image+%282%29.jpeg Jason katz - Jason Katz New York, United States Jason N. Katz MD, MHS, FACC, FAHA is a Professor of Medicine in the NYU Grossman School of Medicine. He is Associate Chief of Cardiology and Director of Inpatient Cardiology at Bellevue Hospital. In addition, he serves as Associate Director of the NYU LVAD Program and as Program Director for the NYU Advanced Heart Failure & Transplant Cardiology Fellowship. His research interests focus on optimizing the care of patients with cardiogenic shock, examining best practices for the use of temporary and durable mechanical circulatory support devices, and enhancing the delivery and quality of care within the contemporary cardiovascular ICU. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/58ddcbac-76e0-4bf3-a89f-a8d69593855d/Image+%282%29.jpeg Jason katz - Jason Katz New York, United States Jason N. Katz MD, MHS, FACC, FAHA is a Professor of Medicine in the NYU Grossman School of Medicine. He is Associate Chief of Cardiology and Director of Inpatient Cardiology at Bellevue Hospital. In addition, he serves as Associate Director of the NYU LVAD Program and as Program Director for the NYU Advanced Heart Failure & Transplant Cardiology Fellowship. His research interests focus on optimizing the care of patients with cardiogenic shock, examining best practices for the use of temporary and durable mechanical circulatory support devices, and enhancing the delivery and quality of care within the contemporary cardiovascular ICU. https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy-copy-copy-1 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/40fdbd65-f9d6-4cb2-9d5b-e8919a3bf9ba/Kapur+Navin.PNG Navin Kapur - Navin Kapur Boston, United States He made his medical school in Paris and his secondary specialty in Montpellier France. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/40fdbd65-f9d6-4cb2-9d5b-e8919a3bf9ba/Kapur+Navin.PNG Navin Kapur - Navin Kapur Boston, United States He made his medical school in Paris and his secondary specialty in Montpellier France. https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/298d2fdc-f367-4e28-98dc-7ab3766edd98/Bohula_Headshot_Sept_2019.pdf+%281%29_page-0001.jpg Erin Bohula - Erin Bohula Boston, United States Erin Bohula is an Associate Physician in Cardiovascular Medicine at Brigham and Women’s Hospital (BWH), Boston, MA, USA, an Investigator at the TIMI Study Group and an Assistant Professor at Harvard Medical School. Dr Bohula earned her DPhil in Molecular Biology from University of Oxford, Oxford, UK on a Rhodes Scholarship in molecular oncology. Following training at Harvard Medical School & BWH, she is board certified in internal medicine, cardiology, and critical care medicine. Dr Bohula studies pharmacologic interventions for cardiometabolic diseases, such as hyperlipidaemia, obesity and atherosclerotic cardiovascular disease. Her recent trial involvement includes IMPROVE-IT, FOURIER, CAMELLIA-TIMI 61, and VESALIUS-CV. As a cardiac intensivist, she was involved in creating the Critical Care Cardiology Trials Network, a North American research collaborative of cardiology critical care units (CICU) and helped to lead their inaugural RCT, COVID-PACT, studying the efficacy and safety of antithrombotic therapy in critically-ill COVID-19 patients. She has received multiple awards, including the ACC W. Proctor Harvey Young Teaching Award and the Eugene Braunwald Faculty Award. She is the vice chair of the AHA Acute Care and General Cardiology Council. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/298d2fdc-f367-4e28-98dc-7ab3766edd98/Bohula_Headshot_Sept_2019.pdf+%281%29_page-0001.jpg Erin Bohula - Erin Bohula Boston, United States Erin Bohula is an Associate Physician in Cardiovascular Medicine at Brigham and Women’s Hospital (BWH), Boston, MA, USA, an Investigator at the TIMI Study Group and an Assistant Professor at Harvard Medical School. Dr Bohula earned her DPhil in Molecular Biology from University of Oxford, Oxford, UK on a Rhodes Scholarship in molecular oncology. Following training at Harvard Medical School & BWH, she is board certified in internal medicine, cardiology, and critical care medicine. Dr Bohula studies pharmacologic interventions for cardiometabolic diseases, such as hyperlipidaemia, obesity and atherosclerotic cardiovascular disease. Her recent trial involvement includes IMPROVE-IT, FOURIER, CAMELLIA-TIMI 61, and VESALIUS-CV. As a cardiac intensivist, she was involved in creating the Critical Care Cardiology Trials Network, a North American research collaborative of cardiology critical care units (CICU) and helped to lead their inaugural RCT, COVID-PACT, studying the efficacy and safety of antithrombotic therapy in critically-ill COVID-19 patients. She has received multiple awards, including the ACC W. Proctor Harvey Young Teaching Award and the Eugene Braunwald Faculty Award. She is the vice chair of the AHA Acute Care and General Cardiology Council. https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/7d41da0d-934f-40ab-adb2-b9c11f5533c6/Moller+Jacob+%281%29.png Jacob Møller - Jacob Møller Odense, Denmark Professor of Medicine at Odense University Hospital and University of Southern Denmark and cardiac intensivist at the Cardiac Intensive Care Unit at Copehagen University Hospital Rigshospitalet, Denmark. Dr Moller is a committed clinical cardiologist with strong interest in patient care, education and research. Dr. Moller’s special research interests are in cardiogenic shock, mechanical circulatory support and cardiac arrest. He has authored more than 350 original papers and multiple reviews, editorials, and consensus statements. He currently serves on steering committees of several clinical trials in cardiovascular medicine and is leading some of them. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/7d41da0d-934f-40ab-adb2-b9c11f5533c6/Moller+Jacob+%281%29.png Jacob Møller - Jacob Møller Odense, Denmark Professor of Medicine at Odense University Hospital and University of Southern Denmark and cardiac intensivist at the Cardiac Intensive Care Unit at Copehagen University Hospital Rigshospitalet, Denmark. Dr Moller is a committed clinical cardiologist with strong interest in patient care, education and research. Dr. Moller’s special research interests are in cardiogenic shock, mechanical circulatory support and cardiac arrest. He has authored more than 350 original papers and multiple reviews, editorials, and consensus statements. He currently serves on steering committees of several clinical trials in cardiovascular medicine and is leading some of them. https://www.3ctmeeting.com/alexandre-mebazaa-2024-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3211fd8f-82ac-4f42-aa76-e265720546f2/Thiele+Holger+%281%29.jpg Holger Thiele - Holger Thiele Leipzig, Germany Holger Thiele is the Medical Director of the Department of Internal Medicine/Cardiology at the Heart Center Leipzig at University of Leipzig which is one of the largest heart centers in Europe. He is full professor of cardiology at the University of Leipzig and he is also the president elect of the German Cardiac Society (term 2023-2025). His main research interests are acute myocardial infarction, acute heart failure, cardiogenic shock, mechanical circulatory support, acute cardiovascular care, interventional cardiology and structural heart disease. He has been the guideline chair of the ESC NSTE-ACS guidelines 2020. Professor Thiele has published over 780 articles in international scientific journals such as the New England Journal of Medicine, The Lancet, JAMA, Circulation, JACC, and the European Heart Journal with a cumulative impact factor of >8900, h-index 121. He has received multiple awards from the German Society of Cardiology and other organisations. Furthermore, he has been awarded as most cited researcher in 2020, 2021 and also once again in 2022. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3211fd8f-82ac-4f42-aa76-e265720546f2/Thiele+Holger+%281%29.jpg Holger Thiele - Holger Thiele Leipzig, Germany Holger Thiele is the Medical Director of the Department of Internal Medicine/Cardiology at the Heart Center Leipzig at University of Leipzig which is one of the largest heart centers in Europe. He is full professor of cardiology at the University of Leipzig and he is also the president elect of the German Cardiac Society (term 2023-2025). His main research interests are acute myocardial infarction, acute heart failure, cardiogenic shock, mechanical circulatory support, acute cardiovascular care, interventional cardiology and structural heart disease. He has been the guideline chair of the ESC NSTE-ACS guidelines 2020. Professor Thiele has published over 780 articles in international scientific journals such as the New England Journal of Medicine, The Lancet, JAMA, Circulation, JACC, and the European Heart Journal with a cumulative impact factor of >8900, h-index 121. He has received multiple awards from the German Society of Cardiology and other organisations. Furthermore, he has been awarded as most cited researcher in 2020, 2021 and also once again in 2022. https://www.3ctmeeting.com/peter-pickkers-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3e645280-4b1f-434d-9dc0-5aa7f2710e1c/EuroPCR_portr%C3%A6t_2022+%281%29.png Helle Søholm - Helle Søholm Copenhagen, Denmark Mrs. Helle Soeholm graduated from Copenhagen University Medical School in 2010 and gained her PhD in 2015 in acute cardiac care with focus on cardiac arrest. In 2021 she finished her specialist training in cardiology, and she is now working as an interventional cardiologist primarily with percutaneous coronary interventions at Copenhagen University Hospital, Rigshospitalet. Her research focus is acute cardiac care with a special focus on cardiogenic shock, cardiac arrest and acute coronary syndrome. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3e645280-4b1f-434d-9dc0-5aa7f2710e1c/EuroPCR_portr%C3%A6t_2022+%281%29.png Helle Søholm - Helle Søholm Copenhagen, Denmark Mrs. Helle Soeholm graduated from Copenhagen University Medical School in 2010 and gained her PhD in 2015 in acute cardiac care with focus on cardiac arrest. In 2021 she finished her specialist training in cardiology, and she is now working as an interventional cardiologist primarily with percutaneous coronary interventions at Copenhagen University Hospital, Rigshospitalet. Her research focus is acute cardiac care with a special focus on cardiogenic shock, cardiac arrest and acute coronary syndrome. https://www.3ctmeeting.com/peter-pickkers-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1f981082-3adc-449b-8b7f-fa68917f8e57/MONROE+Rhonda+%281%29.jpeg Rhonda Monroe - Rhonda Monroe Charlotte, United States Rhonda E. Monroe has overcome five coronary artery dissections, three heart attacks, two strokes, congestive heart failure, 3 defibrillator implants, a hematoma evacuation, a failed quadruple bypass surgery, failed stents, repeat bypass surgery, a pericardial window, and much more. She now advocates for others. Rhonda recently launched BOOST – Better Outcomes Optimal Scientific Therapies™ to shift the culture of care and promote evidence-based therapies to improve patient outcomes. Rhonda’s work has garnered media attention including US News & World Report, WebMD, and CNNHealth.com. She appeared on the Today Show and has been featured in TIME magazine for her innovative community education program, Look Good, Feel Good: A Heart and Hair Affair which addresses disparities in healthcare. Rhonda also starred in a national Bayer aspirin commercial and was the recipient of the West Virginia Governor’s Volunteer Service Award. Rhonda is a native of Washington, D.C. currently residing in Charlotte, NC https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1f981082-3adc-449b-8b7f-fa68917f8e57/MONROE+Rhonda+%281%29.jpeg Rhonda Monroe - Rhonda Monroe Charlotte, United States Rhonda E. Monroe has overcome five coronary artery dissections, three heart attacks, two strokes, congestive heart failure, 3 defibrillator implants, a hematoma evacuation, a failed quadruple bypass surgery, failed stents, repeat bypass surgery, a pericardial window, and much more. She now advocates for others. Rhonda recently launched BOOST – Better Outcomes Optimal Scientific Therapies™ to shift the culture of care and promote evidence-based therapies to improve patient outcomes. Rhonda’s work has garnered media attention including US News & World Report, WebMD, and CNNHealth.com. She appeared on the Today Show and has been featured in TIME magazine for her innovative community education program, Look Good, Feel Good: A Heart and Hair Affair which addresses disparities in healthcare. Rhonda also starred in a national Bayer aspirin commercial and was the recipient of the West Virginia Governor’s Volunteer Service Award. Rhonda is a native of Washington, D.C. currently residing in Charlotte, NC https://www.3ctmeeting.com/peter-pickkers-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/aae890c4-ca08-4c52-adf2-8409995f10d8/Brian+Cuthbertson+photo+2017+%283%29.JPG Brian Cuthbertson - Brian Cuthbertson Nijmegen, Netherlands Brian Cuthbertson is an Attending Physician and former Chief of the Department of Critical Care Medicine at Sunnybrook Health Sciences Centre. He is a Professor in the University Department of Anaesthesiology and Pain Medicine as well as the Interdepartmental Division of Critical Care Medicine at the University of Toronto. He is the Vice Chair (Research) in the University Department of Anaesthesiology and Pain Medicine. He is also an Honorary Professor of Critical Care Medicine at the University of Aberdeen. His research interests include improving outcomes from critical illness and major surgery and he has led a large number of multicentre trials in these areas. He has over 200 peer-reviewed publications, $40million of research grants and an H index of 52. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/aae890c4-ca08-4c52-adf2-8409995f10d8/Brian+Cuthbertson+photo+2017+%283%29.JPG Brian Cuthbertson - Brian Cuthbertson Nijmegen, Netherlands Brian Cuthbertson is an Attending Physician and former Chief of the Department of Critical Care Medicine at Sunnybrook Health Sciences Centre. He is a Professor in the University Department of Anaesthesiology and Pain Medicine as well as the Interdepartmental Division of Critical Care Medicine at the University of Toronto. He is the Vice Chair (Research) in the University Department of Anaesthesiology and Pain Medicine. He is also an Honorary Professor of Critical Care Medicine at the University of Aberdeen. His research interests include improving outcomes from critical illness and major surgery and he has led a large number of multicentre trials in these areas. He has over 200 peer-reviewed publications, $40million of research grants and an H index of 52. https://www.3ctmeeting.com/peter-pickkers-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e89d6d45-0736-4e35-b6a5-61dcb94f2e05/R.+Mathew+-+ICU+photo+%281%29_page-0001.jpg Rebecca Mathew - Rebecca Mathew Ottawa, Canada Dr. Rebecca Mathew is a cardiologist and critical care medicine specialist at the University of Ottawa Heart Institute (UOHI). She is also appointed as an assistant professor in the Faculty of Medicine at the University of Ottawa. Dr. Mathew earned her medical degree at the Northern Ontario School of Medicine in 2012. She completed her residency in internal medicine at McMaster University in 2015. She subsequently completed a fellowship in adult cardiology at the UOHI in 2019. She pursued a fellowship in critical care medicine at the University of Ottawa, graduating in 2021. As a clinician investigator, Dr. Mathew’s clinical and research interests include all aspects of acute cardiac critical care, treatment strategies in cardiogenic shock and the long-term management and prognosis of survivors of cardiac critical illness. Her academic interest is focused on resident education in the critical care setting. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e89d6d45-0736-4e35-b6a5-61dcb94f2e05/R.+Mathew+-+ICU+photo+%281%29_page-0001.jpg Rebecca Mathew - Rebecca Mathew Ottawa, Canada Dr. Rebecca Mathew is a cardiologist and critical care medicine specialist at the University of Ottawa Heart Institute (UOHI). She is also appointed as an assistant professor in the Faculty of Medicine at the University of Ottawa. Dr. Mathew earned her medical degree at the Northern Ontario School of Medicine in 2012. She completed her residency in internal medicine at McMaster University in 2015. She subsequently completed a fellowship in adult cardiology at the UOHI in 2019. She pursued a fellowship in critical care medicine at the University of Ottawa, graduating in 2021. As a clinician investigator, Dr. Mathew’s clinical and research interests include all aspects of acute cardiac critical care, treatment strategies in cardiogenic shock and the long-term management and prognosis of survivors of cardiac critical illness. Her academic interest is focused on resident education in the critical care setting. https://www.3ctmeeting.com/peter-pickkers-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/fce2b454-0f2e-4341-8baf-54078bb5c427/Karakas+Mahir+%281%29.jpg Mahir Karakas - Mahir Karakas Hamburg, Germany Dr. Mahir Karakas is a 41-year-old specialist for cardiology, intensive care medicine, emergency medicine and genetic counseling at the University Medical Center Hamburg-Eppendorf in Germany. He is the designated “W3-Professoressor for translational research and innovative clinical trials” at the Hamburg University (Else Kroener-Fresenius-Foundation). His research ranges from issues related to the prevention of cardiovascular disease, biomarkers of cardiometabolic diseases to clinical pharmacology of cardiovascular compounds, and animal models of myocardial infarction. Furthermore, he is involved in multiple randomized multi-centre clinical trials evaluating the effects of new pharmacologic compounds in cardiometabolic diseases, infectious diseases and sepsis, and is the head of the steering committee of various multi-centre, randomized, double-blinded investigator-initiated trials in the field of acute coronary syndrome, atrial fibrillation, heart failure, cardiogenic shock, COVID-19, ARDS, and sepsis. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/fce2b454-0f2e-4341-8baf-54078bb5c427/Karakas+Mahir+%281%29.jpg Mahir Karakas - Mahir Karakas Hamburg, Germany Dr. Mahir Karakas is a 41-year-old specialist for cardiology, intensive care medicine, emergency medicine and genetic counseling at the University Medical Center Hamburg-Eppendorf in Germany. He is the designated “W3-Professoressor for translational research and innovative clinical trials” at the Hamburg University (Else Kroener-Fresenius-Foundation). His research ranges from issues related to the prevention of cardiovascular disease, biomarkers of cardiometabolic diseases to clinical pharmacology of cardiovascular compounds, and animal models of myocardial infarction. Furthermore, he is involved in multiple randomized multi-centre clinical trials evaluating the effects of new pharmacologic compounds in cardiometabolic diseases, infectious diseases and sepsis, and is the head of the steering committee of various multi-centre, randomized, double-blinded investigator-initiated trials in the field of acute coronary syndrome, atrial fibrillation, heart failure, cardiogenic shock, COVID-19, ARDS, and sepsis. https://www.3ctmeeting.com/peter-pickkers-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/35380bba-dfe7-4534-ae8f-4ca0183589c8/Zeymer+Uwe+%281%29.JPG Uwe Zeymer - Uwe Zeymer Ludwigshafen, Germany Doctor Uwe Zeymer is Head of Interventional Cardiology at the Heart Center Ludwigshafen, Department of Cardiology, Germany. He is Vice-Director of the Institut für Herzinfarktforschung Ludwigshafen. He has been board certified in internal medicine, cardiology, interventional cardiology and intensive care medicine. After his graduation from Medical School at the Universities of Munich and Marburg in 1985, Dr Zeymer gained experience as a resident, fellow and attendee in the Department of Cardiology, Municipal Hospital, Kassel, and as a clinical research fellow in the Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, USA. He is full Professoressor of Medicine at the University of Göttingen. Dr. Zeymer is or has chaired or been a member of the Steering Committee numerous trials in patients with acute coronary syndromes, antithrombotic therapies and anticoagulants. In addition he has been chair or member of the Steering committee of several international registries in interventional cardiology, treatment of hypertension, anticoagulation for atrial fibrillation and acute coronary syndromes. Dr. Zeymer has authored and co-authored over 450 scientific papers on cardiovascular disease in journals such as the New England Journal of Medicine, Lancet, JAMA, European Heart Journal, Circulation and Journal of the American College of Cardiology. Dr. Zeymer has been the Chair of the Scientific Committee of the Acute Cardiovascular Care Association of the ESC, the Chair of the Workung Group of Thrombosis of the German Cardiac Society and the Chair of the Working for Quality Insurance and Registries of the German Cardiac Society. He was President of the annual Autumn Meeting of the German Cardiac Society 2013. He is currently chairing the ongoing STEMI-Registry of the EORP of the ESC. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/35380bba-dfe7-4534-ae8f-4ca0183589c8/Zeymer+Uwe+%281%29.JPG Uwe Zeymer - Uwe Zeymer Ludwigshafen, Germany Doctor Uwe Zeymer is Head of Interventional Cardiology at the Heart Center Ludwigshafen, Department of Cardiology, Germany. He is Vice-Director of the Institut für Herzinfarktforschung Ludwigshafen. He has been board certified in internal medicine, cardiology, interventional cardiology and intensive care medicine. After his graduation from Medical School at the Universities of Munich and Marburg in 1985, Dr Zeymer gained experience as a resident, fellow and attendee in the Department of Cardiology, Municipal Hospital, Kassel, and as a clinical research fellow in the Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, USA. He is full Professoressor of Medicine at the University of Göttingen. Dr. Zeymer is or has chaired or been a member of the Steering Committee numerous trials in patients with acute coronary syndromes, antithrombotic therapies and anticoagulants. In addition he has been chair or member of the Steering committee of several international registries in interventional cardiology, treatment of hypertension, anticoagulation for atrial fibrillation and acute coronary syndromes. Dr. Zeymer has authored and co-authored over 450 scientific papers on cardiovascular disease in journals such as the New England Journal of Medicine, Lancet, JAMA, European Heart Journal, Circulation and Journal of the American College of Cardiology. Dr. Zeymer has been the Chair of the Scientific Committee of the Acute Cardiovascular Care Association of the ESC, the Chair of the Workung Group of Thrombosis of the German Cardiac Society and the Chair of the Working for Quality Insurance and Registries of the German Cardiac Society. He was President of the annual Autumn Meeting of the German Cardiac Society 2013. He is currently chairing the ongoing STEMI-Registry of the EORP of the ESC. https://www.3ctmeeting.com/peter-pickkers-copy-copy-copy-copy-copy-copy-copy daily 0.75 2025-06-18 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/5762aa12-7fa3-4eab-817c-7d44e18985ca/Van+Spall+Hariette+%281%29.jpg Harriette Van Spall - Harriette Van Spall Hamilton, Canada Dr. Van Spall is a cardiologist, clinical trialist, and implementation scientist funded by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada. She leads both investigator-initiated and industry-sponsored Phase III clinical trials in heart failure. In addition to industry funding, she has garnered more than $6.2 million in peer-reviewed research funding and has won several research awards, including the prestigious Canadian Institutes of Health Research Mid-Career Lectureship Award in Cardiovascular Sciences and the American Heart Association Nanette Wenger Research Award. Her work is published in high-impact medical journals and cited in international guidelines and by regulatory and federal funding agencies. She is a member of international guideline committees and clinical trial steering committees. She is an invited speaker, media correspondent, and an editorial board member at several leading CV journals including those in the EHJ, Circulation, and JACC family. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/5762aa12-7fa3-4eab-817c-7d44e18985ca/Van+Spall+Hariette+%281%29.jpg Harriette Van Spall - Harriette Van Spall Hamilton, Canada Dr. Van Spall is a cardiologist, clinical trialist, and implementation scientist funded by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada. She leads both investigator-initiated and industry-sponsored Phase III clinical trials in heart failure. In addition to industry funding, she has garnered more than $6.2 million in peer-reviewed research funding and has won several research awards, including the prestigious Canadian Institutes of Health Research Mid-Career Lectureship Award in Cardiovascular Sciences and the American Heart Association Nanette Wenger Research Award. Her work is published in high-impact medical journals and cited in international guidelines and by regulatory and federal funding agencies. She is a member of international guideline committees and clinical trial steering committees. She is an invited speaker, media correspondent, and an editorial board member at several leading CV journals including those in the EHJ, Circulation, and JACC family. https://www.3ctmeeting.com/peter-pickkers-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/160f8a61-ef78-4906-a0f8-81625de6cc34/Sionis+Alessandro+%281%29.jpg Alessandro Sionis - Alessandro Sionis Barcelona, Spain Dr. Sionis is the Director of the Acute Cardiac Unit at Hospital de la Santa Creu i Sant Pau in Barcelona and Professor of Cardiology at the Universitat Autònoma de Barcelona. He is the past-President of the Acute Cardiovascular Care Chapter of the Spanish Society of Cardiology. He is the current Secretary and member of the executive Board of the Association for Acute Cardiovascular Care of the European Society of Cardiology (ESC), member of the Education Committee of ESC, Chair of the Council for Accreditation and Certification of the ESC and Vice-president for UEMS (European Union of Medical Specialists) Cardiology. He has published over 300 scientific articles in peer-reviewed medical journals mainly in the fields of cardiology, emergency medicine and critical care. His research interests have largely focused on acute and critical care cardiology. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/160f8a61-ef78-4906-a0f8-81625de6cc34/Sionis+Alessandro+%281%29.jpg Alessandro Sionis - Alessandro Sionis Barcelona, Spain Dr. Sionis is the Director of the Acute Cardiac Unit at Hospital de la Santa Creu i Sant Pau in Barcelona and Professor of Cardiology at the Universitat Autònoma de Barcelona. He is the past-President of the Acute Cardiovascular Care Chapter of the Spanish Society of Cardiology. He is the current Secretary and member of the executive Board of the Association for Acute Cardiovascular Care of the European Society of Cardiology (ESC), member of the Education Committee of ESC, Chair of the Council for Accreditation and Certification of the ESC and Vice-president for UEMS (European Union of Medical Specialists) Cardiology. He has published over 300 scientific articles in peer-reviewed medical journals mainly in the fields of cardiology, emergency medicine and critical care. His research interests have largely focused on acute and critical care cardiology. https://www.3ctmeeting.com/peter-pickkers-copy-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/10f3263a-7466-485a-8d40-87a173780ff8/PHOTO-2021-12-07-15-59-27+copia+%281%29.jpg Alice Sacco - Alice Sacco Milan, Italy Dr. Alice Sacco, an intensivist cardiologist, has been working at the CICU of "De Gasperis" Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, since 2008. She obtained the "Lifelong II level Certification in Acute Cardiac Care" from the European Society of Cardiology in 2016. Her expertise lies in the management of acute coronary syndromes, myocarditis, pulmonary embolism and cardiogenic shock. Her research focuses on cardiogenic shock and pulmonary embolism, with a strong interest in end-of-life management and bioethics. She loves classical music and the mountains. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/10f3263a-7466-485a-8d40-87a173780ff8/PHOTO-2021-12-07-15-59-27+copia+%281%29.jpg Alice Sacco - Alice Sacco Milan, Italy Dr. Alice Sacco, an intensivist cardiologist, has been working at the CICU of "De Gasperis" Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, since 2008. She obtained the "Lifelong II level Certification in Acute Cardiac Care" from the European Society of Cardiology in 2016. Her expertise lies in the management of acute coronary syndromes, myocarditis, pulmonary embolism and cardiogenic shock. Her research focuses on cardiogenic shock and pulmonary embolism, with a strong interest in end-of-life management and bioethics. She loves classical music and the mountains. https://www.3ctmeeting.com/peter-pickkers-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/f9b358cf-019f-4438-8f1c-3522136fea41/ALAIN+COMBES+REAPITIESALPETRIERE001+%283%29.jpg Alain Combes - Alain Combes Paris, France Professor Alain Combes, MD, PhD is Professor of Intensive Care Medicine at Sorbonne Université, Paris, and head of the ICU department at La Pitié-Salpêtrière Hospital, Assistance Publique Hopitaux de Paris, France. Main research interests: -Care of the critically ill cardiac patient (cardiogenic shock, acute myocardial infarction, cardiac arrest, complicated heart surgery and heart transplantation) -Mechanical circulatory assistance and extracorporeal membrane oxygenation - Rescue therapies for severe respiratory failure, including ECMO and ECCO2R -Infections in critically patients, such as pulmonary infections in mechanically ventilated ICU patients and endocarditis. Professor Combes is Member of -The Société de Réanimation de Langue Française (SRLF) -The European Society of Intensive Care Medicine (ESICM) -Editor of Intensive Care Medicine -The American Thoracic Society (ATS) -The European Society of Cardiology (ESC) -The Association for Acute CardioVascular Care, ESC-ACVC oBoard member of the ESC-ACVC -The Extra Corporeal Life Support Organization (ELSO), oPast President of the EURO-ELSO -The International ECMO network (ECMONet) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/f9b358cf-019f-4438-8f1c-3522136fea41/ALAIN+COMBES+REAPITIESALPETRIERE001+%283%29.jpg Alain Combes - Alain Combes Paris, France Professor Alain Combes, MD, PhD is Professor of Intensive Care Medicine at Sorbonne Université, Paris, and head of the ICU department at La Pitié-Salpêtrière Hospital, Assistance Publique Hopitaux de Paris, France. Main research interests: -Care of the critically ill cardiac patient (cardiogenic shock, acute myocardial infarction, cardiac arrest, complicated heart surgery and heart transplantation) -Mechanical circulatory assistance and extracorporeal membrane oxygenation - Rescue therapies for severe respiratory failure, including ECMO and ECCO2R -Infections in critically patients, such as pulmonary infections in mechanically ventilated ICU patients and endocarditis. Professor Combes is Member of -The Société de Réanimation de Langue Française (SRLF) -The European Society of Intensive Care Medicine (ESICM) -Editor of Intensive Care Medicine -The American Thoracic Society (ATS) -The European Society of Cardiology (ESC) -The Association for Acute CardioVascular Care, ESC-ACVC oBoard member of the ESC-ACVC -The Extra Corporeal Life Support Organization (ELSO), oPast President of the EURO-ELSO -The International ECMO network (ECMONet) https://www.3ctmeeting.com/alain-combes-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/302bc871-e19b-44df-963d-ef560902cfc9/Gorgis+Sarah+%281%29.jpg Sarah Gorgis - Sarah Gorgis Cleveland, United States Sarah Gorgis MD is a Cardiac Intensivist at Henry Ford Hospital in Detroit, Michigan. She served as Chief Medical Resident and Chief Cardiology Fellow at Henry Ford Hospital and went on to do Critical Care Medicine training at the Cleveland Clinic. She was an investigator with the National Cardiogenic Shock Initiative and has participated in many prospective trials involving acute myocardial infarction and cardiogenic shock. Her clinical interests are in managing complex mixed shock, optimizing ventilator settings in cardiogenic shock, mechanical support devices, RV dysfunction, antiplatelet therapy in AMICS, and cardiopulmonary exercise testing. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/302bc871-e19b-44df-963d-ef560902cfc9/Gorgis+Sarah+%281%29.jpg Sarah Gorgis - Sarah Gorgis Cleveland, United States Sarah Gorgis MD is a Cardiac Intensivist at Henry Ford Hospital in Detroit, Michigan. She served as Chief Medical Resident and Chief Cardiology Fellow at Henry Ford Hospital and went on to do Critical Care Medicine training at the Cleveland Clinic. She was an investigator with the National Cardiogenic Shock Initiative and has participated in many prospective trials involving acute myocardial infarction and cardiogenic shock. Her clinical interests are in managing complex mixed shock, optimizing ventilator settings in cardiogenic shock, mechanical support devices, RV dysfunction, antiplatelet therapy in AMICS, and cardiopulmonary exercise testing. https://www.3ctmeeting.com/alain-combes-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6c2bd39e-798e-4a60-a1a2-649edb5bbe0b/LZ_2024+%282%29.jpg Lucy Zhang - Lucy Zhang Falls Church, United States Dr. Zhang is a neurointensivist and stroke neurologist at Inova Fairfax Hospital in Northern Virginia. She is an adjunct professor at University of Virginia School of Medicine. She completed her vascular neurology training at Cleveland Clinic, followed by neurocritical care fellowship at Johns Hopkins. Her research area of interest is neurologic complications of patients on mechanical circulatory support devices. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6c2bd39e-798e-4a60-a1a2-649edb5bbe0b/LZ_2024+%282%29.jpg Lucy Zhang - Lucy Zhang Falls Church, United States Dr. Zhang is a neurointensivist and stroke neurologist at Inova Fairfax Hospital in Northern Virginia. She is an adjunct professor at University of Virginia School of Medicine. She completed her vascular neurology training at Cleveland Clinic, followed by neurocritical care fellowship at Johns Hopkins. Her research area of interest is neurologic complications of patients on mechanical circulatory support devices. https://www.3ctmeeting.com/alain-combes-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2364464a-88b9-49cd-8d05-92bd8eed5019/Balim+Senman+%283%29.jpeg Balimkiz Senman - Balimkiz Senman Durham, United States Balim Senman, MD, is a senior Cardiology fellow at Duke University. She completed her Internal Medicine training at Brigham and Women’s Hospital. Following her general Cardiology training, she will become a fellow in Critical Care Medicine at Duke and then plans to pursue an additional year of Interventional Cardiology fellowship training thereafter. Dr. Senman has an extensive background in basic science immunology research, but more recently has pivoted to clinical investigation focused on cardiogenic shock, resuscitation, and the design and testing of novel ways to optimize mechanical circulatory support. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2364464a-88b9-49cd-8d05-92bd8eed5019/Balim+Senman+%283%29.jpeg Balimkiz Senman - Balimkiz Senman Durham, United States Balim Senman, MD, is a senior Cardiology fellow at Duke University. She completed her Internal Medicine training at Brigham and Women’s Hospital. Following her general Cardiology training, she will become a fellow in Critical Care Medicine at Duke and then plans to pursue an additional year of Interventional Cardiology fellowship training thereafter. Dr. Senman has an extensive background in basic science immunology research, but more recently has pivoted to clinical investigation focused on cardiogenic shock, resuscitation, and the design and testing of novel ways to optimize mechanical circulatory support. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/57eeac5c-d2cf-44b8-8b8b-aab5bba24a96/KRUCOFF+Mitchell+%281%29.png Mitchell Krucoff - Mitchell Krucoff Durham, United States Dr. Mitchell W. Krucoff, interventional cardiologist, graduated Yale University 1976 Magna Cum Laude, and M.D. and Alpha Omega Alpha Medical Honor Society from George Washington University 1980. At Duke University since 1988 he is tenured Professor of Medicine/Cardiology and Director of the Cardiovascular Devices Unit at the DCRI, and works as a Special Government Employee for the U.S. Food and Drug Administration (FDA). Under FDA-Duke Memos of Understanding he co-Directs 3 public-private partnerships focused on regulatory landscape with regard to cardiac safety (CSRC), medical device evidence (NEST PASSION Programs) and international regulatory harmonization (Japan-USA HBD). He has been principal investigator, study chair, executive committee, steering committee and safety monitoring committees of numerous medical device studies with over 450 publications. He is the founding Co-chair of the American Heart Association Cardiogenic Shock Registry and a founding Board member of the Academic Research Consortium (ARC). https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/57eeac5c-d2cf-44b8-8b8b-aab5bba24a96/KRUCOFF+Mitchell+%281%29.png Mitchell Krucoff - Mitchell Krucoff Durham, United States Dr. Mitchell W. Krucoff, interventional cardiologist, graduated Yale University 1976 Magna Cum Laude, and M.D. and Alpha Omega Alpha Medical Honor Society from George Washington University 1980. At Duke University since 1988 he is tenured Professor of Medicine/Cardiology and Director of the Cardiovascular Devices Unit at the DCRI, and works as a Special Government Employee for the U.S. Food and Drug Administration (FDA). Under FDA-Duke Memos of Understanding he co-Directs 3 public-private partnerships focused on regulatory landscape with regard to cardiac safety (CSRC), medical device evidence (NEST PASSION Programs) and international regulatory harmonization (Japan-USA HBD). He has been principal investigator, study chair, executive committee, steering committee and safety monitoring committees of numerous medical device studies with over 450 publications. He is the founding Co-chair of the American Heart Association Cardiogenic Shock Registry and a founding Board member of the Academic Research Consortium (ARC). https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/89d97740-8ad4-4e4e-91f4-127c161e9a02/Sato+Naoki+%281%29.png Naoki Sato - Naoki Sato Tokyo, Japan After completing medical school from Nippon Medical School (NMS) in Tokyo, Japan, Dr.Sato did his residency for two years at NMS and had trained cardiac catheterization and intervention for another three years. He had done basic research regarding heart failure under the direction of Prof. Stephen F. Vatner at Harvard Medical School for 4 years. He had several awards, e.g., AHA Melvin L. Marcus Young Investigator Award in Cardiovascular Integrated Physiology, the Samuel A. Levine award from AHA, Massachusetts affiliate, etc. He was professor of department of cardiovascular medicine and director of intensive care unit in NMS. He conducted many trials and registries, such as the largest acute heart failure registry (ATTEND) in Japan and works as a PI for many HF trials including global trials. His speciality is heart failure. He works as executive director of the Japanese Heart Failure Society and Japanese Society of Intensive Care Medicine. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/89d97740-8ad4-4e4e-91f4-127c161e9a02/Sato+Naoki+%281%29.png Naoki Sato - Naoki Sato Tokyo, Japan After completing medical school from Nippon Medical School (NMS) in Tokyo, Japan, Dr.Sato did his residency for two years at NMS and had trained cardiac catheterization and intervention for another three years. He had done basic research regarding heart failure under the direction of Prof. Stephen F. Vatner at Harvard Medical School for 4 years. He had several awards, e.g., AHA Melvin L. Marcus Young Investigator Award in Cardiovascular Integrated Physiology, the Samuel A. Levine award from AHA, Massachusetts affiliate, etc. He was professor of department of cardiovascular medicine and director of intensive care unit in NMS. He conducted many trials and registries, such as the largest acute heart failure registry (ATTEND) in Japan and works as a PI for many HF trials including global trials. His speciality is heart failure. He works as executive director of the Japanese Heart Failure Society and Japanese Society of Intensive Care Medicine. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/99314d7c-f2f4-48c1-94fb-c073e847ece3/Spencer+Stuart+%281%29.jpg Stuart Spencer - Stuart Spencer London, United Kingdom Stuart Spencer joined The Lancet in 1999 and throughout his time there has led the Fast Track team that aims to select, review and publish prestigious manuscripts within 4 weeks of receipt. After graduating Stuart moved into research which started at the Brompton Hospital, London, looking at scoliosis in children before moving to the Veterinary School site at Bristol University. During this period he was invited to establish a research unit in The Netherlands. Later he set up a research team for a major pharmaceutical company in Switzerland, and then spent 9 years as a senior researcher in New Zealand. He has had two senior research fellowships at Leuven University, Belgium, and visiting Professoressorships at King’s College, London and Hong Kong University, and a doctorate of medicine from Umea University, Sweden. Stuart is also a Trustee of the Scoliosis Association (UK), is on the British Scoliosis Research Fund grants committee, and the steering Committee of the Swedish National GP Research School. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/99314d7c-f2f4-48c1-94fb-c073e847ece3/Spencer+Stuart+%281%29.jpg Stuart Spencer - Stuart Spencer London, United Kingdom Stuart Spencer joined The Lancet in 1999 and throughout his time there has led the Fast Track team that aims to select, review and publish prestigious manuscripts within 4 weeks of receipt. After graduating Stuart moved into research which started at the Brompton Hospital, London, looking at scoliosis in children before moving to the Veterinary School site at Bristol University. During this period he was invited to establish a research unit in The Netherlands. Later he set up a research team for a major pharmaceutical company in Switzerland, and then spent 9 years as a senior researcher in New Zealand. He has had two senior research fellowships at Leuven University, Belgium, and visiting Professoressorships at King’s College, London and Hong Kong University, and a doctorate of medicine from Umea University, Sweden. Stuart is also a Trustee of the Scoliosis Association (UK), is on the British Scoliosis Research Fund grants committee, and the steering Committee of the Swedish National GP Research School. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/a0871932-d48f-42cf-bb9f-97b74a7a7952/BEIRAS-Andres-_1_.jpg Andres Beiras - Andres Beiras Getinge, Germany Professor Andres Beiras-Fernandez joined Getinge AB as Global Medical Director of the Cardiopulmonary Business within the Department of Corporate Medical Affairs, providing clinical experience in a highly motivated work environment comprising Medical & Clinical Affairs. Formerly, he occupied the position of Deputy Chairman (Ltd. OA) at the Clinic for Thoracic, Cardiac and Thoracic Vascular Surgery, University of Mainz, Germany. The focus of his scientific research is endothelial inflammation and perfusion systems, while his clinical focus is cardiac assist (IABP, ECLS/ECMO, Impella) and LVAD implantation. He led the mechanical circulatory support program at the University of Mainz. Surgical focus is the minimal-invasive off-pump LVAD implantation and hybrid-surgery, including MVR (Neochord) and ventricle remodeling (Bioventrix). Certified for transapical and transfemoral aortic TAVI procedures. High Interest in Mitral and Tricuspid interventional treatment, including TMVR and replacement. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/a0871932-d48f-42cf-bb9f-97b74a7a7952/BEIRAS-Andres-_1_.jpg Andres Beiras - Andres Beiras Getinge, Germany Professor Andres Beiras-Fernandez joined Getinge AB as Global Medical Director of the Cardiopulmonary Business within the Department of Corporate Medical Affairs, providing clinical experience in a highly motivated work environment comprising Medical & Clinical Affairs. Formerly, he occupied the position of Deputy Chairman (Ltd. OA) at the Clinic for Thoracic, Cardiac and Thoracic Vascular Surgery, University of Mainz, Germany. The focus of his scientific research is endothelial inflammation and perfusion systems, while his clinical focus is cardiac assist (IABP, ECLS/ECMO, Impella) and LVAD implantation. He led the mechanical circulatory support program at the University of Mainz. Surgical focus is the minimal-invasive off-pump LVAD implantation and hybrid-surgery, including MVR (Neochord) and ventricle remodeling (Bioventrix). Certified for transapical and transfemoral aortic TAVI procedures. High Interest in Mitral and Tricuspid interventional treatment, including TMVR and replacement. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/5f7dbc63-48cc-4f4b-bcb9-ad835105fd37/BOURGEOIS+Karine+%281%29.jpg Karine Bourgeois - Karine Bourgeois 4TEEN4, Germany Author of more than 300 papers with more than 42000 citations, H index 88. The main field of interest and research are Sepsis, Infection, Mechanical ventilation, ARDS. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/5f7dbc63-48cc-4f4b-bcb9-ad835105fd37/BOURGEOIS+Karine+%281%29.jpg Karine Bourgeois - Karine Bourgeois 4TEEN4, Germany Author of more than 300 papers with more than 42000 citations, H index 88. The main field of interest and research are Sepsis, Infection, Mechanical ventilation, ARDS. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/a5e9323b-d3e8-4d8c-8fa5-e4a15409ff9d/KOSTRUBIEC+Maciej.jpg Maciej Kostrubiec - Maciej Kostrubiec EMA, Poland Prof. Maciej Kostrubiec, MD, PhD has been a cardiologist consultant at Mid and South Essex Hospital NHS Trust in the United Kingdom since 2019 and he is a lecturer at The Medical University of Warsaw, Fellow of the European Cardiac Society (FESC), and Fellow of European Association of Cardiovascular Imaging (FEACVI). Since 2012, he has been a subject matter expert at The Office for Registration of Medicinal Products in Poland and The European Medicines Agency (EMA). Also, a member of the EMA Cardiovascular Working Party of CHMP. Prof. Kostrubiec is an expert in the fields of right heart failure, especially secondary to venous thromboembolic disease and imaging cardiology including invasive investigations (RHC/LHC). Currently, in the UK he is primarily involved in specialist service for patients with heart failure with a special interest in HFpHF and cardiac imaging (echo and cardiac CT). https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/a5e9323b-d3e8-4d8c-8fa5-e4a15409ff9d/KOSTRUBIEC+Maciej.jpg Maciej Kostrubiec - Maciej Kostrubiec EMA, Poland Prof. Maciej Kostrubiec, MD, PhD has been a cardiologist consultant at Mid and South Essex Hospital NHS Trust in the United Kingdom since 2019 and he is a lecturer at The Medical University of Warsaw, Fellow of the European Cardiac Society (FESC), and Fellow of European Association of Cardiovascular Imaging (FEACVI). Since 2012, he has been a subject matter expert at The Office for Registration of Medicinal Products in Poland and The European Medicines Agency (EMA). Also, a member of the EMA Cardiovascular Working Party of CHMP. Prof. Kostrubiec is an expert in the fields of right heart failure, especially secondary to venous thromboembolic disease and imaging cardiology including invasive investigations (RHC/LHC). Currently, in the UK he is primarily involved in specialist service for patients with heart failure with a special interest in HFpHF and cardiac imaging (echo and cardiac CT). https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2fc52bd1-e026-4740-b208-95bc1a63c481/Sopko+George+%281%29.png George Sopko - George Sopko NHLBI, United States Dr. Sopko plans, develops, directs, coordinates, and conducts basic, applied, and clinical research in cardiovascular disease. He has responsibility for promoting efforts to enhance understanding of the etiology and pathophysiology of heart disease; to improve its methods of diagnosis, treatment and prevention; to participate in developing policy and prioritization regarding pioneering research programs, both domestic and international, to meet national needs. He served as the Program or Deputy Program Director for many NIH-supported clinical studies, notably Catheter Ablation Registry (CAR), Thrombolysis In Myocardial Infarction (TIMI II), Coronary Artery Surgery Study (CASS), Bypass Angioplasty Revascularization Investigation (BARI), Women’s Ischemic Syndrome Evaluation (WISE1 and WISE2), Occluded Artery Trial (OAT), Surgical Treatment of Congestive Heart Failure (STICH), Resuscitation Outcomes Consortium (ROC), SIREN (Strategies to Innovate EmeRgENcy Care Clinical Trials). Dr. Sopko has served on multiple NIH task forces and panels and co-chaired a number of workshop/working groups, served as the NIH or NHLBI representative, and has received a number of awards. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/2fc52bd1-e026-4740-b208-95bc1a63c481/Sopko+George+%281%29.png George Sopko - George Sopko NHLBI, United States Dr. Sopko plans, develops, directs, coordinates, and conducts basic, applied, and clinical research in cardiovascular disease. He has responsibility for promoting efforts to enhance understanding of the etiology and pathophysiology of heart disease; to improve its methods of diagnosis, treatment and prevention; to participate in developing policy and prioritization regarding pioneering research programs, both domestic and international, to meet national needs. He served as the Program or Deputy Program Director for many NIH-supported clinical studies, notably Catheter Ablation Registry (CAR), Thrombolysis In Myocardial Infarction (TIMI II), Coronary Artery Surgery Study (CASS), Bypass Angioplasty Revascularization Investigation (BARI), Women’s Ischemic Syndrome Evaluation (WISE1 and WISE2), Occluded Artery Trial (OAT), Surgical Treatment of Congestive Heart Failure (STICH), Resuscitation Outcomes Consortium (ROC), SIREN (Strategies to Innovate EmeRgENcy Care Clinical Trials). Dr. Sopko has served on multiple NIH task forces and panels and co-chaired a number of workshop/working groups, served as the NIH or NHLBI representative, and has received a number of awards. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/453bfe36-fc37-4afd-8d6e-de19daa2fd57/Rosner+Carolyn+%281%29.jpg Carolyn Rosner - Carolyn Rosner Falls Church, United States Carolyn Rosner, MSN, NP-C, MBA is the Director of Innovative Programs at Inova Heart and Vascular Institute, overseeing the strategy and operations of several cardiovascular programs, including ECMO, cardiogenic shock, complex coronary therapeutics and interventional heart failure. Clinical and research expertise encompasses the management of cardiogenic shock, complex coronary artery disease, as well as decompensated heart failure and adult congenital heart disease. She completed all of her nursing education at Marymount University, including an MSN with a concentration as a Family Nurse Practitioner in 2011, and completed an MBA in Health Care Management from the Johns Hopkins University’s Carey Business School. She is passionate about improving access, quality and value in cardiovascular care and improving the utilization of advanced practice providers in the health care system. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/453bfe36-fc37-4afd-8d6e-de19daa2fd57/Rosner+Carolyn+%281%29.jpg Carolyn Rosner - Carolyn Rosner Falls Church, United States Carolyn Rosner, MSN, NP-C, MBA is the Director of Innovative Programs at Inova Heart and Vascular Institute, overseeing the strategy and operations of several cardiovascular programs, including ECMO, cardiogenic shock, complex coronary therapeutics and interventional heart failure. Clinical and research expertise encompasses the management of cardiogenic shock, complex coronary artery disease, as well as decompensated heart failure and adult congenital heart disease. She completed all of her nursing education at Marymount University, including an MSN with a concentration as a Family Nurse Practitioner in 2011, and completed an MBA in Health Care Management from the Johns Hopkins University’s Carey Business School. She is passionate about improving access, quality and value in cardiovascular care and improving the utilization of advanced practice providers in the health care system. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e7073ec5-9235-4524-ab4b-ef0ce4cedead/Wesley_Self_photo+%281%29.jpg Wesley Self - Wesley Self Nashville, United States Wesley Self, MD, MPH is the Vice President for Clinical Research Networks & Strategy at Vanderbilt University Medical Center, a practicing emergency physician, and clinical researcher. He leads a team of investigators and study personnel that has successfully conducted numerous clinical trials and epidemiologic programs during the past decade in ARDS, sepsis, and pneumonia. He has published over 180 peer reviewed manuscripts, was named one of the top 90 pneumonia researchers in the world in 2018 and co-authored the 2021 American College of Emergency Physicians sepsis guidelines. He is the principal investigator of several multicenter research programs, including the CDC-funded IVY Network, which is a national program investigating the epidemiology of respiratory viruses and vaccines effectiveness, and the clinical coordinating center for the NHLBI-funded ACTIV-4 host response clinical trials platform, which is a program investigating host-targeted investigational drugs for the treatment of COVID-19. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e7073ec5-9235-4524-ab4b-ef0ce4cedead/Wesley_Self_photo+%281%29.jpg Wesley Self - Wesley Self Nashville, United States Wesley Self, MD, MPH is the Vice President for Clinical Research Networks & Strategy at Vanderbilt University Medical Center, a practicing emergency physician, and clinical researcher. He leads a team of investigators and study personnel that has successfully conducted numerous clinical trials and epidemiologic programs during the past decade in ARDS, sepsis, and pneumonia. He has published over 180 peer reviewed manuscripts, was named one of the top 90 pneumonia researchers in the world in 2018 and co-authored the 2021 American College of Emergency Physicians sepsis guidelines. He is the principal investigator of several multicenter research programs, including the CDC-funded IVY Network, which is a national program investigating the epidemiology of respiratory viruses and vaccines effectiveness, and the clinical coordinating center for the NHLBI-funded ACTIV-4 host response clinical trials platform, which is a program investigating host-targeted investigational drugs for the treatment of COVID-19. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-1 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1a2d8f63-7acf-4165-b222-995a510fc98a/profile_pic+%281%29.png Amelia Maiga - Amelia Maiga Nashville, United States Amelia Maiga, MD, MPH is a trauma surgeon, intensivist, and NIH-funded scientist committed to changing practice for patients with critical illness and injury. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1a2d8f63-7acf-4165-b222-995a510fc98a/profile_pic+%281%29.png Amelia Maiga - Amelia Maiga Nashville, United States Amelia Maiga, MD, MPH is a trauma surgeon, intensivist, and NIH-funded scientist committed to changing practice for patients with critical illness and injury. https://www.3ctmeeting.com/alain-combes-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-copy-1-1 daily 0.75 2024-06-05 https://www.3ctmeeting.com/wesley-self-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/5dc0ef6d-2880-4fc5-91ab-6c4dd9611337/Ghorbel+Anis+%281%29.jpg Anis Ghorbel - Anis Ghorbel Precisia Care, Switzerland Anis Ghorbel, CEO and Co-Founder of Precisia Care SA, brings 15 years of international experience in technology and medical software to the company. He is a French engineer with a background in computer science and an EMBA from Mediterranean School of Business. Anis has led projects in major hospitals across the USA, Europe, and North Africa. With entrepreneurial experience, Anis co-founded Precisia Care, a Swiss startup that focuses on empowering healthcare providers with innovative solutions and cutting-edge technology. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/5dc0ef6d-2880-4fc5-91ab-6c4dd9611337/Ghorbel+Anis+%281%29.jpg Anis Ghorbel - Anis Ghorbel Precisia Care, Switzerland Anis Ghorbel, CEO and Co-Founder of Precisia Care SA, brings 15 years of international experience in technology and medical software to the company. He is a French engineer with a background in computer science and an EMBA from Mediterranean School of Business. Anis has led projects in major hospitals across the USA, Europe, and North Africa. With entrepreneurial experience, Anis co-founded Precisia Care, a Swiss startup that focuses on empowering healthcare providers with innovative solutions and cutting-edge technology. https://www.3ctmeeting.com/wesley-self-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c55e8b49-e234-483d-b6df-33efad3ae7bb/Barkauskas+Christina+%282%29.jpg Christina Barkauskas - Christina Barkauskas Durham, United States Wesley Christina Barkauskas is a pulmonologist, intensivist, and stem cell biologist (Assistant Professoressor of Medicine - Pulmonary, Allergy, and Critical Care Medicine at Duke University). She has extensive experience with multi-site COVID therapeutic trials, and has extensive basic science background with expertise in understanding the fundamental mechanisms involved in lung injury and repair and in exploring novel treatments for acute respiratory distress syndrome (ARDS). As a practicing pulmonary and critical care physician, she is an expert in management of patients with lung disorders, critical illness, and the sequelae thereof. She is currently the co-chair of ACTIV3b/TESICO: Therapeutics for Severely Ill Inpatients with COVID-19, a multi-site international platform study evaluating the safety and efficacy of aviptadil vs. placebo in patients with ARDS.Self, MD, MPH is the Vice President for Clinical Research Networks & Strategy at Vanderbilt University Medical Center, a practicing emergency physician, and clinical researcher. He leads a team of investigators and study personnel that has successfully conducted numerous clinical trials and epidemiologic programs during the past decade in ARDS, sepsis, and pneumonia. He has published over 180 peer reviewed manuscripts, was named one of the top 90 pneumonia researchers in the world in 2018 and co-authored the 2021 American College of Emergency Physicians sepsis guidelines. He is the principal investigator of several multicenter research programs, including the CDC-funded IVY Network, which is a national program investigating the epidemiology of respiratory viruses and vaccines effectiveness, and the clinical coordinating center for the NHLBI-funded ACTIV-4 host response clinical trials platform, which is a program investigating host-targeted investigational drugs for the treatment of COVID-19. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c55e8b49-e234-483d-b6df-33efad3ae7bb/Barkauskas+Christina+%282%29.jpg Christina Barkauskas - Christina Barkauskas Durham, United States Wesley Christina Barkauskas is a pulmonologist, intensivist, and stem cell biologist (Assistant Professoressor of Medicine - Pulmonary, Allergy, and Critical Care Medicine at Duke University). She has extensive experience with multi-site COVID therapeutic trials, and has extensive basic science background with expertise in understanding the fundamental mechanisms involved in lung injury and repair and in exploring novel treatments for acute respiratory distress syndrome (ARDS). As a practicing pulmonary and critical care physician, she is an expert in management of patients with lung disorders, critical illness, and the sequelae thereof. She is currently the co-chair of ACTIV3b/TESICO: Therapeutics for Severely Ill Inpatients with COVID-19, a multi-site international platform study evaluating the safety and efficacy of aviptadil vs. placebo in patients with ARDS.Self, MD, MPH is the Vice President for Clinical Research Networks & Strategy at Vanderbilt University Medical Center, a practicing emergency physician, and clinical researcher. He leads a team of investigators and study personnel that has successfully conducted numerous clinical trials and epidemiologic programs during the past decade in ARDS, sepsis, and pneumonia. He has published over 180 peer reviewed manuscripts, was named one of the top 90 pneumonia researchers in the world in 2018 and co-authored the 2021 American College of Emergency Physicians sepsis guidelines. He is the principal investigator of several multicenter research programs, including the CDC-funded IVY Network, which is a national program investigating the epidemiology of respiratory viruses and vaccines effectiveness, and the clinical coordinating center for the NHLBI-funded ACTIV-4 host response clinical trials platform, which is a program investigating host-targeted investigational drugs for the treatment of COVID-19. https://www.3ctmeeting.com/wesley-self-copy-copy-1 daily 0.75 2024-06-13 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3dd07034-f328-4325-8e19-9ef4e69ed3d4/SAHETYA+sarina+1+%281%29.jpg Sarina Sahetya - Sarina Saheyta Baltimore, United States Dr. Sarina Sahetya is an Assistant Professor and the Director of Quality and Safety for the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University. Dr. Sahetya received her undergraduate degree from Vanderbilt University and her medical degree from the University of Louisville School of Medicine. She completed her Internal Medicine residency and Pulmonary and Critical Care training at Johns Hopkins Hospital prior to joining as faculty. She also earned a Masters of Health Sciences in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Sahetya’s research focuses on utilizing respiratory physiology to optimize mechanical ventilation for patients with acute respiratory failure. Currently, she has funding from the NIH and DoD to investigate the use of a driving pressure-targeted mechanical ventilation strategy for patients with ARDS. She has contributed to international consensus recommendations on lung and diaphragm protective mechanical ventilation and was a co-chair for the recent American Thoracic Society Clinical Practice Guideline for the Management of Patients with Acute Respiratory Distress Syndrome. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3dd07034-f328-4325-8e19-9ef4e69ed3d4/SAHETYA+sarina+1+%281%29.jpg Sarina Sahetya - Sarina Saheyta Baltimore, United States Dr. Sarina Sahetya is an Assistant Professor and the Director of Quality and Safety for the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University. Dr. Sahetya received her undergraduate degree from Vanderbilt University and her medical degree from the University of Louisville School of Medicine. She completed her Internal Medicine residency and Pulmonary and Critical Care training at Johns Hopkins Hospital prior to joining as faculty. She also earned a Masters of Health Sciences in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Sahetya’s research focuses on utilizing respiratory physiology to optimize mechanical ventilation for patients with acute respiratory failure. Currently, she has funding from the NIH and DoD to investigate the use of a driving pressure-targeted mechanical ventilation strategy for patients with ARDS. She has contributed to international consensus recommendations on lung and diaphragm protective mechanical ventilation and was a co-chair for the recent American Thoracic Society Clinical Practice Guideline for the Management of Patients with Acute Respiratory Distress Syndrome. https://www.3ctmeeting.com/wesley-self-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/329e13cc-3380-4378-aa88-09c7738a26b3/RUBIN+Eileen+%281%29.jpg Eileen Rubin - Eileen Rubin Chicago, United States Eileen Rubin, JD, is President and CEO of ARDS Foundation, a nonProfessorit organization dedicated towards the support, education, knowledge and awareness of those in the acute respiratory distress syndrome (ARDS) Community. ARDS Foundation also supports medical Professoressionals and facilitates their medical research. ARDS Foundation is an organization that has been in existence for over 20 years, working diligently to support this community. Eileen, as a member of many committees working toward research on ARDS, and often a speaker at medical conferences, workshops and meetings, she brings the patient and family perspective to those who are fighting critical illness. Eileen is dedicated to seeing a day when there is actually some sort of viable treatment that will offer a solution, a cure, for the huge number of ARDS patients in the United States and Worldwide. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/329e13cc-3380-4378-aa88-09c7738a26b3/RUBIN+Eileen+%281%29.jpg Eileen Rubin - Eileen Rubin Chicago, United States Eileen Rubin, JD, is President and CEO of ARDS Foundation, a nonProfessorit organization dedicated towards the support, education, knowledge and awareness of those in the acute respiratory distress syndrome (ARDS) Community. ARDS Foundation also supports medical Professoressionals and facilitates their medical research. ARDS Foundation is an organization that has been in existence for over 20 years, working diligently to support this community. Eileen, as a member of many committees working toward research on ARDS, and often a speaker at medical conferences, workshops and meetings, she brings the patient and family perspective to those who are fighting critical illness. Eileen is dedicated to seeing a day when there is actually some sort of viable treatment that will offer a solution, a cure, for the huge number of ARDS patients in the United States and Worldwide. https://www.3ctmeeting.com/wesley-self-copy-copy-copy-1 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/65289105-c613-4894-843c-d8deb51e6eec/pic+2+%281%29.jpg Aya Holimann - Aya Holimann Getinge, Germany Dr. Hollmann Aya is a consultant in intensive care medicine with more than 15 years of clinical experience at different institutions. His academic focus of interest was the cardiovascular physiology applied at critically ill patients. He has published several publications on the topic and was also member of the faculty of the ESICM. Since 2021 he serves as Medical Affairs Manager for Getinge MCP. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/65289105-c613-4894-843c-d8deb51e6eec/pic+2+%281%29.jpg Aya Holimann - Aya Holimann Getinge, Germany Dr. Hollmann Aya is a consultant in intensive care medicine with more than 15 years of clinical experience at different institutions. His academic focus of interest was the cardiovascular physiology applied at critically ill patients. He has published several publications on the topic and was also member of the faculty of the ESICM. Since 2021 he serves as Medical Affairs Manager for Getinge MCP. https://www.3ctmeeting.com/wesley-self-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3052428a-1f29-475e-9690-328bdd63ce9f/FRANCOIS+Bruno+%281%29.jpg Bruno François - Bruno François Limoges, France Dr. François is a critical care physician at the University Hospital of Limoges, France. He works in a 22 bed medical/surgical ICU and is the head of the Limoges Clinical Investigation Center of which main expertise is Infectious Diseases in critically ill patients. He has been national coordinator for numerous emergency trials especially in Sepsis and VAP, and has participated in several advisory boards for multinational trials, Clinical Evaluation Committees and Adjudication Committees. He is more specifically interested in new drugs and innovative strategies in critically ill patients. He is author of many publications in the ICU field especially about Sepsis and VAP and is also reviewer for several medical journals. He has an expertise in the bedside organization of clinical research in the ICU. He created the CRICS network and has lead the CRICS-TRIGGERSEP network which integrate all research activities in Sepsis from basic science to clinical trials. Since 2012, he is co-coordinating the COMBACTE-Net consortium. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3052428a-1f29-475e-9690-328bdd63ce9f/FRANCOIS+Bruno+%281%29.jpg Bruno François - Bruno François Limoges, France Dr. François is a critical care physician at the University Hospital of Limoges, France. He works in a 22 bed medical/surgical ICU and is the head of the Limoges Clinical Investigation Center of which main expertise is Infectious Diseases in critically ill patients. He has been national coordinator for numerous emergency trials especially in Sepsis and VAP, and has participated in several advisory boards for multinational trials, Clinical Evaluation Committees and Adjudication Committees. He is more specifically interested in new drugs and innovative strategies in critically ill patients. He is author of many publications in the ICU field especially about Sepsis and VAP and is also reviewer for several medical journals. He has an expertise in the bedside organization of clinical research in the ICU. He created the CRICS network and has lead the CRICS-TRIGGERSEP network which integrate all research activities in Sepsis from basic science to clinical trials. Since 2012, he is co-coordinating the COMBACTE-Net consortium. https://www.3ctmeeting.com/wesley-self-copy-copy-copy-copy-1 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e85ef44c-7d86-40cc-be40-846b9ee094c3/Salcedo+Margarita+%281%29.jpg Margarita Salcedo - Margarita Salcedo Inotrem, France Dr. Margarita Salcedo Magguilli is a seasoned executive with extensive international experience in early-stage drug development. She currently serves as the Head of Development at a prestigious pharmaceutical company and has previously held key positions in translational research and medicine within renowned organizations. Her expertise lies in oncology drug development, where she has made significant contributions to advancing treatment options. Dr. Salcedo Magguilli is highly regarded for her leadership skills and commitment to improving patient outcomes. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e85ef44c-7d86-40cc-be40-846b9ee094c3/Salcedo+Margarita+%281%29.jpg Margarita Salcedo - Margarita Salcedo Inotrem, France Dr. Margarita Salcedo Magguilli is a seasoned executive with extensive international experience in early-stage drug development. She currently serves as the Head of Development at a prestigious pharmaceutical company and has previously held key positions in translational research and medicine within renowned organizations. Her expertise lies in oncology drug development, where she has made significant contributions to advancing treatment options. Dr. Salcedo Magguilli is highly regarded for her leadership skills and commitment to improving patient outcomes. https://www.3ctmeeting.com/wesley-self-copy-copy-copy-copy-2 daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/9e1c951b-751c-45b1-a471-071821bdeb2f/NIELSEN+Nathan+%281%29.jpg Nathan Nielsen - Nathan Nielsen Albuquerque, United States Nathan D. Nielsen, M.D., M.Sc., FCCM, is an Intensivist and Transfusion Medicine specialist presently based in Albuquerque, New Mexico in the United States. He is the International Representative for North America on the Council of the European Society of Intensive Care Medicine (ESICM), the Executive Editor of the ESICM Academy and Co-Chair of the Disseminated Intravascular Coagulation (DIC) Scientific and Standardization Committee of the International Society of Thrombosis and Hemostasis. He has been the Scientific Content Editor of the Global Sepsis Alliance since 2018, and has lectured on sepsis, blood transfusion, DIC, and other critical care topics on five continents. Dr. Nielsen has been a major contributor to several innovative global intensive care training initiatives and an active participant in several multinational sepsis therapeutic trials. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/9e1c951b-751c-45b1-a471-071821bdeb2f/NIELSEN+Nathan+%281%29.jpg Nathan Nielsen - Nathan Nielsen Albuquerque, United States Nathan D. Nielsen, M.D., M.Sc., FCCM, is an Intensivist and Transfusion Medicine specialist presently based in Albuquerque, New Mexico in the United States. He is the International Representative for North America on the Council of the European Society of Intensive Care Medicine (ESICM), the Executive Editor of the ESICM Academy and Co-Chair of the Disseminated Intravascular Coagulation (DIC) Scientific and Standardization Committee of the International Society of Thrombosis and Hemostasis. He has been the Scientific Content Editor of the Global Sepsis Alliance since 2018, and has lectured on sepsis, blood transfusion, DIC, and other critical care topics on five continents. Dr. Nielsen has been a major contributor to several innovative global intensive care training initiatives and an active participant in several multinational sepsis therapeutic trials. https://www.3ctmeeting.com/wesley-self-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/da8da77d-eebe-408a-a567-7fc00e246e8e/Stanley+Diana+%281%29.jpg Diana Stanley - Diana Stanley New York, United States Dr Diana Stanley trained as a physician in the UK and worked in general practice before beginning her career in publishing at the BMJ Evidence Centre in 2011. She joined the inaugural team of The Lancet Respiratory Medicine in 2012 where she is now Deputy Editor for the journal, based in the New York office. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/da8da77d-eebe-408a-a567-7fc00e246e8e/Stanley+Diana+%281%29.jpg Diana Stanley - Diana Stanley New York, United States Dr Diana Stanley trained as a physician in the UK and worked in general practice before beginning her career in publishing at the BMJ Evidence Centre in 2011. She joined the inaugural team of The Lancet Respiratory Medicine in 2012 where she is now Deputy Editor for the journal, based in the New York office. https://www.3ctmeeting.com/wesley-self-copy-copy-copy-copy-copy-1 daily 0.75 2024-06-05 https://www.3ctmeeting.com/wesley-self-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://www.3ctmeeting.com/wesley-self-copy-copy-copy-copy-copy-copy-1 daily 0.75 2024-06-05 https://www.3ctmeeting.com/wesley-self-copy-copy-copy-copy-copy-copy-copy daily 0.75 2024-06-05 https://www.3ctmeeting.com/scientific-program-1 daily 0.75 2024-06-06 https://www.3ctmeeting.com/evaluation daily 0.75 2025-07-07 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/8de34cf4-e7a9-4a32-bb38-231afd34e0e6/Thank+you%21+%285%29.gif Evaluation - Thank you for joining us at 3CT 2025 Drop below your feedback for this year’s meeting and recommendations for next year’s edition. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/8de34cf4-e7a9-4a32-bb38-231afd34e0e6/Thank+you%21+%285%29.gif Evaluation - Thank you for joining us at 3CT 2025 Drop below your feedback for this year’s meeting and recommendations for next year’s edition. https://www.3ctmeeting.com/scientific-program-2 daily 0.75 2024-11-14 https://www.3ctmeeting.com/2026innovationaward daily 0.75 2026-03-04 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/4034c9c8-05b3-4b81-9906-02b64284f9f7/3CT+2025+Linkedin+%288%29.png 2026 Innovation Award - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753367265441-67YHFK98NBEP94I5STTI/WhatsApp+Image+2025-07-24+at+16.05.46+%282%29.jpeg 2026 Innovation Award https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753367265718-QGX2QFPA8P97QDDNW1M1/WhatsApp+Image+2025-07-24+at+16.05.46+%281%29.jpeg 2026 Innovation Award https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753367267009-HR68E8CWEAUZGRR6D7ZB/WhatsApp+Image+2025-07-24+at+16.05.46.jpeg 2026 Innovation Award https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753367263907-XSTGU8KFL1C4R3XO0HI5/WhatsApp+Image+2025-07-24+at+16.05.46+%284%29.jpeg 2026 Innovation Award https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1753367263958-E822IF9VB083URJYYZ7N/WhatsApp+Image+2025-07-24+at+16.05.46+%283%29.jpeg 2026 Innovation Award https://www.3ctmeeting.com/2024 daily 0.75 2025-02-06 https://www.3ctmeeting.com/shockco-op daily 0.75 2025-11-12 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/a5b06403-65d4-48f5-a544-e471678e4db9/Design+sans+titre+%287%29.png https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e702f9c1-7141-4115-98f5-6859dc8e275e/Design+sans+titre+%2810%29.png https://www.3ctmeeting.com/new-page-5 daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/eafdc062-5d37-4617-bede-03f528fbbda5/Prof+photo+%281%29.jpg Neil Aggrawal https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/eafdc062-5d37-4617-bede-03f528fbbda5/Prof+photo+%281%29.jpg Neil Aggrawal https://www.3ctmeeting.com/narges-alipanah-lechner daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/7dd032ef-ef35-46ac-a256-f66572e240aa/IMG_4634_1024+%281%29.jpeg Narges Alipanah Lechner - Narges Alipanah-Lechner San Francisco, United States Narges Alipanah-Lechner, MD, MAS, is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at UCSF. She received her undergraduate degree from Johns Hopkins University and her medical degree and master’s degree in clinical and epidemiological research from UCSF. Dr. Alipanah-Lechner’s research interest is to apply complementary systems biology approaches within precision medicine to improve the diagnosis and treatment of patients with syndromes of critical illness. Her post-doctoral fellowship in the laboratories of Drs. Calfee and Matthay led to the discovery of novel subtypes of severe COVID-19 pneumonia as well as metabolic differences amongst patients with phenotypes of ARDS. She leads the biology committee of the first international platform trial utilizing precision medicine in ARDS and was awarded the American Society for Clinical Investigation’s 2024 Emerging Generation Award. In addition to her research endeavors, she attends in the medical and neurological intensive care units at UCSF. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/7dd032ef-ef35-46ac-a256-f66572e240aa/IMG_4634_1024+%281%29.jpeg Narges Alipanah Lechner - Narges Alipanah-Lechner San Francisco, United States Narges Alipanah-Lechner, MD, MAS, is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at UCSF. She received her undergraduate degree from Johns Hopkins University and her medical degree and master’s degree in clinical and epidemiological research from UCSF. Dr. Alipanah-Lechner’s research interest is to apply complementary systems biology approaches within precision medicine to improve the diagnosis and treatment of patients with syndromes of critical illness. Her post-doctoral fellowship in the laboratories of Drs. Calfee and Matthay led to the discovery of novel subtypes of severe COVID-19 pneumonia as well as metabolic differences amongst patients with phenotypes of ARDS. She leads the biology committee of the first international platform trial utilizing precision medicine in ARDS and was awarded the American Society for Clinical Investigation’s 2024 Emerging Generation Award. In addition to her research endeavors, she attends in the medical and neurological intensive care units at UCSF. https://www.3ctmeeting.com/riyaz-bashir daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/032d3aae-e942-4d59-9eb9-fb16ac9dad75/Riyaz.jpeg Riyaz Bashir - Riyaz Bashir Mount Laurel, United States Dr. Riyaz Bashir is an accomplished interventional cardiologist and professor of medicine at the Lewis Katz School of Medicine at Temple University in Philadelphia, where he serves as the program director for the interventional cardiovascular fellowship program. He also directs the vascular and endovascular medicine program at Temple University Hospital. Dr. Bashir has co-invented the Bashir Endovascular Catheters, which are now utilized across the U.S. for treating Pulmonary, arterial, and venous blood clots. With expertise in complex coronary interventions, peripheral vascular disease, and endovascular techniques, Dr. Bashir has contributed significantly to advancing vascular catheter-based therapies for thrombosis management. Known for his commitment to education, he has mentored hundreds of house staff and fellows and has actively participated in clinical trials, shaping the field of cardiovascular diseases. Dr. Bashir frequently lectures nationally and internationally, sharing insights from his extensive clinical and research experience. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/032d3aae-e942-4d59-9eb9-fb16ac9dad75/Riyaz.jpeg Riyaz Bashir - Riyaz Bashir Mount Laurel, United States Dr. Riyaz Bashir is an accomplished interventional cardiologist and professor of medicine at the Lewis Katz School of Medicine at Temple University in Philadelphia, where he serves as the program director for the interventional cardiovascular fellowship program. He also directs the vascular and endovascular medicine program at Temple University Hospital. Dr. Bashir has co-invented the Bashir Endovascular Catheters, which are now utilized across the U.S. for treating Pulmonary, arterial, and venous blood clots. With expertise in complex coronary interventions, peripheral vascular disease, and endovascular techniques, Dr. Bashir has contributed significantly to advancing vascular catheter-based therapies for thrombosis management. Known for his commitment to education, he has mentored hundreds of house staff and fellows and has actively participated in clinical trials, shaping the field of cardiovascular diseases. Dr. Bashir frequently lectures nationally and internationally, sharing insights from his extensive clinical and research experience. https://www.3ctmeeting.com/new-page-y9zpk daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/ac967049-03a5-472b-baee-0515f250c868/Belohlavek_photo.jpg Jan Belo - Jan Belohlavek Prague, Czech Republic Jan Belohlavek, MD, PhD, Prof. of Medicine, is the Deputy head of the 2nd Department of Internal Medicine, Cardiovascular Medicine at the General University Hospital in Prague, Czech Republic, board certified in Cardiology, Angiology, Critical care, and licenced in Invasive cardiology. He is an author or coauthor of more than 240 peer reviewed articles, his main clinical and research activities focus on refractory cardiac arrest, ECPR (extracorporeal cardiopulmonary resuscitation), ECMO reperfusion, cardiogenic shock and the use of mechanical circulatory devices. He is a chair of the Czech Association of Acute Cardiology, from 2019 till 2022 was the Euro-ELSO President, currently is the member of the Scientific Committee of Euro-ELSO and member of the steering committee of the Czech Society of Cardiology, the Czech Society of Intensive Care Medicine and the Association of Heart Failure of the Czech Society of Cardiology. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/ac967049-03a5-472b-baee-0515f250c868/Belohlavek_photo.jpg Jan Belo - Jan Belohlavek Prague, Czech Republic Jan Belohlavek, MD, PhD, Prof. of Medicine, is the Deputy head of the 2nd Department of Internal Medicine, Cardiovascular Medicine at the General University Hospital in Prague, Czech Republic, board certified in Cardiology, Angiology, Critical care, and licenced in Invasive cardiology. He is an author or coauthor of more than 240 peer reviewed articles, his main clinical and research activities focus on refractory cardiac arrest, ECPR (extracorporeal cardiopulmonary resuscitation), ECMO reperfusion, cardiogenic shock and the use of mechanical circulatory devices. He is a chair of the Czech Association of Acute Cardiology, from 2019 till 2022 was the Euro-ELSO President, currently is the member of the Scientific Committee of Euro-ELSO and member of the steering committee of the Czech Society of Cardiology, the Czech Society of Intensive Care Medicine and the Association of Heart Failure of the Czech Society of Cardiology. https://www.3ctmeeting.com/jan-biegus daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/baab91af-1b0f-4ed9-98ea-d7a72139c4a9/Foto1.jpg Jan biegus - Jan Biegus Associate Professor, Cardiologist, Researcher Wroclaw, Poland Jan Biegus is an Associate Professor at Wroclaw Medical University and cardiologist specializing in acute heart failure. He earned his MD in 2016 and PhD in 2020, focusing on biomarkers and organ dysfunction in heart failure (AHF). He serves as Deputy Head of the Intensive Cardiac Care Unit and Deputy Director of Scientific Affairs in the Institute of Heart Diseases. Dr. Biegus is an award-winning researcher recognized by the Polish Cardiac Society and the Ministry of Education and Science, and a Fulbright Senior Award 2023 (Duke University). He has led and contributed to numerous cardiovascular research projects, including large-scale clinical trials. He is actively involved in the European Society of Cardiology, serving as Chair of the Cardio-Renal Diseases Committee (2024-2026). He serves as Deputy Editor of ESC Heart Failure. His primary research interests include AHF, congestion management, renal function. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/baab91af-1b0f-4ed9-98ea-d7a72139c4a9/Foto1.jpg Jan biegus - Jan Biegus Associate Professor, Cardiologist, Researcher Wroclaw, Poland Jan Biegus is an Associate Professor at Wroclaw Medical University and cardiologist specializing in acute heart failure. He earned his MD in 2016 and PhD in 2020, focusing on biomarkers and organ dysfunction in heart failure (AHF). He serves as Deputy Head of the Intensive Cardiac Care Unit and Deputy Director of Scientific Affairs in the Institute of Heart Diseases. Dr. Biegus is an award-winning researcher recognized by the Polish Cardiac Society and the Ministry of Education and Science, and a Fulbright Senior Award 2023 (Duke University). He has led and contributed to numerous cardiovascular research projects, including large-scale clinical trials. He is actively involved in the European Society of Cardiology, serving as Chair of the Cardio-Renal Diseases Committee (2024-2026). He serves as Deputy Editor of ESC Heart Failure. His primary research interests include AHF, congestion management, renal function. https://www.3ctmeeting.com/susanna-price-copy daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e81a77e9-e9ab-4c94-a7b0-11aa272cc263/HFSA_headshot_bozkurt2.png BiykemBozkurt - Biykem Bozkurt Bellaire,United States Dr. Biykem Bozkurt is the Senior Dean of Faculty, the Mary and Gordon Cain Chair and Professor of Medicine; Director of Winters Center of Heart Failure; Associate Director of Cardiovascular Research Institute at Baylor College of Medicine in Houston TX. Dr. Bozkurt is the Editor-in-Chief of JACC: Heart Failure. She has been listed in Clarivate World’s Highly Cited Researchers (top 1% Web of Science) in 2018, 2019, 2020, 2023 and 2024. She served as the President of the Heart Failure Society of America in 2019-2020, led the Universal Definition and Classification of Heart Failure as the Chair in 2021, and is the Vice-Chair of the 2022 AHA/ACC Heart Failure Guidelines Writing Committee. Dr. Bozkurt actively participates in clinical and translational research; provides advanced heart failure patient care; presents at national and international scientific sessions; teaches and mentors trainees and faculty. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e81a77e9-e9ab-4c94-a7b0-11aa272cc263/HFSA_headshot_bozkurt2.png BiykemBozkurt - Biykem Bozkurt Bellaire,United States Dr. Biykem Bozkurt is the Senior Dean of Faculty, the Mary and Gordon Cain Chair and Professor of Medicine; Director of Winters Center of Heart Failure; Associate Director of Cardiovascular Research Institute at Baylor College of Medicine in Houston TX. Dr. Bozkurt is the Editor-in-Chief of JACC: Heart Failure. She has been listed in Clarivate World’s Highly Cited Researchers (top 1% Web of Science) in 2018, 2019, 2020, 2023 and 2024. She served as the President of the Heart Failure Society of America in 2019-2020, led the Universal Definition and Classification of Heart Failure as the Chair in 2021, and is the Vice-Chair of the 2022 AHA/ACC Heart Failure Guidelines Writing Committee. Dr. Bozkurt actively participates in clinical and translational research; provides advanced heart failure patient care; presents at national and international scientific sessions; teaches and mentors trainees and faculty. https://www.3ctmeeting.com/susanna-price-copy-1 daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/20b4b07c-0b11-4164-89e5-a96218c0915a/HeroShot.JPG Chousterman - Benjamin Chousterman Paris, France Pr Benjamin G. Chousterman, MD, PhD is a professor of Anesthesiology and Critical Care at Université Paris Cité – Hôpital Lariboisière and a team leader in INSERM U942 MASCOT. Pr Chousterman graduated from Université Pierre et Marie Curie in Paris, France. Pr Chousterman defended a PhD in Immunology from Université Pierre et Marie Curie and made a postdoctoral fellowship in Swirski Lab at Center for System Biology, Massachusetts General Hospital, Harvard Medical School, Boston. He is now head of the Surgical intensive care unit. His main topic of interest are the immunology of acute conditions and clinical trials. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/20b4b07c-0b11-4164-89e5-a96218c0915a/HeroShot.JPG Chousterman - Benjamin Chousterman Paris, France Pr Benjamin G. Chousterman, MD, PhD is a professor of Anesthesiology and Critical Care at Université Paris Cité – Hôpital Lariboisière and a team leader in INSERM U942 MASCOT. Pr Chousterman graduated from Université Pierre et Marie Curie in Paris, France. Pr Chousterman defended a PhD in Immunology from Université Pierre et Marie Curie and made a postdoctoral fellowship in Swirski Lab at Center for System Biology, Massachusetts General Hospital, Harvard Medical School, Boston. He is now head of the Surgical intensive care unit. His main topic of interest are the immunology of acute conditions and clinical trials. https://www.3ctmeeting.com/arianna-colosio daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/aa2b8f7a-65e6-4ab9-bef2-390162ea5c34/AriColosio_Pic.jpg Arianna colosio - Arianna Colosio London, UK I completed my PhD in Human Genetics and Molecular Oncology at the European School of Molecular Medicine (SEMM), in Milan. Italy, before moving to the UK to continue my research as a postdoctoral research associate at Imperial College London. I then worked in different life science industries and joined The Lancet Respiratory Medicine as a part-time deputy editor in 2024. I am particularly interested in clinical trials and public health interventions, and I have recently obtained an MSc in Public Health from The London School of Hygiene and Tropical Medicine in London, UK. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/aa2b8f7a-65e6-4ab9-bef2-390162ea5c34/AriColosio_Pic.jpg Arianna colosio - Arianna Colosio London, UK I completed my PhD in Human Genetics and Molecular Oncology at the European School of Molecular Medicine (SEMM), in Milan. Italy, before moving to the UK to continue my research as a postdoctoral research associate at Imperial College London. I then worked in different life science industries and joined The Lancet Respiratory Medicine as a part-time deputy editor in 2024. I am particularly interested in clinical trials and public health interventions, and I have recently obtained an MSc in Public Health from The London School of Hygiene and Tropical Medicine in London, UK. https://www.3ctmeeting.com/claudia-do-santos daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1766ba63-352f-4634-947c-35910926e0b0/DosSantos-Claudia.jpg Claudia do santos - Claudia Dos Santos Toronto, Canada Dr dos Santos is Professor of Medicine at the University of Toronto attending at St Michael’s Hospital MSICU. She holds a Tier 1 Canada Research Chair for Translational CCM. She is a scientist at the Keenan Research Centre. Her research is aimed at building a world-class program in translational molecular critical care with three distinct areas of expertise: patient-based discovery (omics/bioinformatics); in-vitro mechanistic research; and in-vivo preclinical research. She was scientific director for the Canadian Critical Care Society and is co-director of CRAFT, the Centre for Research and Applications in Fluidic Technologies (CRAFT), a joint venture with the National Research Council of Canada. She creates and leads the PREcision meDIcine for CriTical Care (PREDICT) program and biobank as well as ARIATNE, Advanced RNA-Intelligence for Accelerated Therapeutic Nanoparticle Engineering, a collaboration with the Nanomedicine Innovation Network (NMIN) to develop RNA-therapies for rapid response to infection and pandemic preparedness. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1766ba63-352f-4634-947c-35910926e0b0/DosSantos-Claudia.jpg Claudia do santos - Claudia Dos Santos Toronto, Canada Dr dos Santos is Professor of Medicine at the University of Toronto attending at St Michael’s Hospital MSICU. She holds a Tier 1 Canada Research Chair for Translational CCM. She is a scientist at the Keenan Research Centre. Her research is aimed at building a world-class program in translational molecular critical care with three distinct areas of expertise: patient-based discovery (omics/bioinformatics); in-vitro mechanistic research; and in-vivo preclinical research. She was scientific director for the Canadian Critical Care Society and is co-director of CRAFT, the Centre for Research and Applications in Fluidic Technologies (CRAFT), a joint venture with the National Research Council of Canada. She creates and leads the PREcision meDIcine for CriTical Care (PREDICT) program and biobank as well as ARIATNE, Advanced RNA-Intelligence for Accelerated Therapeutic Nanoparticle Engineering, a collaboration with the Nanomedicine Innovation Network (NMIN) to develop RNA-therapies for rapid response to infection and pandemic preparedness. https://www.3ctmeeting.com/claudia-do-santos-copy daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/7e010c70-7594-49c1-a98a-0ba80ba95ad1/Stavros+Drakos+Head+shot.jpg Stravos Drakos - Stravos Drakos Salt Lake City, United States Dr Drakos is the Co-Director of the Cardiovascular, Renal and Metabolism Center (CRMC), Medical Director of the historic Cardiac Mechanical Support/Artificial Heart Program, and CoChief Heart Failure & Transplant. He holds the H.A. and Edna Benning Presidential Endowed Chair and his research interests are focused on myocardial recovery in the chronic heart failure (HF) setting and the acute setting (i.e. acute HF/cardiogenic shock). Dr Drakos' team is utilizing clinical and biological information derived from studies in humans and small or large animal HF models to understand and enhance myocardial recovery. Original work generated by Dr. Drakos' research team in the clinical arena and in his lab led to the establishment of the awardwinning multidisciplinary Utah Cardiac Recovery Program-UCAR. He is the chairperson of the Clinical Integrative Cardiovascular and Hematological Sciences (CCHS) at the NIH, co-directs the annual international Utah Cardiac Recovery Symposium (U-CARS) and is an elected member of the ASCI (American Society of Clinical Investigation). He is a visiting professor in academic medical centers nationally and internationally and mentored over the years several individuals who are now independent faculty in academic medical centers in the US and overseas. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/7e010c70-7594-49c1-a98a-0ba80ba95ad1/Stavros+Drakos+Head+shot.jpg Stravos Drakos - Stravos Drakos Salt Lake City, United States Dr Drakos is the Co-Director of the Cardiovascular, Renal and Metabolism Center (CRMC), Medical Director of the historic Cardiac Mechanical Support/Artificial Heart Program, and CoChief Heart Failure & Transplant. He holds the H.A. and Edna Benning Presidential Endowed Chair and his research interests are focused on myocardial recovery in the chronic heart failure (HF) setting and the acute setting (i.e. acute HF/cardiogenic shock). Dr Drakos' team is utilizing clinical and biological information derived from studies in humans and small or large animal HF models to understand and enhance myocardial recovery. Original work generated by Dr. Drakos' research team in the clinical arena and in his lab led to the establishment of the awardwinning multidisciplinary Utah Cardiac Recovery Program-UCAR. He is the chairperson of the Clinical Integrative Cardiovascular and Hematological Sciences (CCHS) at the NIH, co-directs the annual international Utah Cardiac Recovery Symposium (U-CARS) and is an elected member of the ASCI (American Society of Clinical Investigation). He is a visiting professor in academic medical centers nationally and internationally and mentored over the years several individuals who are now independent faculty in academic medical centers in the US and overseas. https://www.3ctmeeting.com/stravos-drakos-copy daily 0.75 2025-06-18 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/7ae401c2-177f-45ea-bd25-e35f82b6bae4/Jackie+Duda+on+Capitol+Hill.JPEG Jacie duda - Jackie Duda New Market, United States Septic shock survivor, Jackie Duda is a wife, mom, former educator, nationally published journalist, member of the Sepsis Alliance Advisory Board and the Frederick County Commission on Disabilities. She moderates the Sepsis Connect online peer support group, “Invisible Disabilities after Sepsis” and has written half a dozen articles on sepsis since 2023. Disabled since 2014 due to Crohn’s Disease, POTS, and hypermobile Ehlers-Danlos Syndrome, Jackie is a vocal advocate for sepsis and people with disabilities. She also suffers from severe osteoporosis and is an Ambassador with the Bone Health and Osteoporosis Foundation BHOF. She frequently travels to Capitol Hill with Sepsis Alliance and other organizations to advocate for sepsis awareness, sepsis legislation, and related issues. She also does public speaking in her community and around the country. Jackie’s podcast, “The 1:20 Pod” debuted in May 2025, to discuss sepsis, disability and chronic illness. She also launched a Substack to house a collection of essays she writes that will become the foundation for her first book, a memoir of her medical and personal challenges. She celebrates her “Life Day” every May 22 by doing something special with her family and by advocating for sepsis on her Instagram @jackiesjourney4. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/7ae401c2-177f-45ea-bd25-e35f82b6bae4/Jackie+Duda+on+Capitol+Hill.JPEG Jacie duda - Jackie Duda New Market, United States Septic shock survivor, Jackie Duda is a wife, mom, former educator, nationally published journalist, member of the Sepsis Alliance Advisory Board and the Frederick County Commission on Disabilities. She moderates the Sepsis Connect online peer support group, “Invisible Disabilities after Sepsis” and has written half a dozen articles on sepsis since 2023. Disabled since 2014 due to Crohn’s Disease, POTS, and hypermobile Ehlers-Danlos Syndrome, Jackie is a vocal advocate for sepsis and people with disabilities. She also suffers from severe osteoporosis and is an Ambassador with the Bone Health and Osteoporosis Foundation BHOF. She frequently travels to Capitol Hill with Sepsis Alliance and other organizations to advocate for sepsis awareness, sepsis legislation, and related issues. She also does public speaking in her community and around the country. Jackie’s podcast, “The 1:20 Pod” debuted in May 2025, to discuss sepsis, disability and chronic illness. She also launched a Substack to house a collection of essays she writes that will become the foundation for her first book, a memoir of her medical and personal challenges. She celebrates her “Life Day” every May 22 by doing something special with her family and by advocating for sepsis on her Instagram @jackiesjourney4. https://www.3ctmeeting.com/christopher-oconnor-copy daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/63b2358f-4c15-4722-900d-596fd8a5d710/_Y1A6464.jpg Nick Hartshrone - Nick Hartshorne-Evans Hapton,GRB Since January 2010, he has been living with heart failure, transforming his personal struggle into a powerful mission. His experience with the condition inspired him to establish the Pumping Marvellous Foundation, the UK's only patient-led heart failure charity. Nick's leadership has propelled the Pumping Marvellous Foundation to provide patient-centred solutions, leveraging his profound understanding of heart failure and the healthcare system. His dedication has led to Nick’s place on the 2025 Kings New Year Honours List, an Honorary Doctorate from Glasgow Caledonian University, and recognition as an HSJ winner. · Patient Expert - NHSE Heart Failure Expert Advisory Board · Patient Expert - NHSE HiN Cardiovascular Disease Clinical Working Group · Patient Expert - NHS England Heart Failure Expert Board sub-committee member · NHSE patient expert committee member, HF @Home project, HF VW · NHSE patient expert committee member HF VW · Patient expert - NICE on Technology Assessments · Patient expert - NICE Chronic Heart Failure Guidelines 2018 · Patient Expert on 2023 NICE Quality Standards for Heart Failure https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/63b2358f-4c15-4722-900d-596fd8a5d710/_Y1A6464.jpg Nick Hartshrone - Nick Hartshorne-Evans Hapton,GRB Since January 2010, he has been living with heart failure, transforming his personal struggle into a powerful mission. His experience with the condition inspired him to establish the Pumping Marvellous Foundation, the UK's only patient-led heart failure charity. Nick's leadership has propelled the Pumping Marvellous Foundation to provide patient-centred solutions, leveraging his profound understanding of heart failure and the healthcare system. His dedication has led to Nick’s place on the 2025 Kings New Year Honours List, an Honorary Doctorate from Glasgow Caledonian University, and recognition as an HSJ winner. · Patient Expert - NHSE Heart Failure Expert Advisory Board · Patient Expert - NHSE HiN Cardiovascular Disease Clinical Working Group · Patient Expert - NHS England Heart Failure Expert Board sub-committee member · NHSE patient expert committee member, HF @Home project, HF VW · NHSE patient expert committee member HF VW · Patient expert - NICE on Technology Assessments · Patient expert - NICE Chronic Heart Failure Guidelines 2018 · Patient Expert on 2023 NICE Quality Standards for Heart Failure https://www.3ctmeeting.com/jacie-duda-copy daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/19da95c1-298c-4ee7-8734-be4512c2393f/Headshot+2022.JPG Anna Hemnes - Anna Hemnes Nashville, United States Dr. Hemnes is a translational physician-scientist with a research focus on the role of altered metabolism in pulmonary vascular disease and right heart failure. Her basic research is on the effect of BMPR2 mutation on insulin-mediated intracellular signaling in the pulmonary vasculature and the right ventricle. Her clinical research interests include the role of insulin resistance and metabolic syndrome in human pulmonary vascular disease with a focus on genetic susceptibility to these conditions, and deep molecular phenotyping of pulmonary vascular disease. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/19da95c1-298c-4ee7-8734-be4512c2393f/Headshot+2022.JPG Anna Hemnes - Anna Hemnes Nashville, United States Dr. Hemnes is a translational physician-scientist with a research focus on the role of altered metabolism in pulmonary vascular disease and right heart failure. Her basic research is on the effect of BMPR2 mutation on insulin-mediated intracellular signaling in the pulmonary vasculature and the right ventricle. Her clinical research interests include the role of insulin resistance and metabolic syndrome in human pulmonary vascular disease with a focus on genetic susceptibility to these conditions, and deep molecular phenotyping of pulmonary vascular disease. https://www.3ctmeeting.com/jan-belo-copy daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/4f70fe3c-71fd-493f-a903-f26c4e392497/Hibbert%2C+Benjamin_30216927_20230626+%281%29.jpg Benjamin hibbert - Benjamin Hibbert Rochester, United States Dr. Ben Hibbert is a Professor of Medicine and the Chair for the Division of Critical Care Cardiology at Mayo Clinic. He completed his Honors Bachelors of Science earning the University Gold Medal for highest standing. In 2006 he completed a Doctorate in Medicine then followed with Internal Medicine training where he served as Chief Resident. He subsequently went on to complete his Cardiology training where he served as Chief Fellow. He received designations completing the Clinician Investigator Program while obtaining his PhD in Biochemistry. From 2013-2015, he completed a fellowship in Interventional Cardiology with a focus on Structural Heart Interventions.  He is a fellow of the Royal College of Physicians and Surgeons of Canada with specialties in Internal Medicine, Cardiology, and Clinical Research. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/4f70fe3c-71fd-493f-a903-f26c4e392497/Hibbert%2C+Benjamin_30216927_20230626+%281%29.jpg Benjamin hibbert - Benjamin Hibbert Rochester, United States Dr. Ben Hibbert is a Professor of Medicine and the Chair for the Division of Critical Care Cardiology at Mayo Clinic. He completed his Honors Bachelors of Science earning the University Gold Medal for highest standing. In 2006 he completed a Doctorate in Medicine then followed with Internal Medicine training where he served as Chief Resident. He subsequently went on to complete his Cardiology training where he served as Chief Fellow. He received designations completing the Clinician Investigator Program while obtaining his PhD in Biochemistry. From 2013-2015, he completed a fellowship in Interventional Cardiology with a focus on Structural Heart Interventions.  He is a fellow of the Royal College of Physicians and Surgeons of Canada with specialties in Internal Medicine, Cardiology, and Clinical Research. https://www.3ctmeeting.com/sarah-louise-holle daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e6ab5e40-f0e1-46e9-9bf3-d0ed65007b03/Billede+til+CV+%281%29.jpg Sarah Louise Holle - Sarah Louise Duus Holle Copenhagen, Denmark Dr. Sarah Louise Duus Holle is a Danish medical doctor and Ph.D. student specializing in acute cardiology at Copenhagen University Hospital, Rigshospitalet. She earned her MD, Bachelor of Science in Medicine (BMSc), and Bachelor of Science (BSc) in Pharmaceutical Sciences from the University of Copenhagen. Her professional journey includes residency roles in cardiology and emergency medicine, along with extensive hands-on experience in echocardiography. Currently, she is a co-investiagator to the DOBERMANN trial, a RCT focused on improving outcomes in myocardial infarction. Dr. Holle has presented her work at leading cardiology congresses, including ESC, ACVC, and EuroEcho and serves as an abstract grader for the ACVC conference. Her research is published in prominent journals like NEJM and Trials, covering topics such as acute cardiology, biomarkers, infective endocarditis, and cardiac imaging. With a strong foundation in both clinical and academic cardiology, Dr. Holle is dedicated to advancing patient care through evidence-based research. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/e6ab5e40-f0e1-46e9-9bf3-d0ed65007b03/Billede+til+CV+%281%29.jpg Sarah Louise Holle - Sarah Louise Duus Holle Copenhagen, Denmark Dr. Sarah Louise Duus Holle is a Danish medical doctor and Ph.D. student specializing in acute cardiology at Copenhagen University Hospital, Rigshospitalet. She earned her MD, Bachelor of Science in Medicine (BMSc), and Bachelor of Science (BSc) in Pharmaceutical Sciences from the University of Copenhagen. Her professional journey includes residency roles in cardiology and emergency medicine, along with extensive hands-on experience in echocardiography. Currently, she is a co-investiagator to the DOBERMANN trial, a RCT focused on improving outcomes in myocardial infarction. Dr. Holle has presented her work at leading cardiology congresses, including ESC, ACVC, and EuroEcho and serves as an abstract grader for the ACVC conference. Her research is published in prominent journals like NEJM and Trials, covering topics such as acute cardiology, biomarkers, infective endocarditis, and cardiac imaging. With a strong foundation in both clinical and academic cardiology, Dr. Holle is dedicated to advancing patient care through evidence-based research. https://www.3ctmeeting.com/anastasia-ivanova daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/dba80051-bd6f-4c86-8f6c-c03303b6e810/Anastasia_Ivanova_2017_edited.jpg Anastasia Ivanova - Anastasia Ivanova Chapel Hill, United States Anastasia Ivanova is a professor of Biostatistics at UNC at Chapel Hill. Her statistical expertise spans all aspects of the design, analysis, and interpretation of clinical trials including dose-finding, adaptive designs and precision medicine. Most recently, she serves as principal investigator of PrecISE, a biomarker-stratified adaptive trial investigating five potential interventions for severe asthma. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/dba80051-bd6f-4c86-8f6c-c03303b6e810/Anastasia_Ivanova_2017_edited.jpg Anastasia Ivanova - Anastasia Ivanova Chapel Hill, United States Anastasia Ivanova is a professor of Biostatistics at UNC at Chapel Hill. Her statistical expertise spans all aspects of the design, analysis, and interpretation of clinical trials including dose-finding, adaptive designs and precision medicine. Most recently, she serves as principal investigator of PrecISE, a biomarker-stratified adaptive trial investigating five potential interventions for severe asthma. https://www.3ctmeeting.com/arianna-colosio-1 daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/0803ca5c-8be6-410a-a415-102c4e9c5a82/Jung+Christian+Prof+Dr_A_4071-resized.jpg Christian jung - Christian Jung Düsseldorf, Germany Prof. Christian Jung, MD PhD is a professor for interventional cardiology and cardiovascular critical care medicine at the Heinrich-Heine-University, Düsseldorf, Germany. He and group have a broad approach in basic, translational and clinical research with a specific focus on hemodynamics, endothelial function and microcirculation. Consequently, cardiogenic shock is a major research interest. In these different fields, novel digital technologies are applied with the ultimate goal to improve patient care. Prof. Jung is the co-PI of INDICATE (https://indicate-europe.eu) a new EU-funded project in intensive care medicine. INDICATE aims to advance patient-centered care and promoting ethically responsible data use and the development and implementation of trustworthy AI models. Furthermore, among others, Prof. Jung is an editor of Intensive Care Medicine. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/0803ca5c-8be6-410a-a415-102c4e9c5a82/Jung+Christian+Prof+Dr_A_4071-resized.jpg Christian jung - Christian Jung Düsseldorf, Germany Prof. Christian Jung, MD PhD is a professor for interventional cardiology and cardiovascular critical care medicine at the Heinrich-Heine-University, Düsseldorf, Germany. He and group have a broad approach in basic, translational and clinical research with a specific focus on hemodynamics, endothelial function and microcirculation. Consequently, cardiogenic shock is a major research interest. In these different fields, novel digital technologies are applied with the ultimate goal to improve patient care. Prof. Jung is the co-PI of INDICATE (https://indicate-europe.eu) a new EU-funded project in intensive care medicine. INDICATE aims to advance patient-centered care and promoting ethically responsible data use and the development and implementation of trustworthy AI models. Furthermore, among others, Prof. Jung is an editor of Intensive Care Medicine. https://www.3ctmeeting.com/claudia-do-santos-copy-1 daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/34141b73-9274-4b20-8691-3870598fb006/JHLDukepic3+edited.jpeg Jerorld levy - Jerrold Levy Durham, United States Jerrold H Levy, MD, FCCM, is a Professor of Anesthesiology, Critical Care, and Surgery (Cardiothoracic) at Duke University Medical Center and Vice Chair of the ISTH Scientific Subcommittees. His medical degree was from the University of Miami, where he was an internal medicine resident, followed by an Anesthesiology residency and fellowship in Critical Care at Massachusetts General Hospital/Harvard Medical School. Previously he was Professor and Deputy Chair of Research at Emory University. He is an Associate Editor for Journal of Thrombosis and Haemostasis and an editor at JTCVS. His research interests include anticoagulation and reversal, coagulopathy and acute inflammation therapies in critically ill patients and ECLS, and recombinant and purified protein concentrates for coagulopathy and bleeding. He has authored over 550 publications on PubMed with an h-index of 108 and i10-index of 464. He is also fluent in French and conversational in Spanish and Japanese. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/34141b73-9274-4b20-8691-3870598fb006/JHLDukepic3+edited.jpeg Jerorld levy - Jerrold Levy Durham, United States Jerrold H Levy, MD, FCCM, is a Professor of Anesthesiology, Critical Care, and Surgery (Cardiothoracic) at Duke University Medical Center and Vice Chair of the ISTH Scientific Subcommittees. His medical degree was from the University of Miami, where he was an internal medicine resident, followed by an Anesthesiology residency and fellowship in Critical Care at Massachusetts General Hospital/Harvard Medical School. Previously he was Professor and Deputy Chair of Research at Emory University. He is an Associate Editor for Journal of Thrombosis and Haemostasis and an editor at JTCVS. His research interests include anticoagulation and reversal, coagulopathy and acute inflammation therapies in critically ill patients and ECLS, and recombinant and purified protein concentrates for coagulopathy and bleeding. He has authored over 550 publications on PubMed with an h-index of 108 and i10-index of 464. He is also fluent in French and conversational in Spanish and Japanese. https://www.3ctmeeting.com/shir-lynn-lim daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3609c001-cf58-45ea-b1b6-8e2cfd0741ff/Dr+Lim+Shir+Lynn+staff+pass.jpg Shir Lynn Lim - Shir Lynn Lim Singapore Dr Shir Lynn Lim is a Senior Consultant Cardiologist at the National University Heart Centre Singapore and holds appointments with the Yong Loo Lin School of Medicine and Duke-NUS Medical School. She leads the national In-Hospital Cardiac Arrest Workgroup and is a member of the National Post-Cardiac Arrest and Survivorship Workgroup as well as Pan-Asian Resuscitation Outcomes Study. She is the founding Director of the Clinical Trials Unit of NUHCS and the inaugural lead of the Early Phase Mechanistic Clinical Trials Platform of the CArdiovascular DiseasE National Collaborative Enterprise (CADENCE), a national clinical translational program set up in February 2023 which aims to synergize cardiovascular research and technology capabilities across Singapore. She is also an Associate Editor of Resuscitation. Aligned with her clinical subspecialty of critical care cardiology, her research is focused on acute cardiac conditions such as cardiorenal syndrome, cardiac arrest and cardiogenic shock. Her overarching goal as a clinician-scientist is to improve the long-term outcomes of critically ill cardiac patients through the use of biomarkers and mechanistic early phase clinical trials during the acute phase, as well as the use of novel strategies, knowledge translation and clinical implementation in improving survivorship. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3609c001-cf58-45ea-b1b6-8e2cfd0741ff/Dr+Lim+Shir+Lynn+staff+pass.jpg Shir Lynn Lim - Shir Lynn Lim Singapore Dr Shir Lynn Lim is a Senior Consultant Cardiologist at the National University Heart Centre Singapore and holds appointments with the Yong Loo Lin School of Medicine and Duke-NUS Medical School. She leads the national In-Hospital Cardiac Arrest Workgroup and is a member of the National Post-Cardiac Arrest and Survivorship Workgroup as well as Pan-Asian Resuscitation Outcomes Study. She is the founding Director of the Clinical Trials Unit of NUHCS and the inaugural lead of the Early Phase Mechanistic Clinical Trials Platform of the CArdiovascular DiseasE National Collaborative Enterprise (CADENCE), a national clinical translational program set up in February 2023 which aims to synergize cardiovascular research and technology capabilities across Singapore. She is also an Associate Editor of Resuscitation. Aligned with her clinical subspecialty of critical care cardiology, her research is focused on acute cardiac conditions such as cardiorenal syndrome, cardiac arrest and cardiogenic shock. Her overarching goal as a clinician-scientist is to improve the long-term outcomes of critically ill cardiac patients through the use of biomarkers and mechanistic early phase clinical trials during the acute phase, as well as the use of novel strategies, knowledge translation and clinical implementation in improving survivorship. https://www.3ctmeeting.com/claudia-do-santos-copy-1-1 daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6eefa05e-1b4a-4a5c-8c82-70af730e45e6/McLaughlin__001+-+Preferred+Photo.JPG vallerie Mc - Vallerie Mclaughlin Ann Arbor, United States Vallerie V. McLaughlin, MD, is the Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine and Director of the Pulmonary Hypertension (PH) Program at the University of Michigan, Ann Arbor, MI. She is a Fellow of the American College of Cardiology and the American Heart Association. She has served as Chair of the American Heart Association “Women in Cardiology” Committee, Chair of the American College of Cardiology/American Heart Association Clinical Expert Consensus Document on PH, member of the American College of Cardiology Scientific Sessions Program Committee, and member of the Scientific Committee for the World Symposium on Pulmonary Hypertension 2008, 2013, 2018 and 2024. Professor McLaughlin is a past Chair of the Scientific Leadership Council of the Pulmonary Hypertension Association, past Editor-in-Chief of Advances in Pulmonary Hypertension and past Chair of the Pulmonary Hypertension Association Board of Trustees. She was inaugurated as a charter member into the Clinical Excellence Society at the University of Michigan and is a founding member of the World Symposia on Pulmonary Hypertension Association. Her research interests focus on PH. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6eefa05e-1b4a-4a5c-8c82-70af730e45e6/McLaughlin__001+-+Preferred+Photo.JPG vallerie Mc - Vallerie Mclaughlin Ann Arbor, United States Vallerie V. McLaughlin, MD, is the Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine and Director of the Pulmonary Hypertension (PH) Program at the University of Michigan, Ann Arbor, MI. She is a Fellow of the American College of Cardiology and the American Heart Association. She has served as Chair of the American Heart Association “Women in Cardiology” Committee, Chair of the American College of Cardiology/American Heart Association Clinical Expert Consensus Document on PH, member of the American College of Cardiology Scientific Sessions Program Committee, and member of the Scientific Committee for the World Symposium on Pulmonary Hypertension 2008, 2013, 2018 and 2024. Professor McLaughlin is a past Chair of the Scientific Leadership Council of the Pulmonary Hypertension Association, past Editor-in-Chief of Advances in Pulmonary Hypertension and past Chair of the Pulmonary Hypertension Association Board of Trustees. She was inaugurated as a charter member into the Clinical Excellence Society at the University of Michigan and is a founding member of the World Symposia on Pulmonary Hypertension Association. Her research interests focus on PH. https://www.3ctmeeting.com/michael-pinsky daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6f1bfd7c-b6be-4468-ab83-bc5560d31865/Pinsky+2008.JPG Michael Pinsky - Michael Pinsky Pittsburgh, United States Dr. Pinsky is a Professor of Critical Care Medicine, Bioengineering, Cardiovascular Diseases, Clinical & Translational Science, and Anesthesiology at the University of Pittsburgh and a faculty member of the Center for Military Medicine Research. He is now Director Emeritus of the Cardiopulmonary Research Laboratory which he ran for the last 42 years until 2023. He received his MD from McGill University post-graduate internal medicine residency and pulmonary fellowship at Stanford University and advanced physiological at Johns Hopkins Medical Institutes. His research interests include cardiopulmonary physiology, advanced hemodynamic monitorng in critical illness, predictive analytics and AI in healthcare. He is the PI on one R01 and co-investigator on 3 DoD and 5 NIH R01 grants. He has edited 27 medical textbooks, authored >450 peer-reviewed publications, >220 chapters and supported >500 abstract presentations. He is on the editorial boards of Critical Care, Journal of Critical Care, Annals of Critical Care, and Intensive Care Medicine. He is an ad hoc reviewer for NHLBI K, R and Special Interest Awards annually. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6f1bfd7c-b6be-4468-ab83-bc5560d31865/Pinsky+2008.JPG Michael Pinsky - Michael Pinsky Pittsburgh, United States Dr. Pinsky is a Professor of Critical Care Medicine, Bioengineering, Cardiovascular Diseases, Clinical & Translational Science, and Anesthesiology at the University of Pittsburgh and a faculty member of the Center for Military Medicine Research. He is now Director Emeritus of the Cardiopulmonary Research Laboratory which he ran for the last 42 years until 2023. He received his MD from McGill University post-graduate internal medicine residency and pulmonary fellowship at Stanford University and advanced physiological at Johns Hopkins Medical Institutes. His research interests include cardiopulmonary physiology, advanced hemodynamic monitorng in critical illness, predictive analytics and AI in healthcare. He is the PI on one R01 and co-investigator on 3 DoD and 5 NIH R01 grants. He has edited 27 medical textbooks, authored >450 peer-reviewed publications, >220 chapters and supported >500 abstract presentations. He is on the editorial boards of Critical Care, Journal of Critical Care, Annals of Critical Care, and Intensive Care Medicine. He is an ad hoc reviewer for NHLBI K, R and Special Interest Awards annually. https://www.3ctmeeting.com/pablo-sanchez daily 0.75 2025-05-13 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6714dd96-cc64-4744-9917-93701204e288/UCSF_profile_photo.jpg Pablo sanchez - Pablo Sanchez San Francisco, United States Dr. Pablo Sanchez is an Assistant Professor of Medicine in the Division of Cardiology at UCSF, and intensivist cardiac and cardiothoracic intensive care units at UCSF. He earned his medical degree from the University of Arizona College of Medicine. He completed a residency in internal medicine at Brigham and Women's Hospital, an affiliate of Harvard Medical School, serving as chief resident. He also completed a fellowship in cardiovascular medicine, serving as chief fellow, and a fellowship in critical care medicine at Stanford University. His research interests center on evaluating the differential effect of cardiac injury and dysfunction on clinical outcomes of molecular subphenotypes of the acute respiratory distress syndrome (ARDS), sepsis and septic shock, to refine risk stratification, monitoring and management strategies. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6714dd96-cc64-4744-9917-93701204e288/UCSF_profile_photo.jpg Pablo sanchez - Pablo Sanchez San Francisco, United States Dr. Pablo Sanchez is an Assistant Professor of Medicine in the Division of Cardiology at UCSF, and intensivist cardiac and cardiothoracic intensive care units at UCSF. He earned his medical degree from the University of Arizona College of Medicine. He completed a residency in internal medicine at Brigham and Women's Hospital, an affiliate of Harvard Medical School, serving as chief resident. He also completed a fellowship in cardiovascular medicine, serving as chief fellow, and a fellowship in critical care medicine at Stanford University. His research interests center on evaluating the differential effect of cardiac injury and dysfunction on clinical outcomes of molecular subphenotypes of the acute respiratory distress syndrome (ARDS), sepsis and septic shock, to refine risk stratification, monitoring and management strategies. https://www.3ctmeeting.com/axel-vater daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/05a7cf7f-8675-445a-8fc1-d78299f44fc0/20240917+Portrait+AV+York_crop.jpg Axel Vater - Axel Vater Berlin, Germany Dr. Axel Vater, Chief Scientific Officer of Aptarion Biotech AG received his training as an Engineer in Biotechnology at the Technische Universität Berlin, Germany, including a research semester at Harvard Medical School. He received his PhD from TU Berlin for experimental work on L-configured aptamers performed at Noxxon Pharma. He subsequently joined the in vivo imaging division of Schering/later Bayer. After three years in “Big Pharma” Axel returned to Noxxon overseeing the generation and (pre‑)clinical development of new L-aptamers in various disease areas with special interest in targeting the tumor microenvironment and the complement system. Axel now continues his work on the development of L-aptamers for life-threatening diseases as CSO of Aptarion Biotech, which he co-founded in 2016. Aptarion’s lead asset, the C5a-neutralizing L-aptamer AON-D21, is currently being tested in a Phase 2 trial in 150 patients with severe community-acquired pneumonia across western Europe. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/05a7cf7f-8675-445a-8fc1-d78299f44fc0/20240917+Portrait+AV+York_crop.jpg Axel Vater - Axel Vater Berlin, Germany Dr. Axel Vater, Chief Scientific Officer of Aptarion Biotech AG received his training as an Engineer in Biotechnology at the Technische Universität Berlin, Germany, including a research semester at Harvard Medical School. He received his PhD from TU Berlin for experimental work on L-configured aptamers performed at Noxxon Pharma. He subsequently joined the in vivo imaging division of Schering/later Bayer. After three years in “Big Pharma” Axel returned to Noxxon overseeing the generation and (pre‑)clinical development of new L-aptamers in various disease areas with special interest in targeting the tumor microenvironment and the complement system. Axel now continues his work on the development of L-aptamers for life-threatening diseases as CSO of Aptarion Biotech, which he co-founded in 2016. Aptarion’s lead asset, the C5a-neutralizing L-aptamer AON-D21, is currently being tested in a Phase 2 trial in 150 patients with severe community-acquired pneumonia across western Europe. https://www.3ctmeeting.com/elrick-zeymer daily 0.75 2025-04-17 https://www.3ctmeeting.com/workshop-participants daily 0.75 2026-02-20 https://www.3ctmeeting.com/arianna-colosio-copy daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/ad4172b1-871e-4363-9144-026f8f90398b/Abiomed_ChapmanProfile+%281%29.jpg Roberta Chapman - Roberta Chapman Danvers, United States Roberta (Bobbi) Bogaev Chapman, MD, FACC, FACP is the Vice President for Heart Failure at Abiomed in Danvers, Massachusetts where she leads the Women’s Heart Initiative and works collaboratively on all Abiomed sponsored clinical trials, education, patient advocacy and developing best practices for patients with heart failure. Dr. Chapman received her mechanical engineering degree from Virginia Tech and her medical degree and training from the University of Virginia. She is board certified in cardiology and advanced heart failure. Dr. Chapman served as the Medical Director of the Heart Transplant program at Methodist Hospital in San Antonio and the Texas Heart Institute in Houston, Texas where she was faculty at Baylor College of Medicine and directed the heart failure fellowship training program. Prior to joining Abiomed, she served as Medical Director of the Advanced Heart Failure Program and Chief of Cardiology for Bon Secours Mercy Health in Richmond, Virginia. She has authored peer review articles, book chapters, and abstracts in the fields of heart failure, mechanical circulatory support, and sex specific outcomes. She spent two years during her fellowship in basic science research and has been actively involved in translational and clinical research for the past twenty years. Dr. Chapman advocates for women with heart disease and is an avid supporter of the AHA’s Go Red campaign, serving on multiple AHA boards and Go Red executive leadership teams in San Antonio, Houston and Richmond, Virginia. She and one of her LVAD patients, “The Bionic Bride” made several appearances on the Today Show, showcasing the advanced technology of continuous flow pumps. She is passionate about the prevention of heart disease, early treatment of heart failure and cardiogenic shock, and optimizing outcomes for patients who require mechanical circulatory support. Dr. Chapman is committed and dedicated to helping patients live long, fulfilling lives. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/ad4172b1-871e-4363-9144-026f8f90398b/Abiomed_ChapmanProfile+%281%29.jpg Roberta Chapman - Roberta Chapman Danvers, United States Roberta (Bobbi) Bogaev Chapman, MD, FACC, FACP is the Vice President for Heart Failure at Abiomed in Danvers, Massachusetts where she leads the Women’s Heart Initiative and works collaboratively on all Abiomed sponsored clinical trials, education, patient advocacy and developing best practices for patients with heart failure. Dr. Chapman received her mechanical engineering degree from Virginia Tech and her medical degree and training from the University of Virginia. She is board certified in cardiology and advanced heart failure. Dr. Chapman served as the Medical Director of the Heart Transplant program at Methodist Hospital in San Antonio and the Texas Heart Institute in Houston, Texas where she was faculty at Baylor College of Medicine and directed the heart failure fellowship training program. Prior to joining Abiomed, she served as Medical Director of the Advanced Heart Failure Program and Chief of Cardiology for Bon Secours Mercy Health in Richmond, Virginia. She has authored peer review articles, book chapters, and abstracts in the fields of heart failure, mechanical circulatory support, and sex specific outcomes. She spent two years during her fellowship in basic science research and has been actively involved in translational and clinical research for the past twenty years. Dr. Chapman advocates for women with heart disease and is an avid supporter of the AHA’s Go Red campaign, serving on multiple AHA boards and Go Red executive leadership teams in San Antonio, Houston and Richmond, Virginia. She and one of her LVAD patients, “The Bionic Bride” made several appearances on the Today Show, showcasing the advanced technology of continuous flow pumps. She is passionate about the prevention of heart disease, early treatment of heart failure and cardiogenic shock, and optimizing outcomes for patients who require mechanical circulatory support. Dr. Chapman is committed and dedicated to helping patients live long, fulfilling lives. https://www.3ctmeeting.com/liesbeth-hof daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/4845e660-9e6f-4c9c-9253-cef0bfe3833e/Screenshot+2023-11-14+093410_kleiner.jpg Liesbeth hof - Liesbeth Hof Utrecht, Netherlands Liesbeth Hof has a Master in Medical Biology with over 20 years of international experiences in the pharmaceutical and biotech industry. During the very early phase of her career, she worked at the ministry of health, after which she moved to Novartis Global in Switzerland and later UK where she worked within global regulatory affairs. Following her time at big pharma she moved to the consultancy organisation ProPharma Group, where she managed a team of consultants and guided start-up and biotech companies in their development programs. Since 2022, she has been working with AM-Pharma, being responsible for the project management of the development programs and operational implementation. Over the years, Liesbeth drove diverse cross-functional global teams to deliver successful regulatory submissions within different therapeutic areas. She also led strategic planning and ensured achievement of major milestones at different stages of the product’s life cycle. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/4845e660-9e6f-4c9c-9253-cef0bfe3833e/Screenshot+2023-11-14+093410_kleiner.jpg Liesbeth hof - Liesbeth Hof Utrecht, Netherlands Liesbeth Hof has a Master in Medical Biology with over 20 years of international experiences in the pharmaceutical and biotech industry. During the very early phase of her career, she worked at the ministry of health, after which she moved to Novartis Global in Switzerland and later UK where she worked within global regulatory affairs. Following her time at big pharma she moved to the consultancy organisation ProPharma Group, where she managed a team of consultants and guided start-up and biotech companies in their development programs. Since 2022, she has been working with AM-Pharma, being responsible for the project management of the development programs and operational implementation. Over the years, Liesbeth drove diverse cross-functional global teams to deliver successful regulatory submissions within different therapeutic areas. She also led strategic planning and ensured achievement of major milestones at different stages of the product’s life cycle. https://www.3ctmeeting.com/bobby-reddy-jr daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/78b2ce78-6d90-4613-bfe7-f0fb6271d082/Prenosis+Bobby+Reddy+Jr+Photo.jpg Bobby Reddy Jr - Bobby Reddy Jr Chicago, United States Bobby Reddy, Jr., Ph.D. is Co-Founder and CEO of Prenosis, a biologically driven technology company that develops and implements integrated diagnostic-therapeutic products in acute care to improve patient outcomes. Since founding Prenosis in 2016, Bobby has led the company to achieve significant milestones, including the groundbreaking FDA marketing authorization of Sepsis ImmunoScore™ in April 2024, the first-ever FDA-authorized AI diagnostic tool for sepsis, recognized as one of TIME's Best Inventions of 2024. Previously, Bobby served as Research Scientist at the University of Illinois at UrbanaChampaign, developing electrical point-of-care biosensors and managing strategic partnerships with Taiwan Semiconductor Manufacturing Company, Abbott Diagnostics, and Intel. Bobby holds a Ph.D. in Electrical Engineering from UIUC, an M.S. and B.S. in Electrical Engineering and a B.S. in Computer Engineering from UC Irvine. Named to Crain's Chicago Business 40 Under 40, his mission is "to see people diƯerently – to tailor healthcare to each individual's biology. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/78b2ce78-6d90-4613-bfe7-f0fb6271d082/Prenosis+Bobby+Reddy+Jr+Photo.jpg Bobby Reddy Jr - Bobby Reddy Jr Chicago, United States Bobby Reddy, Jr., Ph.D. is Co-Founder and CEO of Prenosis, a biologically driven technology company that develops and implements integrated diagnostic-therapeutic products in acute care to improve patient outcomes. Since founding Prenosis in 2016, Bobby has led the company to achieve significant milestones, including the groundbreaking FDA marketing authorization of Sepsis ImmunoScore™ in April 2024, the first-ever FDA-authorized AI diagnostic tool for sepsis, recognized as one of TIME's Best Inventions of 2024. Previously, Bobby served as Research Scientist at the University of Illinois at UrbanaChampaign, developing electrical point-of-care biosensors and managing strategic partnerships with Taiwan Semiconductor Manufacturing Company, Abbott Diagnostics, and Intel. Bobby holds a Ph.D. in Electrical Engineering from UIUC, an M.S. and B.S. in Electrical Engineering and a B.S. in Computer Engineering from UC Irvine. Named to Crain's Chicago Business 40 Under 40, his mission is "to see people diƯerently – to tailor healthcare to each individual's biology. https://www.3ctmeeting.com/nicolas-gired daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c9398fe4-e6da-4563-9b56-a8d1272f6832/Photo+JACC+lightlight.jpg NIcolas Gired - Nicolas Girerd Vandoeuvre Les Nancy, France Nicolas Girerd, MD, PhD, a Professor of Therapeutics and a leading cardiologist and biostatistician at Nancy CIC-Inserm, France, has a rich background with training in Cardiology (Lyon), a MSc in Clinical Epidemiology (Québec), and a PhD in Biostatistics (Lyon). His work, featured in over 350 international publications, includes the HYPO-ECMO trial (Levy… Girerd, JAMA, 2022) that has influenced cardiogenic shock treatment. He is also the PI of key studies like REMI, AHF-CORE, AMBUSH, and IMICU2-Dyspnea, and contributing as methodologist to trials like EPURE TRANSPLANT and LEVOHEARTSHOCK. Girerd is pioneering AI applications in cardiovascular medicine, demonstrated by his machine learning innovations for heart failure prediction. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c9398fe4-e6da-4563-9b56-a8d1272f6832/Photo+JACC+lightlight.jpg NIcolas Gired - Nicolas Girerd Vandoeuvre Les Nancy, France Nicolas Girerd, MD, PhD, a Professor of Therapeutics and a leading cardiologist and biostatistician at Nancy CIC-Inserm, France, has a rich background with training in Cardiology (Lyon), a MSc in Clinical Epidemiology (Québec), and a PhD in Biostatistics (Lyon). His work, featured in over 350 international publications, includes the HYPO-ECMO trial (Levy… Girerd, JAMA, 2022) that has influenced cardiogenic shock treatment. He is also the PI of key studies like REMI, AHF-CORE, AMBUSH, and IMICU2-Dyspnea, and contributing as methodologist to trials like EPURE TRANSPLANT and LEVOHEARTSHOCK. Girerd is pioneering AI applications in cardiovascular medicine, demonstrated by his machine learning innovations for heart failure prediction. https://www.3ctmeeting.com/carlos-alviar daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3be6eafe-9058-4e39-b0c3-0fb163a06dbf/IMG_5838+%281%29.jpg Carlos Alviar - Carlos Alviar New York, United States Dr. Carlos L. Alviar MD, FACC is a cardiologist and critical care specialist who serves as assistant professor of cardiovascular medicine at New York University Grossman School of Medicine and as the director of the Cardiac Intensive Care Unit and director of the ECMO and ECPR Programs at Bellevue Hospital Center. He received his medical degree from CES University in Colombia, and completed his residency and chief resident year at St. Luke's-Roosevelt Hospital, followed by a fellowship in cardiology at NYU and then critical care medicine at the Cleveland Clinic. Dr. Alviar has extensive clinical and academic experience in the management of cardiac arrest, cardiogenic shock, extracorporeal support and several critical care cardiology conditions. Dr. Alviar has published numerous manuscripts and book chapters and presented his work at many national and international meetings. He is the recipient of several awards for his research endeavors. Lastly, he is co-founder and course director of the NYU Langone Critical Care Cardiology Symposium. His research focus include cardiogenic shock, mechanical ventilation in the cardiovascular patient, cardiac arrest and mechanical circulatory support. Dr. Alviar is a member of the leadership council of the ACC Critical Care Cardiology Section where he also serves as the chair of the educational subcommittee and international outreach working group. He is a member of the Cardiogenic Shock and Cardiac Arrest Study Group of the acute cardiovascular care of the ESC. He also serves as a member of the 3CPR early career committee of the AHA, the CHEST Cardiopulmonary and Vascular network and the planning committee of the Association for acute cardiovascular care of the ESC https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3be6eafe-9058-4e39-b0c3-0fb163a06dbf/IMG_5838+%281%29.jpg Carlos Alviar - Carlos Alviar New York, United States Dr. Carlos L. Alviar MD, FACC is a cardiologist and critical care specialist who serves as assistant professor of cardiovascular medicine at New York University Grossman School of Medicine and as the director of the Cardiac Intensive Care Unit and director of the ECMO and ECPR Programs at Bellevue Hospital Center. He received his medical degree from CES University in Colombia, and completed his residency and chief resident year at St. Luke's-Roosevelt Hospital, followed by a fellowship in cardiology at NYU and then critical care medicine at the Cleveland Clinic. Dr. Alviar has extensive clinical and academic experience in the management of cardiac arrest, cardiogenic shock, extracorporeal support and several critical care cardiology conditions. Dr. Alviar has published numerous manuscripts and book chapters and presented his work at many national and international meetings. He is the recipient of several awards for his research endeavors. Lastly, he is co-founder and course director of the NYU Langone Critical Care Cardiology Symposium. His research focus include cardiogenic shock, mechanical ventilation in the cardiovascular patient, cardiac arrest and mechanical circulatory support. Dr. Alviar is a member of the leadership council of the ACC Critical Care Cardiology Section where he also serves as the chair of the educational subcommittee and international outreach working group. He is a member of the Cardiogenic Shock and Cardiac Arrest Study Group of the acute cardiovascular care of the ESC. He also serves as a member of the 3CPR early career committee of the AHA, the CHEST Cardiopulmonary and Vascular network and the planning committee of the Association for acute cardiovascular care of the ESC https://www.3ctmeeting.com/antoine-herpain daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c4c60032-966e-4c2b-a20b-9faf47466477/AH+pro+picture+2024.jpg Antoine Herpain - Antoine Herpain Bruxelles, Belgium Dr. Antoine Herpain is an Internal Medicine and Intensive Care Medicine Belgian physician dedicated to advanced hemodynamics of transient mechanical circulatory support, critical care echocardiography, and circulatory failure physiopathology. He was trained by Pr. Jean-Louis Vincent and Pr. Daniel De Backer at the Université Libre de Bruxelles (ULB), before becoming in 2023 the head of the Intensive Care department at the Saint-Pierre University Hospital from ULB, in Brussels, Belgium. He was elected president of the Belgian Interdisciplinary Working Group of Acute Cardiology (BIWAC) and is a board member of major international critical care echocardiographic educational initiatives, such as ISICEM and EDEC courses. He also leads preclinical investigations on septic shock, cardiogenic shock, and transient mechanical circulatory supports in the ULB Experimental Laboratory of Intensive Care. Since 2022, he has chaired the Preclinical Research in Acute Cardiac and Critical Care (PRAC3) meeting, which is held every two years at ULB and gathers the international community of cardiogenic and septic shock translational researchers. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c4c60032-966e-4c2b-a20b-9faf47466477/AH+pro+picture+2024.jpg Antoine Herpain - Antoine Herpain Bruxelles, Belgium Dr. Antoine Herpain is an Internal Medicine and Intensive Care Medicine Belgian physician dedicated to advanced hemodynamics of transient mechanical circulatory support, critical care echocardiography, and circulatory failure physiopathology. He was trained by Pr. Jean-Louis Vincent and Pr. Daniel De Backer at the Université Libre de Bruxelles (ULB), before becoming in 2023 the head of the Intensive Care department at the Saint-Pierre University Hospital from ULB, in Brussels, Belgium. He was elected president of the Belgian Interdisciplinary Working Group of Acute Cardiology (BIWAC) and is a board member of major international critical care echocardiographic educational initiatives, such as ISICEM and EDEC courses. He also leads preclinical investigations on septic shock, cardiogenic shock, and transient mechanical circulatory supports in the ULB Experimental Laboratory of Intensive Care. Since 2022, he has chaired the Preclinical Research in Acute Cardiac and Critical Care (PRAC3) meeting, which is held every two years at ULB and gathers the international community of cardiogenic and septic shock translational researchers. https://www.3ctmeeting.com/emma-grainger-copy daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/f761aba6-f809-4fc9-beef-f4f16dbd98c4/Foto.jpg Janine Poss - Janine Pöss Leipzig, Germany Consultant Heart Center Leipzig at University of Leipzig, Department of Cardiology. Focus clinical work: Acute / intensive cardiac care medicine, interventional cardiology. Focus scientific work: Cardiogenic shock / cardiopulmonary resuscitation EXPERIENCE/ACTIVITIES WITHIN EUROPEAN SOCIETY OF CARDIOLOGY Since 04/2022 Board member of the Association for Acute Cardiovascular Care (ACVC) of the ESC Co-Chair of the ACVC Research Section Founding member and chair of “Young ACCA” of the ESC Nucleus member of “Cardiologists of Tomorrow” Founding member and chair/co-chair of “German Chapter of Young Cardiologists” (German Cardiac Society) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/f761aba6-f809-4fc9-beef-f4f16dbd98c4/Foto.jpg Janine Poss - Janine Pöss Leipzig, Germany Consultant Heart Center Leipzig at University of Leipzig, Department of Cardiology. Focus clinical work: Acute / intensive cardiac care medicine, interventional cardiology. Focus scientific work: Cardiogenic shock / cardiopulmonary resuscitation EXPERIENCE/ACTIVITIES WITHIN EUROPEAN SOCIETY OF CARDIOLOGY Since 04/2022 Board member of the Association for Acute Cardiovascular Care (ACVC) of the ESC Co-Chair of the ACVC Research Section Founding member and chair of “Young ACCA” of the ESC Nucleus member of “Cardiologists of Tomorrow” Founding member and chair/co-chair of “German Chapter of Young Cardiologists” (German Cardiac Society) https://www.3ctmeeting.com/stravos-drakos-copy-1 daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/be02f390-c1f0-4e97-a4d3-befc0c8a3212/Ashish+Kumar+Khanna+%281%29.jpg Ashish Khanna - Ashish Khanna Winston-Salem, United States Dr. Ashish Khanna is professor of anesthesiology and vice-chair of research with the department of anesthesiology, section on critical care medicine at the Wake Forest University School of Medicine in Winston-Salem, NC. He is also a member of the Wake Center for Artificial Intelligence Research, Center for Healthcare Innovation, and the Wake Forest Hypertension and Vascular Research Cardiovascular Science Center. He serves as the inaugural director for the Perioperative Outcomes and Informatics Collaborative (POIC) a large perioperative and critical care outcomes collaborative research program that is staffed with several research nurses, fellows, technicians, students, data scientists and administrative staff and is a center of excellence for clinical trials across specialties. His research interests include prediction of post-operative respiratory and cardiac events on the regular nursing floor using wearable monitoring, use of large datasets for perioperative outcomes research, effects of hypotension in critically ill patients and use of novel vasopressors in shock states in the ICU. Dr. Khanna has more than 200 peer reviewed papers, two dozen book chapters, editorials, invited non-peer reviewed articles, and has been invited to talk about this work at prestigious national and international forums. He is heavily engaged with the Society of Critical Care Medicine and currently chairs the Discovery research network, was program co-chair for the 2023 congress and Discovery liaison to the 2024 congress and will serve on the SCCM council from 2025 onwards. He chairs the ASA committee on critical care medicine, and on the board of directors for the Society of Critical Care Anesthesiologists (SOCCA) and the American Society for Enhanced Recovery and Perioperative Medicine (ASER-PM). He has been awarded funding by FAER, NIH/NCATS KL2, NIH/NHLBI, Wake Forest intramural CTSI and several industry and foundation grants. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/be02f390-c1f0-4e97-a4d3-befc0c8a3212/Ashish+Kumar+Khanna+%281%29.jpg Ashish Khanna - Ashish Khanna Winston-Salem, United States Dr. Ashish Khanna is professor of anesthesiology and vice-chair of research with the department of anesthesiology, section on critical care medicine at the Wake Forest University School of Medicine in Winston-Salem, NC. He is also a member of the Wake Center for Artificial Intelligence Research, Center for Healthcare Innovation, and the Wake Forest Hypertension and Vascular Research Cardiovascular Science Center. He serves as the inaugural director for the Perioperative Outcomes and Informatics Collaborative (POIC) a large perioperative and critical care outcomes collaborative research program that is staffed with several research nurses, fellows, technicians, students, data scientists and administrative staff and is a center of excellence for clinical trials across specialties. His research interests include prediction of post-operative respiratory and cardiac events on the regular nursing floor using wearable monitoring, use of large datasets for perioperative outcomes research, effects of hypotension in critically ill patients and use of novel vasopressors in shock states in the ICU. Dr. Khanna has more than 200 peer reviewed papers, two dozen book chapters, editorials, invited non-peer reviewed articles, and has been invited to talk about this work at prestigious national and international forums. He is heavily engaged with the Society of Critical Care Medicine and currently chairs the Discovery research network, was program co-chair for the 2023 congress and Discovery liaison to the 2024 congress and will serve on the SCCM council from 2025 onwards. He chairs the ASA committee on critical care medicine, and on the board of directors for the Society of Critical Care Anesthesiologists (SOCCA) and the American Society for Enhanced Recovery and Perioperative Medicine (ASER-PM). He has been awarded funding by FAER, NIH/NCATS KL2, NIH/NHLBI, Wake Forest intramural CTSI and several industry and foundation grants. https://www.3ctmeeting.com/phyllis-billia daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c43f70e9-1014-4add-8df3-bc75c232edcb/Phyllis+Billia+.png Phyllis Billia - Phyllis Billia Toronto, Canada She is an associate professor at the University Toronto's Department of Medicine. After completing her medical and research training at the University of Toronto, Dr. Billia finished a postdoc fellowship with the world-renowned Dr. Tak W. Mak at the Campbell Family Institute for Cancer Research in Toronto. As a Toronto General Hospital Research Institute scientist, Dr. Billia leads a team that studies the molecular mechanisms involved in heart failure and cardiac regeneration. In addition, she is also interested in understanding the mechanism that drive the inflammatory state in patients with heart failure and cardiogenic shock through clonal hematopoiesis. At University Health Network, Dr. Phyllis Billia is a heart failure clinician with a focus on end-stage heart failure, mechanical circulatory support and cardiogenic shock. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/c43f70e9-1014-4add-8df3-bc75c232edcb/Phyllis+Billia+.png Phyllis Billia - Phyllis Billia Toronto, Canada She is an associate professor at the University Toronto's Department of Medicine. After completing her medical and research training at the University of Toronto, Dr. Billia finished a postdoc fellowship with the world-renowned Dr. Tak W. Mak at the Campbell Family Institute for Cancer Research in Toronto. As a Toronto General Hospital Research Institute scientist, Dr. Billia leads a team that studies the molecular mechanisms involved in heart failure and cardiac regeneration. In addition, she is also interested in understanding the mechanism that drive the inflammatory state in patients with heart failure and cardiogenic shock through clonal hematopoiesis. At University Health Network, Dr. Phyllis Billia is a heart failure clinician with a focus on end-stage heart failure, mechanical circulatory support and cardiogenic shock. https://www.3ctmeeting.com/maria-rosa daily 0.75 2025-04-17 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/16a3e802-b508-4813-a02b-a646efa19581/Dr.MariaCostanzo_web1.jpg Maria rosa - Maria Rosa Costanzo Wheaton, United States Dr. Costanzo received her medical degree summa cum laude from the University of Bologna in Italy. Her postgraduate training included a fellowship in cardiology at Loyola University Medical Center in Maywood, Illinois. Dr. Costanzo is a Fellow of the American College of Cardiology, American Heart Association, European Society of Cardiology, Heart Failure Society of America and Heart Failure Association of the European Society of Cardiology. She is also a member of the Ordine Dei Medici (The Italian National Medical Professional Association). Dr. Costanzo served as Medical Director of the Loyola University Chicago Heart failure and Cardiac Transplant Program from 1988 until 1994. From 1994 until 2001 Dr. Costanzo was the Medical Director of the Heart Failure/Cardiac Transplant Program at Rush University Medical Center and was the John H. and Margaret V. Krehbiel Professor of Cardiology at Rush Medical College. From 1995 until 2000 Dr. Costanzo was the Editor in Chief of the Journal of heart and Lung Transplantation. In 2002 Dr. Costanzo became the Medical Director of the Edward Center for Advanced Heart Failure. In 2002 Dr. Costanzo was appointed by the Secretary of Health and Human Services, the Honorable Tommy Thompson, to serve a four-year term on the National Heart, Lung and Blood Institute Advisory Council. From 2012 to 2019 Dr. Costanzo has been a member of the American Board of Internal Medicine exam writing committee for the specialty of Advanced Heart Failure and Transplant Cardiology. From 2018 to 2021 Dr. Costanzo has served as a Member of the Board of Directors for the Heart Failure Society of America. Dr. Costanzo is currently the Medical Director for the Heart Failure Program at the Midwest Cardiovascular Institute in Naperville, Illinois. Dr. Costanzo has led several multicenter randomized clinical trials including UNLOAD, AVOID-HF and the Pivotal Trial of phrenic nerve stimulation for central sleep apnea. Dr. Costanzo has written more than 300 peer reviewed manuscripts, abstracts, and review articles for journals such as New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, JACC Heart Failure, Circulation Heart Failure, and the European Journal of Heart Failure. Dr. Costanzo was appointed as Associate Editor of the JACC Heart Failure Journal in March 2020, and Associate Editor for Heart Failure of the Journal of the American College of Cardiology in July 2021. She has presented nationally and internationally on numerous topics related to Heart Failure and Cardiac transplantation. In 2023 Dr. Costanzo received the Legacy Award from the European Society of Organ Transplantation. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/16a3e802-b508-4813-a02b-a646efa19581/Dr.MariaCostanzo_web1.jpg Maria rosa - Maria Rosa Costanzo Wheaton, United States Dr. Costanzo received her medical degree summa cum laude from the University of Bologna in Italy. Her postgraduate training included a fellowship in cardiology at Loyola University Medical Center in Maywood, Illinois. Dr. Costanzo is a Fellow of the American College of Cardiology, American Heart Association, European Society of Cardiology, Heart Failure Society of America and Heart Failure Association of the European Society of Cardiology. She is also a member of the Ordine Dei Medici (The Italian National Medical Professional Association). Dr. Costanzo served as Medical Director of the Loyola University Chicago Heart failure and Cardiac Transplant Program from 1988 until 1994. From 1994 until 2001 Dr. Costanzo was the Medical Director of the Heart Failure/Cardiac Transplant Program at Rush University Medical Center and was the John H. and Margaret V. Krehbiel Professor of Cardiology at Rush Medical College. From 1995 until 2000 Dr. Costanzo was the Editor in Chief of the Journal of heart and Lung Transplantation. In 2002 Dr. Costanzo became the Medical Director of the Edward Center for Advanced Heart Failure. In 2002 Dr. Costanzo was appointed by the Secretary of Health and Human Services, the Honorable Tommy Thompson, to serve a four-year term on the National Heart, Lung and Blood Institute Advisory Council. From 2012 to 2019 Dr. Costanzo has been a member of the American Board of Internal Medicine exam writing committee for the specialty of Advanced Heart Failure and Transplant Cardiology. From 2018 to 2021 Dr. Costanzo has served as a Member of the Board of Directors for the Heart Failure Society of America. Dr. Costanzo is currently the Medical Director for the Heart Failure Program at the Midwest Cardiovascular Institute in Naperville, Illinois. Dr. Costanzo has led several multicenter randomized clinical trials including UNLOAD, AVOID-HF and the Pivotal Trial of phrenic nerve stimulation for central sleep apnea. Dr. Costanzo has written more than 300 peer reviewed manuscripts, abstracts, and review articles for journals such as New England Journal of Medicine, Circulation, Journal of the American College of Cardiology, JACC Heart Failure, Circulation Heart Failure, and the European Journal of Heart Failure. Dr. Costanzo was appointed as Associate Editor of the JACC Heart Failure Journal in March 2020, and Associate Editor for Heart Failure of the Journal of the American College of Cardiology in July 2021. She has presented nationally and internationally on numerous topics related to Heart Failure and Cardiac transplantation. In 2023 Dr. Costanzo received the Legacy Award from the European Society of Organ Transplantation. https://www.3ctmeeting.com/erin-bohula daily 0.75 2025-04-18 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6ea85575-200c-46d3-bcaa-475b190ccdd4/erin+Bohula+.png Erin bohula - Erin Bohula May Bo, United States Erin Bohula is an Associate Physician in Cardiovascular Medicine at Brigham and Women’s Hospital (BWH), Boston, MA, USA, an Investigator at the TIMI Study Group and an Assistant Professor at Harvard Medical School. Dr Bohula earned her DPhil in Molecular Biology from University of Oxford, Oxford, UK on a Rhodes Scholarship in molecular oncology. Following training at Harvard Medical School & BWH, she is board certified in internal medicine, cardiology, and critical care medicine. Dr Bohula studies pharmacologic interventions for cardiometabolic diseases, such as hyperlipidaemia, obesity and atherosclerotic cardiovascular disease. Her recent trial involvement includes IMPROVE-IT, FOURIER, CAMELLIA-TIMI 61, and VESALIUS-CV. As a cardiac intensivist, she was involved in creating the Critical Care Cardiology Trials Network, a North American research collaborative of cardiology critical care units (CICU) and helped to lead their inaugural RCT, COVID-PACT, studying the efficacy and safety of antithrombotic therapy in critically-ill COVID-19 patients. She has received multiple awards, including the ACC W. Proctor Harvey Young Teaching Award and the Eugene Braunwald Faculty Award. She is the vice chair of the AHA Acute Care and General Cardiology Council. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/6ea85575-200c-46d3-bcaa-475b190ccdd4/erin+Bohula+.png Erin bohula - Erin Bohula May Bo, United States Erin Bohula is an Associate Physician in Cardiovascular Medicine at Brigham and Women’s Hospital (BWH), Boston, MA, USA, an Investigator at the TIMI Study Group and an Assistant Professor at Harvard Medical School. Dr Bohula earned her DPhil in Molecular Biology from University of Oxford, Oxford, UK on a Rhodes Scholarship in molecular oncology. Following training at Harvard Medical School & BWH, she is board certified in internal medicine, cardiology, and critical care medicine. Dr Bohula studies pharmacologic interventions for cardiometabolic diseases, such as hyperlipidaemia, obesity and atherosclerotic cardiovascular disease. Her recent trial involvement includes IMPROVE-IT, FOURIER, CAMELLIA-TIMI 61, and VESALIUS-CV. As a cardiac intensivist, she was involved in creating the Critical Care Cardiology Trials Network, a North American research collaborative of cardiology critical care units (CICU) and helped to lead their inaugural RCT, COVID-PACT, studying the efficacy and safety of antithrombotic therapy in critically-ill COVID-19 patients. She has received multiple awards, including the ACC W. Proctor Harvey Young Teaching Award and the Eugene Braunwald Faculty Award. She is the vice chair of the AHA Acute Care and General Cardiology Council. https://www.3ctmeeting.com/alexandre-mebazaa-1 daily 0.75 2025-04-18 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3bf7965d-585f-4b74-910b-a03c5bbfea2a/AM+Photo+pro+3.jpeg Alexandre Mebazaa - Alexandre Mebazaa Paris, France Professor Mebazaa was appointed by the “UNIVERSITE DE PARIS”, now called “UNIVERSITE PARIS CITE” as vice-dean of the International relations for the Health University of Paris in July 2021 and is also head of the anesthesia and critical care department of the Saint Louis-Lariboisière - Fernand Widal University Hospitals. Since January 2019, he heads the MASCOT (Cardiovascular Markers in Stressed CONdiTions - UMR-S 942) research unit, which is funded by INSERM and the University of Paris. His research interests include mechanisms of contractile impairment during acute heart failure and worldwide studies on biomarkers in acute cardiac insufficiency. He was a member or Chairman of several study steering committees such as SURVIVE, COMPOSE, TRUE-HF, FROG-ICU, Natrium, Strong-HF. He was cited as "most referenced researcher" for 2021. Since 2020 he has been the FHU PROMICE coordinator (Hospital-University Federation) and co-director for the project “Precision medicine for the comprehensive care of seriously ill patients”), the objectives of which are to show that precise phenotyping of patients associated with biophysical models and big data improve decision-making systems in the perioperative period. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/3bf7965d-585f-4b74-910b-a03c5bbfea2a/AM+Photo+pro+3.jpeg Alexandre Mebazaa - Alexandre Mebazaa Paris, France Professor Mebazaa was appointed by the “UNIVERSITE DE PARIS”, now called “UNIVERSITE PARIS CITE” as vice-dean of the International relations for the Health University of Paris in July 2021 and is also head of the anesthesia and critical care department of the Saint Louis-Lariboisière - Fernand Widal University Hospitals. Since January 2019, he heads the MASCOT (Cardiovascular Markers in Stressed CONdiTions - UMR-S 942) research unit, which is funded by INSERM and the University of Paris. His research interests include mechanisms of contractile impairment during acute heart failure and worldwide studies on biomarkers in acute cardiac insufficiency. He was a member or Chairman of several study steering committees such as SURVIVE, COMPOSE, TRUE-HF, FROG-ICU, Natrium, Strong-HF. He was cited as "most referenced researcher" for 2021. Since 2020 he has been the FHU PROMICE coordinator (Hospital-University Federation) and co-director for the project “Precision medicine for the comprehensive care of seriously ill patients”), the objectives of which are to show that precise phenotyping of patients associated with biophysical models and big data improve decision-making systems in the perioperative period. https://www.3ctmeeting.com/pietro-di-santo daily 0.75 2025-04-24 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/9ce70351-6a7c-45a9-bdac-d38d58ff29f3/OHI_web_7003.jpg Pietro di santo - Pietro Di Santo Ottawa, Canda Dr. Pietro Di Santo is an interventional and critical care cardiologist at the University of Ottawa Heart Institute and an assistant professor in the Faculty of Medicine at the University of Ottawa. He earned his medical degree in 2014 from the University of Ottawa, where he also completed his training in internal medicine, adult cardiology, and interventional cardiology. In parallel, he enrolled in the clinician investigator program, initiating his graduate studies. Dr. Di Santo went on to complete a fellowship in critical care medicine and is currently finalizing a PhD in epidemiology at the University of Ottawa’s School of Epidemiology and Public Health. His clinical and research interests focus on out-of-hospital cardiac arrest, cardiogenic shock, and arrhythmias in the cardiac intensive care unit as well as percutaneous coronary interventions, particularly high-risk and complex coronary disease. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/9ce70351-6a7c-45a9-bdac-d38d58ff29f3/OHI_web_7003.jpg Pietro di santo - Pietro Di Santo Ottawa, Canda Dr. Pietro Di Santo is an interventional and critical care cardiologist at the University of Ottawa Heart Institute and an assistant professor in the Faculty of Medicine at the University of Ottawa. He earned his medical degree in 2014 from the University of Ottawa, where he also completed his training in internal medicine, adult cardiology, and interventional cardiology. In parallel, he enrolled in the clinician investigator program, initiating his graduate studies. Dr. Di Santo went on to complete a fellowship in critical care medicine and is currently finalizing a PhD in epidemiology at the University of Ottawa’s School of Epidemiology and Public Health. His clinical and research interests focus on out-of-hospital cardiac arrest, cardiogenic shock, and arrhythmias in the cardiac intensive care unit as well as percutaneous coronary interventions, particularly high-risk and complex coronary disease. https://www.3ctmeeting.com/maciej-kostrubiec-1 daily 0.75 2025-04-25 https://www.3ctmeeting.com/home-copy daily 0.75 2025-05-13 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1619609160046-EESTQFLWRAG3QQ0M7XKP/Mebazaa+2.jpg Home 2 https://www.3ctmeeting.com/holger-thiele-copy daily 0.75 2025-05-13 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/0d6c8bad-efa5-4589-a714-2ab7bc9a2029/sato+photo2019+2.png Naoki Sato - Naoki Sato Kawaguchi, Japan Director of Department of Cardiovasuclar Medicine After completing medical school from Nippon Medical School (NMS) in Tokyo, Japan, Dr.Sato did his residency for two years at NMS and had trained cardiac catheterization and intervention for another three years. He had done basic research regarding heart failure under the direction of Prof. Stephen F. Vatner at Harvard Medical School for 4 years. He had several awards, e.g., AHA Melvin L. Marcus Young Investigator Award in Cardiovascular Integrated Physiology, the Samuel A. Levine award from AHA, Massachusetts affiliate, etc. He was professor of department of cardiovascular medicine and director of intensive care unit in NMS. He conducted many trials and registries, such as the largest acute heart failure registry (ATTEND) in Japan and works as a PI for many HF trials including global trials. His speciality is heart failure. He works as executive director of the Japanese Heart Failure Society and Japanese Society of Intensive Care Medicine. He served as president of the 28th Annual Meeting of the Japanese Heart Failure Society in Omiya, Saitama Prefecture from October 4 to 6, 2024. He will have the 53th annual meeting of the Japanese Society of Intensive Care Medicine from 5 to 7 March, 2026 in Yokohama, Japan. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/0d6c8bad-efa5-4589-a714-2ab7bc9a2029/sato+photo2019+2.png Naoki Sato - Naoki Sato Kawaguchi, Japan Director of Department of Cardiovasuclar Medicine After completing medical school from Nippon Medical School (NMS) in Tokyo, Japan, Dr.Sato did his residency for two years at NMS and had trained cardiac catheterization and intervention for another three years. He had done basic research regarding heart failure under the direction of Prof. Stephen F. Vatner at Harvard Medical School for 4 years. He had several awards, e.g., AHA Melvin L. Marcus Young Investigator Award in Cardiovascular Integrated Physiology, the Samuel A. Levine award from AHA, Massachusetts affiliate, etc. He was professor of department of cardiovascular medicine and director of intensive care unit in NMS. He conducted many trials and registries, such as the largest acute heart failure registry (ATTEND) in Japan and works as a PI for many HF trials including global trials. His speciality is heart failure. He works as executive director of the Japanese Heart Failure Society and Japanese Society of Intensive Care Medicine. He served as president of the 28th Annual Meeting of the Japanese Heart Failure Society in Omiya, Saitama Prefecture from October 4 to 6, 2024. He will have the 53th annual meeting of the Japanese Society of Intensive Care Medicine from 5 to 7 March, 2026 in Yokohama, Japan. https://www.3ctmeeting.com/pietro-di-santo-1 daily 0.75 2025-05-14 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/12b10415-0c0a-4c94-97de-ca2ad7b2b4de/OHI_web_7003.jpg Pietro Di Santo - Pietro Di Santo Ottawa, Canada Dr. Pietro Di Santo is an interventional and critical care cardiologist at the University of Ottawa Heart Institute and an assistant professor in the Faculty of Medicine at the University of Ottawa. He earned his medical degree in 2014 from the University of Ottawa, where he also completed his training in internal medicine, adult cardiology, and interventional cardiology. In parallel, he enrolled in the clinician investigator program, initiating his graduate studies. Dr. Di Santo went on to complete a fellowship in critical care medicine and is currently finalizing a PhD in epidemiology at the University of Ottawa’s School of Epidemiology and Public Health. His clinical and research interests focus on out-of-hospital cardiac arrest, cardiogenic shock, and arrhythmias in the cardiac intensive care unit as well as percutaneous coronary interventions, particularly high-risk and complex coronary disease. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/12b10415-0c0a-4c94-97de-ca2ad7b2b4de/OHI_web_7003.jpg Pietro Di Santo - Pietro Di Santo Ottawa, Canada Dr. Pietro Di Santo is an interventional and critical care cardiologist at the University of Ottawa Heart Institute and an assistant professor in the Faculty of Medicine at the University of Ottawa. He earned his medical degree in 2014 from the University of Ottawa, where he also completed his training in internal medicine, adult cardiology, and interventional cardiology. In parallel, he enrolled in the clinician investigator program, initiating his graduate studies. Dr. Di Santo went on to complete a fellowship in critical care medicine and is currently finalizing a PhD in epidemiology at the University of Ottawa’s School of Epidemiology and Public Health. His clinical and research interests focus on out-of-hospital cardiac arrest, cardiogenic shock, and arrhythmias in the cardiac intensive care unit as well as percutaneous coronary interventions, particularly high-risk and complex coronary disease. https://www.3ctmeeting.com/mandeep-mehra daily 0.75 2025-05-14 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/5d78d1d6-4831-4691-b94b-42ebec2c7072/MRM+headshot+94KB.jpg Mandeep Mehra - Mandeep Mehra Harvard, United States Professor (Dr.) Mehra holds the William Harvey Chair in Advanced Cardiovascular Medicine, Executive Director of the Center for Advanced Heart Disease at Brigham and Women’s Hospital and is a Professor of Medicine at Harvard Medical School. and was the founding Medical Director of the Heart and Vascular Center at Brigham and Women’s Hospital (2013-2019). He served as Editor-in-Chief of The Journal of Heart and Lung Transplantation from 2010 to 2020, and President of the International Society of Heart and Lung Transplantation (ISHLT) in 2008 and Heart Failure Society of America (HFSA) in 2016. He has also been conferred an Honorary Master’s degree from Harvard University, earned a certificate in Executive Leadership from Harvard Business School and a Master of Science in Health Economics and Management from the London School of Economics (as a Braunwald Scholar). In 2024, he was received the Lifetime Achievement Award from the HFSA. His scholarly work focuses on Advanced Heart Failure, with practice defining contributions to the fields of cardiac transplantation and mechanical circulatory support. Dr. Mehra is regarded as one of the leading global experts in these areas, with his groundbreaking research, innovations, and contributions to practice guidelines helping to shape the future of advanced heart failure care. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/5d78d1d6-4831-4691-b94b-42ebec2c7072/MRM+headshot+94KB.jpg Mandeep Mehra - Mandeep Mehra Harvard, United States Professor (Dr.) Mehra holds the William Harvey Chair in Advanced Cardiovascular Medicine, Executive Director of the Center for Advanced Heart Disease at Brigham and Women’s Hospital and is a Professor of Medicine at Harvard Medical School. and was the founding Medical Director of the Heart and Vascular Center at Brigham and Women’s Hospital (2013-2019). He served as Editor-in-Chief of The Journal of Heart and Lung Transplantation from 2010 to 2020, and President of the International Society of Heart and Lung Transplantation (ISHLT) in 2008 and Heart Failure Society of America (HFSA) in 2016. He has also been conferred an Honorary Master’s degree from Harvard University, earned a certificate in Executive Leadership from Harvard Business School and a Master of Science in Health Economics and Management from the London School of Economics (as a Braunwald Scholar). In 2024, he was received the Lifetime Achievement Award from the HFSA. His scholarly work focuses on Advanced Heart Failure, with practice defining contributions to the fields of cardiac transplantation and mechanical circulatory support. Dr. Mehra is regarded as one of the leading global experts in these areas, with his groundbreaking research, innovations, and contributions to practice guidelines helping to shape the future of advanced heart failure care. https://www.3ctmeeting.com/thomas-hanff daily 0.75 2025-05-14 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/d0fad3ba-c194-4a26-aa7c-506f7be864e7/Hanff+Headshot+for+journals.jpg Thomas Hanff - Thomas Hanff Salt Lake City, Canada Tom Hanff, MD, MSCE, MPH is a heart transplant cardiologist and Assistant Professor at the University of Utah School of Medicine and the Salt Lake City VA hospital. He specializes in the care of patients with advanced heart failure and cardiogenic shock. He received his medical degree and Master of Public Health Degree from Johns Hopkins and completed Internal Medicine Residency and completed his Cardiology Fellowship, Advanced Heart Failure and Transplant Cardiology Fellowship, and a Master of Science in Clinical Epidemiology Degree at the University of Pennsylvania. He is currently investigating the pathophysiologic mechanisms leading to acute kidney injury and death from cardiogenic shock and the impact of mechanical circulatory support on these mechanisms. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/d0fad3ba-c194-4a26-aa7c-506f7be864e7/Hanff+Headshot+for+journals.jpg Thomas Hanff - Thomas Hanff Salt Lake City, Canada Tom Hanff, MD, MSCE, MPH is a heart transplant cardiologist and Assistant Professor at the University of Utah School of Medicine and the Salt Lake City VA hospital. He specializes in the care of patients with advanced heart failure and cardiogenic shock. He received his medical degree and Master of Public Health Degree from Johns Hopkins and completed Internal Medicine Residency and completed his Cardiology Fellowship, Advanced Heart Failure and Transplant Cardiology Fellowship, and a Master of Science in Clinical Epidemiology Degree at the University of Pennsylvania. He is currently investigating the pathophysiologic mechanisms leading to acute kidney injury and death from cardiogenic shock and the impact of mechanical circulatory support on these mechanisms. https://www.3ctmeeting.com/ross-thomson daily 0.75 2025-05-14 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/10530446-370e-4071-a168-8ac25d18f105/Ross+Thomson+EACVI+low+res.jpg Ross Thomson - Ross Thomson London, United Kingom Ross Thomson is an academic cardiologist at St Bartholomew’s Hospital and Queen Mary, University of London. He is a subspecialty fellow in advanced heart failure and cardiac transplantation, and is currently undertaking a PhD. He leads a prospective cohort study collecting high resolution invasive haemodynamics and serial echocardiography to deeply phenotype patients with cardiogenic shock, and is coinvestigator on a multicentre study to validate AI-enabled ECG as a screening and monitoring tool for heart failure. Alongside his clinical and research commitments Dr Thomson founded and now leads the British Heart Foundation’s research translation and commercialisation programme, CardioStars. He sits on the Guidelines & Clinical Practice committee of the British Cardiovascular Society and is the Senior Editor for Journal Watch at the International Society for Heart and Lung Transplantation. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/10530446-370e-4071-a168-8ac25d18f105/Ross+Thomson+EACVI+low+res.jpg Ross Thomson - Ross Thomson London, United Kingom Ross Thomson is an academic cardiologist at St Bartholomew’s Hospital and Queen Mary, University of London. He is a subspecialty fellow in advanced heart failure and cardiac transplantation, and is currently undertaking a PhD. He leads a prospective cohort study collecting high resolution invasive haemodynamics and serial echocardiography to deeply phenotype patients with cardiogenic shock, and is coinvestigator on a multicentre study to validate AI-enabled ECG as a screening and monitoring tool for heart failure. Alongside his clinical and research commitments Dr Thomson founded and now leads the British Heart Foundation’s research translation and commercialisation programme, CardioStars. He sits on the Guidelines & Clinical Practice committee of the British Cardiovascular Society and is the Senior Editor for Journal Watch at the International Society for Heart and Lung Transplantation. https://www.3ctmeeting.com/rafael-kramann daily 0.75 2025-05-14 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/85c291ea-81e4-4e17-99e6-f7e1f392455c/20230131_+Rafael+Kramann_%28UF5659%29.jpg Rafael Kramann - Rafael Kramann Aachen, Deutschland Rafael Kramann, MD, PhD, is Professor and Chair of Medicine 2 (Nephrology, Rheumatology, Immunology, Hypertension) at RWTH Aachen University, Germany, and Founding Director of the Center of Phase Transition in Chronic Disease. He also leads the Laboratory of Translational Kidney and Cardiovascular Research at Erasmus MC, Rotterdam, and holds adjunct positions at MDI Biological Laboratory and the Jackson Laboratory in Maine. His research focuses on chronic kidney disease, cardiovascular disease, and fibrosis using advanced genetic, single-cell, and systems biology tools. He has founded two biotech companies developing novel fibrosis therapies. Dr. Kramann has published over 200 papers and received various major national and international awards. He is a member of the American Society of Clinical Investigation and recipient of various ERC and NWO grants. He also serves as PI at the British Heart Foundation Centre of Excellence, University of Edinburgh where he holds a honorary professorship. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/85c291ea-81e4-4e17-99e6-f7e1f392455c/20230131_+Rafael+Kramann_%28UF5659%29.jpg Rafael Kramann - Rafael Kramann Aachen, Deutschland Rafael Kramann, MD, PhD, is Professor and Chair of Medicine 2 (Nephrology, Rheumatology, Immunology, Hypertension) at RWTH Aachen University, Germany, and Founding Director of the Center of Phase Transition in Chronic Disease. He also leads the Laboratory of Translational Kidney and Cardiovascular Research at Erasmus MC, Rotterdam, and holds adjunct positions at MDI Biological Laboratory and the Jackson Laboratory in Maine. His research focuses on chronic kidney disease, cardiovascular disease, and fibrosis using advanced genetic, single-cell, and systems biology tools. He has founded two biotech companies developing novel fibrosis therapies. Dr. Kramann has published over 200 papers and received various major national and international awards. He is a member of the American Society of Clinical Investigation and recipient of various ERC and NWO grants. He also serves as PI at the British Heart Foundation Centre of Excellence, University of Edinburgh where he holds a honorary professorship. https://www.3ctmeeting.com/deborah-gorth daily 0.75 2025-05-14 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/bc3627d1-0cf2-4bcc-bb5f-59b45bcf4f69/Photo%2C+Gorth%2C+Deborah%2C+Internal+Medicine.jpg Deborah Gorth - Deborah Gorth Philadelphia, United States Deborah Gorth is a physician-scientist. She received a biomedical engineering degree from Brown University before earning her MD/PhD from Thomas Jefferson University. During her Internal Medicine residency at Temple University Hospital, Deborah became interested in critical care cardiology and pulmonary hypertension. She is currently a Fulbright Research Scholar working with Professor Marc Humbert’s group at Université Paris-Saclay studying the pathophysiology of pulmonary hypertension before returning to America for cardiology fellowship. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/bc3627d1-0cf2-4bcc-bb5f-59b45bcf4f69/Photo%2C+Gorth%2C+Deborah%2C+Internal+Medicine.jpg Deborah Gorth - Deborah Gorth Philadelphia, United States Deborah Gorth is a physician-scientist. She received a biomedical engineering degree from Brown University before earning her MD/PhD from Thomas Jefferson University. During her Internal Medicine residency at Temple University Hospital, Deborah became interested in critical care cardiology and pulmonary hypertension. She is currently a Fulbright Research Scholar working with Professor Marc Humbert’s group at Université Paris-Saclay studying the pathophysiology of pulmonary hypertension before returning to America for cardiology fellowship. https://www.3ctmeeting.com/taylor-thompson daily 0.75 2025-05-14 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/ecc48e64-806a-4b96-ae41-9edd699520e2/Taylor+Thompson.jpg Taylor Thompson - Taylor Thompson Boston, United States Dr. Thompson is a Professor of Medicine at Harvard Medical School. He is the former director of the Medical Intensive Care Unit at the Massachusetts General Hospital and an accomplished clinician and educator. For over three decades, he served as the Medical Director of the National Heart, Blood, and Lung-funded ARDS Network and PETAL Clinical Coordinating Centers overseeing the design, conduct, and interpretation of many pivotal clinical trials for patients with ARDS or sepsis. He has chaired or currently chairs a number of DSMBs for investigator-initiated and/or industry trials and is an internationally recognized as an expert critical care Clinical Trialist. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/ecc48e64-806a-4b96-ae41-9edd699520e2/Taylor+Thompson.jpg Taylor Thompson - Taylor Thompson Boston, United States Dr. Thompson is a Professor of Medicine at Harvard Medical School. He is the former director of the Medical Intensive Care Unit at the Massachusetts General Hospital and an accomplished clinician and educator. For over three decades, he served as the Medical Director of the National Heart, Blood, and Lung-funded ARDS Network and PETAL Clinical Coordinating Centers overseeing the design, conduct, and interpretation of many pivotal clinical trials for patients with ARDS or sepsis. He has chaired or currently chairs a number of DSMBs for investigator-initiated and/or industry trials and is an internationally recognized as an expert critical care Clinical Trialist. https://www.3ctmeeting.com/rebecca-matthew daily 0.75 2025-05-16 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/05406f9e-a73d-40aa-bed3-349dc8cde927/Rebecca+Mathew-9.jpg Rebecca Matthew - Rebecca Mathew Ottawa, Canada Dr. Rebecca Mathew is a cardiologist and critical care medicine specialist at the University of Ottawa Heart Institute (UOHI). She is also appointed as an assistant professor in the Faculty of Medicine at the University of Ottawa. Dr. Mathew earned her medical degree at the Northern Ontario School of Medicine in 2012. She completed her residency in internal medicine at McMaster University in 2015. She subsequently completed a fellowship in adult cardiology at the UOHI in 2019. She pursued a fellowship in critical care medicine at the University of Ottawa, graduating in 2021. As a clinician investigator, Dr. Mathew’s clinical and research interests include all aspects of acute cardiac critical care, treatment strategies in cardiogenic shock and the long-term management and prognosis of survivors of cardiac critical illness. Her academic interest is focused on resident education in the critical care setting. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/05406f9e-a73d-40aa-bed3-349dc8cde927/Rebecca+Mathew-9.jpg Rebecca Matthew - Rebecca Mathew Ottawa, Canada Dr. Rebecca Mathew is a cardiologist and critical care medicine specialist at the University of Ottawa Heart Institute (UOHI). She is also appointed as an assistant professor in the Faculty of Medicine at the University of Ottawa. Dr. Mathew earned her medical degree at the Northern Ontario School of Medicine in 2012. She completed her residency in internal medicine at McMaster University in 2015. She subsequently completed a fellowship in adult cardiology at the UOHI in 2019. She pursued a fellowship in critical care medicine at the University of Ottawa, graduating in 2021. As a clinician investigator, Dr. Mathew’s clinical and research interests include all aspects of acute cardiac critical care, treatment strategies in cardiogenic shock and the long-term management and prognosis of survivors of cardiac critical illness. Her academic interest is focused on resident education in the critical care setting. https://www.3ctmeeting.com/home-copy-ancienne daily 0.75 2025-05-26 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1619609160046-EESTQFLWRAG3QQ0M7XKP/Mebazaa+2.jpg Home (Copy) ancienne 2024 https://www.3ctmeeting.com/scientific-committee-copy daily 0.75 2025-05-27 https://www.3ctmeeting.com/scientific-committee-copy-1 daily 0.75 2025-05-27 https://www.3ctmeeting.com/program-at-a-glance-copy daily 0.75 2025-05-27 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/86ca9c4d-7776-408b-a44a-dd6501333b5d/VF+3CT++2025+program+.png Program at a glance (Copy) - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/86ca9c4d-7776-408b-a44a-dd6501333b5d/VF+3CT++2025+program+.png Program at a glance (Copy) - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.3ctmeeting.com/initial-track-copy daily 0.75 2025-05-27 https://www.3ctmeeting.com/literature daily 0.75 2026-02-09 https://www.3ctmeeting.com/home-copy-1 daily 0.75 2025-07-02 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1619609160046-EESTQFLWRAG3QQ0M7XKP/Mebazaa+2.jpg Home (Copy) https://www.3ctmeeting.com/home-copy-2 daily 0.75 2025-07-10 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1619609160046-EESTQFLWRAG3QQ0M7XKP/Mebazaa+2.jpg Home (Copy) https://www.3ctmeeting.com/landing daily 0.75 2025-07-17 https://www.3ctmeeting.com/manreet-kanwar daily 0.75 2026-02-09 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/88b0b24e-1b98-4f75-bdcd-8e6e11d55831/1751364433160.jpg Manreet Kanwar - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.3ctmeeting.com/2026-preliminary-program-2 daily 0.75 2026-02-11 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622228079-1O51YXZ52EYGNIX6GWMC/1.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622227175-8ER2Y44ZSGJ4CZAPLSG2/5.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622228405-XY720271W55MAUXUSNE8/6.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622229325-4BBLNG70CXSQWYZOP9Q6/8.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622229604-04J0SS79WJWCI8UILEF2/9.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622230571-IGMUX75XQ3IDNK2ZTUXP/10.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622230772-KIZMTJU5LBADL39G2J1N/11.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622231736-MYDA7HT5MQD7ZHOO3WDE/12.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770623741159-U19A4QUUFEE2K0L34N8N/3CT+2026+Preliminary+Scientific+Program+%282%29.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622232882-QJIMESAEGDBRLM74A3G3/14.png 2026 Preliminary Program (Copy) https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/1770622233022-KXE7HJVRXBKQ8X0R8SHN/15.png 2026 Preliminary Program (Copy) https://www.3ctmeeting.com/david-morrow daily 0.75 2026-02-20 https://images.squarespace-cdn.com/content/v1/5bbc7fb58d97402a0b1c87ea/22fd603b-d787-47c5-a535-f99dee3ba880/Morrow+David.jpg David Morrow - Make it stand out Whatever it is, the way you tell your story online can make all the difference.